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ZUSAMMENFASSUNG 
 
Die verschiedenen Isoformen der Protein stellt offenbar einen zusätzlichen   Mechanismus zur 
Regulation der Aktivität und Funktion Kinase C (PKC) Superfamilie sind gemeinsame 
Signalproteine sowohl von G Protein-gekoppelten Rezeptoren (GPCRs) als auch von 
Rezeptortyrosinkinasen. Damit erhalten sie eine Schlüsselfunktion im cross-talk dieser 
Rezeptoren und im zellulären Netzwerk der Signaltransduktion. Die Aktivierung verschiedener 
PKC Isoformen vermittelt unterschiedliche zelluläre Reaktionen, wie z. B. Zellwachstum, 
subzelluläre Lokalisierung, Lipid-Protein oder Protein-Protein-Interaktionen. Wie kürzlich 
festgestellt wurde können verschieden PKC Isoformen  durch unterschiedliche  Stimuli auch an 
Tyrosinresten phosphoryliert werden. Dies stellt einen weiteren Mechanismus zur Regulation der     
Aktivität und Funktion von PKCs dar.    


Ziel der vorliegenden Arbeit ist die Untersuchung der Tyrosin-Phosphorylierung von PKC 
Isoformen nach Stimulierung des EGF Rezeoptors (EGFR).  Bisher wurde in der Literatur 
lediglich über eine EGFR-vermittelte Tyrosin-Phosphorylierung und dadurch Inaktivierung von 
PKCδ berichtet, die eine Rolle bei der neoplastischen Transformation von Keratinozyten zu 
spielen scheint (Denning et al., 1996). In unserem zellulären Modell COS-7 Zelle konnten wir 
die Tyrosin-Phosphorylierung vonPKCδ durch EGF reproduzieren und fanden zusätzlich eine 
EGF-induzierte Tyrosin-Phosphorylierung der n(novel) PKCε und der a(atypical) PKCζ. Die 
weiteren Untersuchungen dieser Arbeit konzentrierten sich ausschließlich auf die aPKCζ. Für 
PKCζ ist eine Beteiligung an der Regulation von  proliferativen, apoptotischen als auch anti-
apoptotischen Prozessen bekannt. Weiterhin wurde beschrieben, dass PKCζ mit Hilfe von  
Adaptorproteinen an verschiedene Rezeptorkomplexe (z.B. TNFR, IL-IR, IR, NGFR) oder K+-
Kanäle rekrutiert werden kann.  
 
Wir konnten eine schnelle und Konzentrations-abhängige Tyrosin-Phosphorylierung von PKCζ 
durch den Wachstumsfaktor EGF nachweisen. Diese ist abhängig von den Tyrosinkinase-
Aktivitäten des EGFR und der zytosolischen Tyrosinkinase Src, der Src-spezifischen 
Phosphorylierung des EGFR-Tyrosinrestes 845, und der Aktivität einer PI-3 Kinase. Wir fanden 
weiterhin eine PKC-vermittelte Threonin-Phosphorlyierung  des EGFR und eine reverse 
Korrelation von PKC-Aktivität und deren Tyrosin-Phosphorylierung. Dies deutet darauf hin, 
dass die EGFR-vermittelte Regulation der PKCζ durch die wechselseitige Phosphorylierung von 
EGFR und PKCζ kontrolliert wird.  
 
Nach Stimulierung des EGFR transloziert die PKCζ an die Zellmembran und wird dort 
katalytisch aktiviert. Mittels Ko-Immunopräzipitierung und Ko-Lokalisierung können  wir 
zeigen, dass die EGFR-vermittelte Tyrosin-Phosphorylierung und dadurch Aktivierung der 
PKCζ die physikalische Assoziation beider Proteine einschließt. Wir können ferner nachweisen, 
dass auch eine Transaktivierung des EGFR über G Protein-gekoppelte Rezeptoren, wie z.B. den 
LPAR und den beta2-AR, die Interaktion zwischen EGFR und PKCζ sowie deren Tyrosin-
Phosphorylierung und Aktivierung auslösen kann. 
 
Durch gezielte Mutagenese können wir zeigen, dass der Tyrosinrest 417 von PKCζ  eine 
Schlüsselstellung bei der EGFR-vermittelten Aktivierung der PKCζ besitzt. Tyrosin 417 
befindet sich in unmittelbarer Nähe von Threonin 410  im Aktivierungsloop  der PKCζ. Dessen 
Phosphorylierung durch die Proteinkinase PDK-1 ist ein essentieller Schritt der  katalytischen 
Aktivierung von PKCζ. Substitution sowohl von Thr 410 durch Ala als auch von Tyr 417 durch 
Phe führt dazu, dass PKCζ nicht mehr durch EGF aktiviert werden kann. Wir postulieren 
deshalb, dass die Phosphorylierung beider benachbarter Aminosäuren sowohl für die basale 
Aktivität als auch die EGF-induzierte Aktivierung der PKCζ notwendig ist. 
ERK1/2, NF-κB und PKB/Akt wurden als Targetproteine der PKCζ und der Signaltransduktion 
des EGFR identifiziert. Überexpression von PKCζ resultiert in einer Erhöhung der EGF-
induzierten Aktvierung von ERK1/2 und der Phosphorylierung von IκBα. Dies ist ein 
essentieller Zwischenschritt der Aktivierung   von NF-κB. Beide Effekte treten nicht auf, wenn 
die Mutante PKCζ-Y147F überexpremiert wird. Im Gegensatz dazu wird die Phosphorylierung 
und dadurch Aktivierung von PKB/Akt nicht signifikant durch die Überexpression von Wildtyp-
PKCζ beeinflusst, bei Überexpression der PKCζ-Y417F Mutante jedoch signifikant reduziert. 
Daraus kann geschlussfolgert werden, dass die EGFR-vermittelte Tyrosin-Phosphorylierung von 
PKCζ entweder durch die katalytische Aktivierung der PKCζ oder durch die Generierung von 
Phosphotyrosin-Bindungsstellen in die Regulation  von Signalwegen der Proliferation und des 
zellulären Überlebens, wie z.B. die Aktivierung von ERK1/2, NF-κB und PKB/Akt 
eingebunden ist. Diese Hypothese wird unterstützt durch unsere Befunde, dass die basale DNA 
Synthese durch die Überexpression von PKCζ Wildtyp, nicht aber durch Überexpression der  
PKCζ-Y417F Mutante erhöht wird. 
 
Die hier vorgestellten Ergebnisse identifizieren die PKCζ als neuen Effektor des EGFR. Ihre 
Aktivierung durch Tyrosinphosphorylierung setzt die physikalische Assoziation mit dem EGFR-
Signalkomplex voraus und ist abhängig von der cytosolische Tyrosinkinase Src sowie der Src-
spezifischen Phosphorylierungsstelle Y845 des EGFR. Damit wurde auch ein bisher 
unbekanntes Beispiel für den Synergismus von Src und EGFR bei der Regulation des 
Zellwachstums gefunden. Wir konnten zeigen, dass die EGFR-vermittelte Aktivierung der 
PKCζ nicht nur den bisher bekannten Aktivierungsmechanismus der PDK-1-abhängigen 
Phosphorylierung an Threonin 410 im Aktivierungsloop  einschließt, sondern zusätzlich der 
Tyrosinrest 417 in unmittelbarer Nähe des Aktivierungsloops phosphoryliert werden muß. Diese 
Tyrosinphosphorylierung der PKCζ ist notwendig für deren proliferative und anti-apoptotische 
Aktivitäten.   
SUMMARY 
 
Protein kinase C (PKC) family of serine/threonine protein kinases represents a key mediator 
of a variety of signalling pathways, including those of G protein-coupled receptors (GPCRs), 
receptor tyrosine kinases (RTKs) and their cross talk.  Activation of distinct PKC isoforms is 
implicated in diverse cellular responses such as proliferation, cell cycle control, differentiation, 
tumorigenesis, cell migration, survival and apoptosis. PKC activity and function are highly 
regulated by serine/threonine phosphorylation, subcellular targeting, and lipid-protein and 
protein-protein interactions. Recently, tyrosine phosphorylation of several PKC isoforms in 
response to various stimuli has been identified as an additional mechanism to regulate PKC 
activity and function.  
The current work was aimed on investigation of the tyrosine phosphorylation of PKC 
isoforms upon EGFR stimulation. So far, EGFR-mediated tyrosine phosphorylation and 
inactivation of PKCδ has been reported as an important element of the neoplastic transformation 
in keratinocytes (Denning et al., 1996). We identified that in addition to PKCδ PKCε and PKCζ 
are also tyrosine phosphorylated in response to EGF stimulation in COS-7 cells. This work is 
focused on EGFR-mediated tyrosine phosphorylation of PKCζ. Protein kinase C zeta is an 
atypical PKC, which is involved in proliferative and pro-survival as well as anti-survival 
signalling and is recruited via adaptor proteins to many receptor complexes (TNFR, IL-1R, IR, 
NGFR) and to the K+ channels. 
The rapid tyrosine phosphorylation of PKCζ downstream of EGFR was found to be strongly 
dependent on EGFR and Src tyrosine kinase activities, on Src-phosphorylation site of EGFR 
tyrosine 845, and partly dependent on PI3K activity. We observed threonine phosphorylation of 
EGFR upon stimulation and a reverse correlation between PKCζ activity state and its level of 
tyrosine phosphorylation. This indicates indirectly that reciprocal phosphorylation between 
EGFR and PKCζ might control EGFR-mediated modification of PKCζ. 
In response to EGFR stimulation PKCζ translocates to the plasma membrane and is 
catalytically activated. Using co-immunoprecipitation and co-localization studies we identified 
that EGFR-mediated tyrosine phosphorylation and activation of PKCζ involves physical 
association of PKCζ with EGFR. Furthermore, EGFR transactivation upon stimulation of 
GPCRs (LPAR and β2AR) led also to tyrosine phosphorylation and activation of PKCζ 
accompanied by interaction of PKCζ with the EGFR.  
We identified tyrosine 417 of PKCζ as one major EGFR-dependent phosphorylation site, 
critically implicated in EGFR-mediated activation of PKCζ. Tyrosine 417 is located in the 
vicinity of threonine 410 at the activation loop of PKCζ, whose phosphorylation by PDK-1 is 
known to be necessary for PKCζ catalytic activation. Substitution of either threonine 410 to 
alanine or tyrosine 417 to phenylalanine renders PKCζ unresponsive to activation by EGF. Thus, 
both threonine phosphorylation at the activation loop and tyrosine phosphorylation in its vicinity 
are required for the basal activity and for EGFR-mediated catalytic activation of PKCζ.  
ERK1/2, NF-κB and PKB/Akt activation were identified as targets of PKCζ in EGFR 
downstream signalling. Overexpression of PKCζ wild type caused increase in EGF-induced 
ERK1/2 activity and in IκBα phosphorylation, which is a prerequisite for NF-κB activation. 
Both effects are lost upon expression of PKCζ Y417F. On the other hand, PKB/Akt 
phosphorylation indicative for its activation- was not significantly affected by overexpression of 
PKCζ but is significantly reduced upon expression of PKCζ Y417F. Thus, EGFR-mediated 
tyrosine phosphorylation of PKCζ is implicated either through PKCζ catalytic activation or via 
creation of phosphotyrosine-binding sites in proliferative and pro-survival signalling 
downstream of EGFR through Erk1/2, NF-κB and PKB/Akt activation. Supporting evidence that 
PKCζ pro-proliferative role is provided by its tyrosine phosphorylation was the increased basal 
DNA synthesis upon overexpression of PKCζ wild type, but not of PKCζ Y417F.   
Taken together, we identified PKCζ tyrosine phosphorylation upon EGFR stimulation as a 
novel effector of the synergism between EGFR and Src in the regulation of cell proliferation and 
survival. Moreover, physical association between EGFR and PKCζ has been identified. EGFR-
mediated activation of PKCζ within the EGFR signalling complex involves not only PDK1-
dependent phosphorylation of threonine 410 at the activation loop, but also requires 
phosphorylation of tyrosine 417 in activation loop vicinity. PKCζ tyrosine phosphorylation is 
necessary for its pro-proliferative and pro-survival function. 
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1. INTRODUCTION 
 
Plasma membrane-spanning receptors receive extracellular signals and transmit them into 
specific cellular responses through activation of several signalling cascades. Both receptor 
tyrosine kinases (RTK) as well as G protein-coupled receptors (GPCRs) can activate the 
extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) cascade, 
composed of three sequentially activated by phosphorylation kinases and thereby induce cell 
proliferation. Individual signalling pathways do not function in isolation but are interconnected 
into cellular networks and their extensive cross talk may result either in signal integration and 
thereby amplification /attenuation or signal diversification. The complex interactions between 
GPCR and RTK signalling pathways towards ERK/ MAPK activation are example for such a 
cross talk, which is implicated in normal cellular as well as in pathophysiological processes (e.g. 
cancer, cardiac hypertrophy and cystic fibrosis). In addition to the generation of second 
messengers intracellular signal transduction is mediated by reversible regulation of protein 
function by phosphorylation on serine, threonine and tyrosine residues. Protein phosphorylation 
can control the enzymatic activity, the protein-protein interactions, subcellular localization and 
susceptibility for protease degradation. Members of protein kinase C (PKC) family of 
serine/threonine protein kinases are involved in both GPCR and RTK signalling. PKC regulation 
by tyrosine phosphorylation might contribute to the cross talk mechanisms operating between 
GPCRs and RTKs. 
  
1.1. Epidermal growth factor receptor (EGFR) signalling 
 
RTKs are family of membrane receptors with intrinsic tyrosine kinase activity that transmit 
signals promoting cell proliferation, differentiation, migration and modulation of apoptosis. 
Epidermal growth factor receptor (EGFR, ErbB1, HER1) as a prototypical RTK represents a 
170kDa polypeptide consisting of an extracellular ligand-binding domain, a single 
transmembrane domain and an intracellular domain, harboring the conserved tyrosine kinase 
subdomain. Eight EGFR ligands are described so far-epidermal growth factor (EGF), heparin-
binding epidermal growth factor (HB-EGF), amphiregulin, transforming growth factor alpha 
(TGFα), betacellulin, epiregulin, epigen and crypto (Fischer et al., 2003). Ligand binding to the 
EGFR extracellular domain promotes dimerization of two receptor molecules, activation of 
intrinsic tyrosine kinase activity and subsequent autophosphorylation in trans of set of tyrosine 
residues residing in the intracellular part of the receptor (Schlessinger, 2000) (Figure 1.1.). 
Thereby docking sites for enzymes and adaptor molecules containing SH2 and PTB domains are 
created and a set of signalling pathways is activated (Figure 1.2.). One of the major pathways 
activated downstream of EGFR is the ERK/MAPK cascade initiated by binding of the adaptor 
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protein Grb2 to the activated receptor directly or indirectly (via Shc) and translocation of 
guanine nucleotide exchange factor Sos close to Ras at the plasma membrane. The active GTP-
bound Ras activates Raf, which, in turn, phosphorylates and activates MEK (MAPK kinase). 
MEK phosphorylates MAPK (ERK) on Thr and Tyr residues at the activation loop leading to its 
activation. Activated MAPK phosphorylates multiple cytoplasmic substrates and translocates to 
the nucleus where it phosphorylates and activates transcription factors. 
 
 
 
 
 
 
Figure 1.1. Binding of the docking 
proteins to the specific phosphotyrosine 
residue in the cytoplasmic part of the 
activated EGFR receptor. Presented are 
the autophosphorylation sites (in black) as 
well as Src-phosphorylation sites (in blue). 
Shown are the respective downstream 
signalling cascades and pathways involved 
in receptor internalization and degradation. 
Adapted from Cell Signaling catalog, 2003-
2004. 
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Phospholipase C gamma (PLCγ) binds directly to the activated receptor and is activated by 
tyrosine phosphorylation.  Activated PLCγ hydrolyses PtdIns(4,5)P2 and form two second 
messengers, diacylglycerol (DAG), a potent activator of protein kinase C (PKC) and 
Ins(1,4,5)P3, which stimulates release of intracellular Ca2+. Phosphoinositide 3-kinase (PI3K) is 
activated upon binding of the regulatory subunit p85 to the adaptor protein Gab1 and leads to 
generation of second messengers PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (PIP3), thereby mediating 
membrane translocation and activation via  PDK1 of pro-survival kinase PKB /Akt.  STATs, 
JNK and BMK1/ERK5 are also activated downstream of EGFR activation (Kloth et al., 2003; 
Logan et al., 1997; Kato et al., 1998). EGFR activity is under tight autoinhibitory control via 
recruitment of protein-tyrosine phosphatases (PTPs) and dephosphorylation of regulatory 
phospho-tyrosine residues, process that is counteracted by receptor-induced H2O2 generation and 
PTP inactivation (Oestman and Boehmer, 2001). PKC phosphorylates EGFR in the 
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juxtamembrane region leading to receptor desensitization (Cochet et al., 1984). Attenuation and 
/or termination of EGFR signalling also involve either endocytosis of the receptor and its 
lysosomal degradation mediated by Eps or proteosomal degradation mediated by Cbl –
dependent ubiquitination (Liebmann and Boehmer, 2000). Recently, considerable evidence that 
EGFR continues to signal in the endosomal compartment has been presented (Hough et al., 
2002). 
 
 
 
 
 
Figure 1.2. Signalling 
pathways activated by 
EGFR. Shown is the 
activation of MAPK, 
JNK, PI3K/PKB, PLCγ 
ERK5, STAT and the 
pathway leading to 
hydrogen peroxide 
generation. Adapted from 
Schlessinger, 2000.  
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1.2. Cross talk between G-protein coupled receptors (GPCRs) and receptor tyrosine 
kinases (RTKs) 
 
GPCR family of seven-transmembrane domain receptors transduces a huge variety of 
extracellular signals via Gα and Gβγ subunits of heterotrimeric G-proteins to several effectors 
like adenylate cyclase (AC), PLCβ, PI3K, PKC, PLD, PLA2, Ca2+ and K+ channels (Liebmann 
and Boehmer, 2000). In addition to their involvement in many tissue-specific, competely 
differentiated cell functions GPCRs can elicit mitogenic responses as well via activation of 
ERK/MAPK cascade, which is originally employed in the RTK mitogenic signalling (Gutkind, 
1998). Diverse pathways link GPCR signalling to ERK/MAPK activation (Figure 1.3.). GPCR-
induced RTK transactivation might involve stimulation of membrane-bound metalloproteinases 
(MP), which, in turn, induce extracellular release of EGF-like ligands from their latent, plasma 
membrane-spanning precursors as well as pathways that do not involve EGF-like ligand release. 
Moreover, GPCR-mediated activation of the ERK/MAPK cascade can take place by a number 
of alternative mechanisms independently of RTK activation (Wetzker and Boehmer, 2003). 
RTKs can also modulate the activity of signalling pathways, traditionally thought to be 
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controlled exclusively by GPCRs – for example AC activation upon Gαs activation induced by 
EGFR (Poppleton et al., 1996). Many aspects of the cross talk between GPCR and RTK involve 
tyrosine phosphorylation: GPCR-induced tyrosine phosphorylation of RTKs (transactivation), 
GPCR- and RTK-induced tyrosine phopshorylation of Gα subunits, homologous (ligand-
induced), and heterologous (RTK-induced) tyrosine phosphorylation of GPCRs (Liebmann and 
Boehmer, 2000). For example, EGFR-induced tyrosine phosphorylation of Gαs leads to the loss 
of its susceptibility to GPCRs (Liebmann et al., 1996). PKC isoforms are activated downstream 
of both GPCRs and RTKs via classical DAG-dependent pathway through activation of PLCβ/γ 
and PLD or DAG-independent via PI3K activation.  
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Figure 1.3. Pathways 
that couple GPCR 
signalling to RTK and 
ERK/MAPK activation. 
Presented are the RTK 
transactivation-involving 
pathways-with (1) or 
without EGF-like ligand 
release (2) as well as 
RTK-independent 
activation of ERK/MAPK 
by GPCRs (3) and the 
intermediate signalling 
proteins. Adapted from 
Wetzker and Boehmer, 
2003. 
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A role of PKC isoforms in EGFR transactivation upstream (Shah and Catt, 2002) or downstream 
of the receptor (Buteau et al., 2003) as well as in EGFR-independent ERK/MAPK activation by 
GPCRs (Adomeit et al., 1999) has been demonstrated. Tyrosine phosphorylation of PKC 
isoforms by RTKs directly stimulated by growth factors or transactivated by GPCRs has been 
suggested to bring about additional level of complexity and functional specificity in cellular 
signalling (Liebmann and Boehmer, 2000).  
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1.3. Protein kinase C –family members, domain structure and regulation 
 
1.3.1. PKC family members and domain structure 
 
PKC family of serine/threonine protein kinases represents a key player in a variety of cellular 
processes including proliferation, differentiation, apoptosis, survival and tumorigenesis.  The 
mammalian protein kinase C family comprises 10 isozymes grouped into three subfamilies 
based on their primary structure and cofactor dependences: conventional or classical PKC (α, 
alternatively spliced βI and βII and γ), novel PKC (δ, ε, η, θ) and atypical PKC (ζ, ι/λ). PKCµ/D 
and ν (PKD) and PKC-related kinases (PRK) are considered as more distantly related to PKC 
family enzymes with some unique features (Figure 1.4.). The activity of classical isoforms 
(cPKCs) is stimulated by cofactors diacylglycerol (DAG), Ca2+and phosphatidylserine (PtdSer). 
Novel PKC isoforms (nPKCs) are Ca2+-independent, but stimulated by DAG and PtdSer, 
whereas atypical PKCs (aPKCs) are Ca2+and DAG unresponsive, but stimulated by PtdSer. The 
single polypeptide chain of all PKC isozymes consists of carboxy-terminal kinase domain and 
amino-terminal regulatory moiety, connected via proteolitically labile ‘hinge’region. Both 
domains contain conserved (C) regions of extended sequence homology and variable (V) 
regions. As a multidomain protein PKC is under acute lipid and protein-mediated 
conformational regulation of interdomain interactions (Newton, 2003). The regulatory moiety 
consists of pseudosubstrate (PS) and two membrane targeting modules- C1 and C2 domains. PS 
resembles the substrate except of harboring alanine at the phosphoacceptor position and 
occupies the substrate-binding cavity of the catalytic domain thereby keeping the enzyme in an 
autoinhibited conformation.  The C1 domain present in all PKC isoforms is a Cys-rich region 
that binds the second messenger of phospholipid metabolism DAG and tumor-promoting 
phorbol esters (PE) and in ligand-bound form confers specific binding to PtdSer in the 
membrane. 
 
 
 
 
 
Figure 1.4.  Protein kinase C 
family  members- domain  
structure and cofactor  
dependency (Newton, 2001).   
 
Rho-binding
PRKs N C
PtdSer  DAG  Ca 2+
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C1 domain of classical and novel PKCs represents a tandem repeat. Atypical PKCs possess only 
one copy of C1 domain termed atypical C1 that does not bind DAG and PE due to compromised 
face of the ligand-binding pocket. C2 domain is found in classical and novel PKCs. The C2 
domain of cPKCs binds to the anionic lipids in the membrane in a Ca2+-dependent manner, 
whereas novel C2 domain does not bind Ca2+ due to the absence of key aspartic acid residues 
involved in coordination of Ca2+. The highly conserved among all ABC kinases (PKA, PKB and 
PKC) catalytic domain (CD) comprises ATP binding (C3) and substrate binding (C4) domains 
PKC phosphorylates substrates on Ser or Thr residues, typically in the context of basic sequence, 
with modest selectivity for specific residues at particular positions. Despite the large number of 
PKC isotypes, substrate promiscuity and the expression of multiple isoforms in the same cell, 
individual PKC isoforms seem to have unique function. Protein kinase C function is regulated by: 
(1) phosphorylation–based maturation (2) catalytic activation by cofactor binding and (3) 
targeting through interaction with PKC-binding proteins (Newton, 2001).  
 
1.3.2. Maturation of PKC involves Ser/Thr phosphorylation 
 
PKC maturation involves phosphorylation of three highly conserved residues in the catalytic 
domain (Figure 1.5.). The first and rate-limiting step is phosphoinositide-dependent kinase (PDK-
1)- mediated phosphorylation of threonine residue at the activation loop (AL) (Dutil et al., 1998). 
Newly synthesized, immature to signal PKC species associate with the membrane compartment 
via weak interaction of pseudosubstrate, C1 and C2 domains in an ‘open’ conformation that 
exposes the AL for phosphorylation by PDK-1 (Figure 1.6). The negative charge at the AL site 
aligns correctly the residues for catalysis and unmasks the entrance to the substrate-binding 
cavity, thereby being absolutely required for the PKC maturation (Orr and Newton, 1994). The 
initial transphosphorylation triggers autophosphorylation of the turn motif (TM) located at the 
proline-rich turn of the kinase domain. 
 
N C
C1A          C1B                C2        
PPP
AL TM HM
Figure 1.5. PKC maturation 
involves three ordered 
phosphorylation events. Shown 
are the conserved phosphorylation 
sites. 
 
Whereas the AL phosphorylation is only necessary to initiate the autophosphorylation (Keranen 
et al., 1995), the negative charge at the turn motif is necessary and sufficient for the function of 
mature PKC. PKC is locked in a catalytically competent, thermally stable and phosphatase 
resistant conformation via anchoring the C-terminus at the top of the upper lob of the kinase core. 
Following TM phosphorylation PKC rapidly autophosphorylates at the hydrophobic motif (HM) 
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by an intramolecular mechanism described for PKCβII (Behn-Krappa and Newton, 1999) or as 
shown for PKCδ by an upstream kinase possibly in complex with PKCζ (Ziegler et al., 1999). 
HM phosphorylation is not essential for function but influences the subcellular localization and 
stability of PKC. Upon completion of these three ordered phosphorylations, catalytically 
competent, mature and resistant to phosphatases PKC is released into the cytosol, where it is 
maintained in an inactive conformation with the pseudosubstate sterically blocking the active site. 
Phosphatases counteract the phosphorylation state of PKC. Complete dephosphorylation is 
observed upon prolonged treatment with phorbol esters (Hansra et al., 1999) and selective 
dephosphorylation of the HM of PKCε upon serum starvation (England et al., 2001). Moreover, 
hydrophobic site transphosphorylation by PKCζ-complex requires active mTOR –mediated 
inhibition of phosphatases (Parekh et al., 2000).  
 
1.3.3. PKC activation 
 
Catalytically competent PKC could be activated by a myriad of stimuli (hormones, 
neurotransmitters, growth factors) that cause hydrolysis of membrane lipids. Conventional PKCs 
are activated downstream of receptor tyrosine kinases (RTK), nonreceptor tyroine kinases, as 
well as Gq-coupled receptors (GPCR) that activate phospholipase C (PLC)-mediated hydrolyses 
of PtdIns(4,5)P2 to DAG and Ins(1,4,5)P3. Ins(1,4,5)P3 mobilizes Ca2+ release from intracellular 
stores. Elevated intracellular Ca2+ recruits PKC to the membrane via C2 domain and further C1 
domain is engaged through DAG and PtdSer high-affinity binding (Figure 1.6.).   
 
 
    
 
 
 
 
Figure 1.6. PKC life cycle from 
the biosynthesis to the catalytic 
activation (Newton, 2003). 
 
 
 
 
 
PtdSer
Conformational switch induced by membrane targeting provides the energy for release of the 
pseudosubstrate from the active site. Thereby PKC adopts an active conformation allowing 
substrate binding and catalysis to proceed. The active state of PKC is highly sensitive to 
phosphatases and dephosphorylated PKC is targeted to proteolysis (ubiquitin-mediated or via 
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caveolin-dependent endosomal targeting). Binding of dephosphorylated TM to the molecular 
chaperone Hsp70 allows rephosphorylation and cycling back to the pool of functional PKC 
(Newton, 2003). This model of PKC life cycle and regulation, mainly valid for classical PKC 
isoforms, is more or less simplified. The regulation is much more complicated when we take into 
account that catalytic activation occurs by a variety of lipids and second messengers of lipid 
metabolism like phosphatidylcholine (PC)-derived DAG, saturated and unsaturated fatty acids 
(FA), ceramide, cholesterol sulfate, phosphatidic acid (PA), lysophosphatidylcholine (lysoPC), 
PIP3 etc (Figure 1.7.). Lipid-protein interactions mediate translocation and subcellular 
redistribution in the process of PKC activation (Shirai and Saito, 2002).  
 
 
 
Figure 1.7. Lipids and products 
of the lipid metabolism that  
activate PKC. The PKC- 
activating lipids are labeled  
in blue, the lipid metabolizing 
enzymes in red. Based on  
Nishizuka, 1995 
 
 
 
 
 
 
1.3.4. PKC-interacting proteins 
 
Protein-protein interactions also target specific PKC isoforms to particular subcellular 
compartments (plasma membrane, nuclear membrane and perinuclear region, nucleus itself, 
Golgi complex) in a proximity to a distinct set of substrates and upstream activators providing 
PKC functional specificity (Jaken and Parker, 2000). PKCs directly interact with some of its 
substrates (STICKs, MARCKS, adducins, vinculin/talin), or with proteins that promote substarte 
phosphorylation (RACKs). PKC is mobile within the cell due to interaction with dynamic 
structures such as F-actin (PKCβ/ε) and caveolae (PKCα). Some PKC-interacting proteins bind 
determinants in the regulatory domain (tubulin binds PS of PKCζ, actin binding motif of PKCε is 
located between C1A and C1B, PH domain of Btk interacts with C1 domain, RACKs bind to 
C2/C2-like domain) while others bind to the kinase core (like PAR3/ASIP binds to V5 of PKCζ) 
(Ron D. and MG Kazanietz, 1999). Moreover, most of the interactions are isoform-specific 
(RACK/β’-COP2 and PKCε, LIP and PKCι/λ, p62/ZIP and aPKC). In addition to their scaffold 
function, some PKC binding proteins are able to influence PKC activity either in activating (LIP 
PIP2
IP3 DAG
PLCβ/γ
Ca2+
cPKC nPKC
PC
PA
PLD
PME
RTK
GPCR
stimulus Growth
factor
FA LysoPC
PLA2
PC-PLC
TNFα
IFNγ
SM
SMase
ceramide
aPKC
cPKC
nPKC
aPKC
PI3K
PIP3
aPKC
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and PKCλ) or inhibiting (PAR4 and aPKCs) manner. PKC activity is coupled to other signalling 
pathways through coordinated binding to scaffold proteins e.g. PKA, PKC, and phosphatase 
bound to AKAP79 (Klauck et al., 1996). 
Among the PKC regulatory mechanism maturation seems to be the most conserved one, while 
both catalytic activation and targeting mechanisms are much more diverse and provide the basis 
for isoform-specific functions. PKC activity and function as well as its protein-protein 
interactions are subjected to control by covalent posttranslational modifications. In addition to the 
described above phosphorylation on serine/threonine residues, tyrosine residues are targeted by 
nitration and phosphorylation. Nitration of tyrosine residues appears to be a stable, even 
irreversible and selective modification altering protein activity and functions. For instance, nitric 
oxid-induced nitration of PKCε tyrosine residues is found to occur in the process of 
cardioprotection and promotes PKCε translocation and activation in the particulate fraction via 
enhanced PKCε –RACK2 interactions (Balafanova et al., 2002).  
  
1.4. Tyrosine phosphorylation of PKC  
 
1.4.1. Tyrosine phosphorylation in regulation of PKC activity and function 
  
Recently, PKC modification by tyrosine phosphorylation has emerged as an additional 
mechanism that modulates its activity and function. In contrast to the serine/threonine 
phosphorylation, tyrosine phosphoryation patterns seem to be isoform-specific, rather than 
common for the whole PKC family. Tyrosine phosphorylation of several PKC isoforms (α, βI, 
βII, γ, δ, ε, θ, ζ and ι/λ) in different cellular context upon a variety of stimuli has been 
demonstrated (Table 1.) Most well investigated is the tyrosine phosphorylation of PKCδ 
(Kikkawa et al., 2002). Growth factor receptors (insulin receptor, PDGF receptor) or nonreceptor 
tyrosine kinases (Src, Fyn, Lyn, Lck, Abl, Pyk2) are implicated as proximate kinases and in some 
cases direct interaction between the respective tyrosine kinase and PKCδ has been documented. 
The consequence of PKCδ tyrosine phosphorylation seems to be cell type and stimulus-specific- 
inhibition of tyrosine phosphorylated PKCδ (Denning et al., 1993), change in the substrate 
specificity (Haleem-Smith et al., 1995) as well as catalytic activation (Konishi et al., 1997) or no 
influence being consequence but not prerequisite for catalytic activation (Ishikawa et al., 1996). 
The tyrosine phosphorylation of PKC in many cases occurs coincident with its membrane 
translocation, but H2O2 induced-tyrosine phosphorylation and activation of PKC is not 
accompanied by membrane translocation. Tyrosine phosphorylation of PKCδ has been shown to 
target more than one tyrosine residue and different stimuli induce phosphorylation of different 
tyrosines. Distinct phosphorylation sites may regulate the PKCδ activity and biological functions 
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differently (Figure 1.8.). Furthermore, tyrosine phosphorylation of one and the same tyrosine 
residue may have different biological outcome in different cellular context. Tyrosine 
phosphorylation at Y311 in H2O2-treated COS-7 cells (Konishi et al., 2001) or by Lck in vitro 
(Konishi et al., 1997) activates PKCδ catalytic activity, while modification at the same residue by 
Src kinase (Blake et al., 1999) inactivates PKCδ and promotes its degradation. In various cell 
systems or in vitro assays tyrosine residues 52, 155 and 187 in the regulatory domain, tyrosines 
311, 332 in the hinge region as well as tyrosines 512 and 565 in the catalytic domain of PKCδ 
have been reported as targets for phosphorylation. 
 
 
 
 
 
 
Y Y YYY YY
C2-like PS C1A  C1BH2N C
52 155 187 311 332 512 565
H2O2 TGFαPE PDGF
Keratinocytes
differentiation
Figure 1.8. PKCδ tyrosine 
residues targeted by  
phosphorylation in response OOH
to various stimuli play Decreased 
activity
Active 
enzyme
Oxydative 
stress /
apoptosis
Glioma cells 
differentiation
Glioma cells
proliferation
Monocytic cells
differentiation
C4C3
different roles.  
 
 
 
 
 
  
 
1.4.2. Tyrosine phosphorylation of atypical PKCs 
 
Wooten et al. 2001a, have shown that the constitutive association of PKCι with the SH-3 domain 
of Src was enhanced by NGF in PC12 cells along with the formation of a signalling complex 
containing NGF receptor (TrkA), Src and PKC λ/ι. Moreover PKCι becomes tyrosine 
phosphorylated in the membrane in Src-dependent manner coincident with its activation by NGF. 
Tyrosines 256, 271 and 325 were identified as major sites phosphorylated by Src in the catalytic 
domain of PKCι with Y325 phosphorylation critically involved in Src-mediated PKCι activation 
and in NGF-promoted survival in serum-free media. This finding implicates receptor-induced and 
Src kinase-mediated tyrosine phosphorylation as a novel mechanism of activation of atypical 
PKC. NGF-induced tyrosine phosphorylation may also regulate the subcellular localization of 
atypical PKCs- phosphotyrosine 256 was shown to facilitate the nuclear import of atypical PKC 
(White et al., 2002) and tyrosine phopshorylation-dependent formation of a complex with 
p62/ZIP to route the activated atypical PKC to the endosomal compartment (Samuels et al., 
2001). PKCζ is tyrosine phosphorylated in complex with active Src (Seibenhener et al., 1999) in  
 
Table 1. Tyrosine phosphorylation of PKC isoforms 
 
Cell line PKC  
 
Stimulus     Tyr kinase /
Interaction 
 
PTyr 
(pY) 
Translocation Tyrosine
phosphoryla-
tion role 
Biological  
function 
 
Reference 
PKCδ FcεRI activation 
 
Lyn/ FcεRI Y52, 
155,565 
Membrane  Substrate
recognition 
modification 
Mast cells 
degranulation 
Haleem-Smith et 
al., 1995; 
Szallasi et al., 
1995  
PKCα 
PKCβI 
FcεRI activation Syk   Y658
(PKCα)  
Y662 
(PKCβI) 
Grb-2 binding
site generation  
 Ras/Erk 
pathway  
activation 
Kawakami et al., 
2003  
 
RBL-2H3 
mast cell  
 
PKCθ FcεRI activation Src and Lyn  Membrane   Liu et al., 2001 
COS-7 
cells 
 
PKCδ 
(α, βI, 
γ, ε, ζ)  
H2O2
 
 
Lck- PKCδ 
in vitro  
  
Y311, 
332,  
512 
(PKCδ) 
No  Increased PKC
activity  
 Oxidative 
stress 
apoptosis  
Konishi et al.,  
1997; 2001 
HaCaT      PKCδ UV  Increased PKC
activity 
Apoptosis 
induction  
Fukunaga et al.,  
2001 
HeLa PKCδ γ-IFN; 
Ceramide 
  Golgi  Increased PKC 
activity 
γ-IFN →JNK 
→SMase 
Kajimoto et al., 
2001  
B Ly PKCδ B cell receptor    Membrane Increased PKC 
activity 
   Barbazuk and
Gold, 1999  
Parotide/  
pancreatic 
acinar 
cells 
PKCδ    Carbachol,
Substance P 
Src  
 
Pyk2/ PKCδ 
Increased PKC
activity 
 GPCR -
promoted 
fluid secretion 
Soltoff et al., 1995 
Benes et al., 2000; 
Wrenn et al., 2001 
 
 
 
Cell line PKC  
 
Stimulus     Tyr kinase /
Interaction 
 
PTyr 
(pY) 
Translocation Tyrosine
phosphorylatio
n role 
Biological  
function 
 
Reference 
v-rasHa / 
primary  
keratino 
cytes 
 
 
PKCδ 
 
 
 
TGFα secretion-  
EGF 
Ca2+  
Src  
Family kinase  
 
 
 
Y52, 155, 
187 
Y64 
Y565  
No 
significant  
 
Decreased PKC 
activity 
 
 
 
Neoplastic 
development / 
Turn off of 
differentiation  
Denning et al., 
1993, 1996, 2000; 
Joseloff et al., 
2002 
 
PMA, PDGF 
 
Src 
Fyn-via Y187 
Y155 
Y187  
 
 
 
 
 
 
 
 Inhibition
proliferation/ 
 Kronfeld et al., 
2000 
Differentiation  
 
C6 glioma 
cells 
 
 
 
 
 
PKCδ 
etoposide  Src, IR, β-
PDGFR in vitro 
Y64, 187 Nuclear 
translocation 
PKCδ cleavage  Apoptosis Blass et al., 2002 
32D  
NIH 3T3 
PKCδ 
 
 
TPA  Y187  
Y155  
PKCδ Y187-Pi 
no effect 
PKCδ Y155F -
tumorigenic 
Monocytic 
differentiation  
Proliferation 
control  
Li et al., 1994, 
1996; Deszo et 
al., 2001; Acs et 
al., 2000  
βII,ζ  
δ 
Insulin  
 
Skeletal 
muscle 
cultures 
 α, βII,δ  
TPA 
PKCδ-Src-IR   Membr. Increased PKC 
activity 
Glucose uptake Braiman et 
al.,1999; 
Rosenweig et al., 
2004  
T cells PKCθ      TCR
activation 
Lck 
 
Y90 Lipid rafts T-cell
activation 
 
Liu et al.,2000  
Platelets PKCθ       Adhesion
receptors 
PKCθ-Btk Platelet
activation 
Crosby and 
Poole, 2002 
PC12 PKC ι,  
 
PKCζ 
NGF PKC ι-Src 
 
PKCζ-Src 
Y 256, 
271, 325 
(PKC ι) 
  Increased PKC
activity 
 Neurite 
differentiation  
 
Wooten et al., 
2001a; 
Seibenhener et 
al., 1999 
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response to insulin in primary skeletal muscle cultures (Braiman et al., 1999) and upon hydrogen 
peroxide treatment of COS-7 cells (Konishi et al., 1997). 
 
1.4.3. Cross-talk between serine/threonine protein kinases and tyrosine kinases 
 
In the context of cellular signalling network a complex bi-directional physical and functional 
interaction takes place between serine-threonine and tyrosine kinase signalling consisting in 
regulation of tyrosine kinases by PKC-dependent phosphorylation and vice versa regulation of 
PKC by phosphorylation and interaction with tyrosine kinases. For example in platelets both 
Bruton’s tyrosine kinase (Btk) and PKCθ are activated upon stimulation of adhesion receptors GP 
Ib-V-IX and GP VI (Crosby and Poole, 2002). Btk is tyrosine phosphorylated downstream of Src 
family kinases as well as phosphorylated on threonine residues in a PKC-dependent manner. 
PKCθ in turn becomes tyrosine phosphorylated in a manner dependent upon Src family and Btk 
kinase activities. A cross talk between Btk and PKCθ in platelets has been proposed, since PKCθ 
positively modulates activity of Btk, which in turn feeds back negatively upon PKCθ. 
Controversely, in murine mast cells PKC- mediated phosphorylation downregulates Btk (Yao et 
al., 1994). Moreover, in other cell types activating tyrosine phosphorylation of PKC by Btk 
(Kawakami et al., 2000) or Src family kinases (Liu et al., 2000) have been reported. Recently 
investigated is reciprocal cross talk between PKCδ and Fyn (Crosby and Poole, 2003) and 
between PKCα and Syk /Src (Pula et al., 2004) in platelets. 
 
1.5. Protein kinase C zeta (PKCζ) 
 
1.5.1. Structure 
 
The zeta isotype of protein kinase C belongs to the atypical PKC subfamily together with the 
PKCι (human) and λ (mouse) orthologs. PKCζ consists of regulatory moiety comprising PB1 
(Phox and Bem1p) domain in V1, pseudosubstrate sequence (PS) and C1 domain, and kinase 
domain (Hirai and Chida, 2003).  
 
 
 
 
 
 
 
 
Figure 1.9. PKCζ domain structure. PKCζ 
consists of PB1, PS and C1 domains in the 
regulatory moiety and catalytic domain. 
Labeled are the AL and TM threonine 
residues, as well as the glutamate in the HM 
site. Shown are the main interacting partners 
for each of PKCζ domains.  
 
 
PB1 PS C1 CD
T410
T560
E
P62/ZIP
PAR-6, MEK 5
Par-4 PAR-3/ASIP
P
P
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Amino-terminally located is the unique among PKC isoforms PB1 domain involved in 
interactions with other PB1 motif- containing proteins, such as PAR-6, ZIP/p62 and MEK5 
(Lamark et al., 2003; Wilson et al., 2003). PKCζ pocesses atypical C1 domain and does not 
respond to the second messenger DAG and PE. In addition PKCζ is Ca2+-insensitive due to the 
lack of C2 domain. The activation loop and turn motif threonine residues in the cataylitic 
domain, respectively Thr-410 and Thr-560, are phosphorylated during maturation. The 
hydrophobic motif of atypical PKCs, in contrast to the others PKC isoforms, possesses a Glu 
residue instead of Ser/Thr that provides a negative charge (Figure 1.9.). 
 
1.5.2. PKCζ activation mechanisms 
 
PKCζ is activated by lipid components, such as phosphatidylinositols, phosphatidic acid, 
arachidonic acid and ceramide. PKCζ activation occurs downstream of PI3K in many signalling 
pathways- in monocytes, adipocytes, etc (Herrera-Velit et al., 1997; Standeart et al., 1997). 
PI3K product PIP3 contributes to PKCζ activation in both indirect and direct ways (Standaert et 
al., 2001). The indirect modulation includes PIP3 binding to the PH domain of PDK1, and 
thereby activated PDK1-mediated phosphorylation of Thr-410 in the activation loop of PKCζ. 
This phosphorylation is essential for PKCζ activation- a T410A mutant loses enzymatic activity 
and respectively T410E mutant, probably mimicking the negative charge of the phosphorylated 
threonine, retains the activity. Phosphorylation by PDK1 triggers autophosphorylation of Thr560 
in the turn motif. Although PKCζ has no PIP3-binding region, PIP3 implies a direct modulation 
on PS-dependent autoinhibition (Figure 1.10).  
 
 
 
Figure 1.10. Activation of PKCζ 
downstream of PI3K and PDK1 
activation via phosphorylation  
and PIP3 interaction. Adapted 
from Hirai and Chida, 2003. 
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Furthermore, PKCζ activity is modulated via specific protein-protein interactions (Figure 1.9.). 
Prostate apoptosis response-4 (Par-4) interacts with the C1 motifs of aPKCs and inhibits their 
activities. The overexpression of Par-4 causes cells to undergo apoptosis dependent on the block 
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of aPKC activity (Diaz-Meco et al., 1996). A product of Caenorhabditis elegans partitioning 
defective gene-3 (PAR-3) and its mammalian homolog ASIP (aPKC-specific interacting protein) 
bind the kinase domain of aPKCs and also inhibit its activity. PAR-6 binds to the PB1 domain of 
aPKCs. Furthermore, PAR-6, PAR-3 and aPKCs form a ternary complex, in which PAR-6 
suppresses aPKC activity, and association of active Cdc42 releases the suppression (Lin et al., 
2000) and association of nucleotide exchange factor ECT2 activates PKCζ (Liu et al., 2004). 
PKCζ binds to Ras (Diaz-Meco et al., 1994a). ZIP/p62 has been found to interact with atypical 
PKCs without modulation of PKCζ activity and being not a PKCζ substrate (Sanchez et al., 
1998). 
 
1.5.3. PKCζ role in MAPK cascade 
 
PKCζ is involved in MAPK cascade activation in various cells in Raf-independent manner (Berra 
et al., 1995; Schoenwasser et al., 1998). Similarly, activated by lipopolysaccharide (LPS) PKCζ 
in human alveolar macrophages associates with MEK1 and activates MEK1, ERK1/2 but not 
Raf1 (Monick et al., 2000). It has been suggested that PKCζ functions as a MEK1 kinase 
independent of Raf1 pathway, but it is still unclear whether PKCζ phosphorylates MEK1 directly 
or indirectly. In HEK293 cells EGF-induced binding of endogenous PKCζ and MEK5 via PB1 
domains is crucial for the increase in ERK5 activity (Diaz-Meco and Moscat, 2001). Function for 
PKCζ as adapter in ERK5 activation is proposed since the effect is independent of its activity. 
Similarly, PKCζ independently of its activity binds to and activates PKBγ/Akt3 (Hodgkinson et 
al., 2002).  
 
1.5.4. PKCζ in receptor and other signalling complexes-the parallels 
 
Atypical PKCs are example how to achieve functional specificity via protein adaptors (Moscat 
and Diaz-Meco, 2000).  PKCζ is critically involved in the cell growth and survival signalling 
from TNFα, IL-1 and NGF receptors through the activation of NF-κB transcription factor. The 
interaction of PKCζ with those receptor-signalling complexes is mediated by PKC zeta-
interacting protein (ZIP/p62) that harbors protein-protein interaction domains like PB1 and ZZ 
(zink finger). The mechanism of activation of PKCζ in the receptor complexes is not yet fully 
understood. ZIP/p62 links aPKCs to the TNFα receptor-signalling complex via selective 
interaction with the receptor-interacting protein RIP (Sanz et al., 1999) and to IL-1 (Sanz et al., 
2000) and NGF receptor complexes via TRAF6 (Wooten et al., 2001b) (Figure 1.11.A). A 
scaffolding role for ZIP/p62 has been proposed, but in addition to its adaptor role ZIP/p62 may 
also regulate PKCζ activity since ZIP/p62 antagonizes Par-4 mediated PKCζ inhibition (Chang et 
al., 2002). The PB1 domain of PKCζ also interacts with PAR-6- another scaffold protein with 
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function in the control of cell polarity. PAR-6 interacts in addition with Cdc42 and Rac via 
CRIB-like domain and with PAR-3 via PDZ domain. 
 
 
Figure 1.11. PKCζ in 
signalling complexes. (A). 
Recruited via ZIP/p62 of 
PKCζ to the receptor 
complexes (B). Parallel 
between the interaction of 
aPKC via p62 with IL1-R 
and via PAR-6 with 
Cdc42.  V1 indicates the 
PB1 domain of aPKC. AID 
(aPKC-interacting domain) 
is motif within PB1 
domains of p62 and PAR-
6. ZF-zinc finger; cat-
catalytic domain. Adapted 
from Hirai and Chida, 
2003 and Moscat and 
Meco, 2000. 
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Mammalian PAR-3 (ASIP) is known to interact with the catalytic domain of aPKCs and to be 
relatively good substrate. There is an outstanding parallelism between ZIP/p62 and PAR-6: 
ZIP/p62 links in cytokine signalling PKCζ to the NF-κB pathway and PAR-6 seems to respond to 
Cdc42 signalling by linking the aPKCs with the actin cytoskeletal structure (Figure 1.11B). This 
provides mechanistic explanation for the requirement of the aPKCs in both Ras- and Cdc42-
induced cell transformation (Qui et al., 2000). ZIP/p62 targets PKCζ activity to the auxiliary β 
subunit of the potassium channel (Gong et al., 1999) or to Grb14 (Cariou et al., 2002). 
 
1.5.5. PKCζ-pro-apoptotic or pro-sirvival signalling 
 
Protein kinase C zeta mediates anti-apoptotic, pro-survival signals, based on its ability to regulate 
ERK-AP1 and NF-κB pathways. PKCζ is involved as IκB kinase (IKK) kinase in the NF-κB 
pathway. IKK phosphorylates the inhibitor protein I κB and triggers its proteolitic degradation 
leading to the release of NF-κB allowing its nuclear translocation. Upon TNFα stimulation PKCζ 
and IKKβ interact through each catalytic domain thereby activating IKKβ (Lallena et al., 1999). 
TNFα-induced IKKβ activation respectively NF-κB pathway is impaired in PKCζ-deficient mice 
(Leitges et al., 2001). Frutos et al., 1999, have demonstrated that PKCζ contributes to the UV-
induced apoptotic cell death via its caspase-3-mediated cleavage that generates inactive fragment 
corresponding to the catalytic domain. This is in keeping with the notion that a pro-survival 
enzyme like PKCζ needs to be blocked for apoptosis to proceed. Partly PKCζ inactivation during 
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apoptosis is mediated via Par-4 activation. PKCζ contributes to pro-survival signalling in many 
cases of drug-induced chemoresistance as a protective signal that is activated in tumor cells 
exposed to cytotoxic agents. Daunorubicin promotes pro-survival activation of Raf-1/MEK/ERK 
cascade with the critical upstream activation of PKCζ via PC-PLC-derived DAG and ROS-
dependent PI-3K activation (Mansat-De Mas et al., 2003). In addition to signalling via MAPK 
pathway PKCζ can exert NF-κB-mediated protective effects against VP-16 (etoposide)-induced 
cytotoxicity (Filomenko et al., 2002). Thereby PKCζ represents an attractive target for 
chemosensitization of tumor cells. On the other hand, through Akt inhibition PKCζ provides anti-
survival signals. In breast cancer cells PKCζ inhibit growth factor-induced activation of pro-
survival PKB/Akt (Mao et al., 2000). PKCζ has been implicated in ceramide-induced Akt 
inhibition and growth arrest (Bourbon et al., 2002). The mechanism of ceramide-promoted cell 
death is related to PKCζ-dependent suppression of 3-phosphoinositide binding to the PH domain 
of PKB/Akt (Powell et al., 2003).  Muller et al., 1995 suggested the role of PKCζ as bifunctional 
pro- and anti-survival modulator on the basis of different lipid cofactors. 
 
1.5.6. Other cellular functions of PKCζ 
 
PKCζ-deficient mice develop normally, but exhibit mildly impaired maturation of B cells and 
reduced number of Peyer’s patches (Martin et al., 2002). PKCζ takes part in the PI3K-p70S6K 
signaling complex but is not sufficient for the complete activation of p70S6K (Romanelli et al., 
1999). Insulin-stimulated via PI3K and PDK1 PKCζ has been directly implicated in the 
translocation of GLUT4 and glucose uptake in adipocytes (Bandyopadhyay et al., 1999). Via the 
ternary complex with PAR-3 and PAR-6 aPKCs controls cell polarity (Ohno et al., 2001) and the 
tight junction formation (Suzuki et al., 2001). Specifically in the brain a 51kDa protein referred 
to as PKMζ and representing the catalytic domain of PKCζ was detected and found to be both 
sufficient and necessary for maintenance of long-term potentiation (LTP) and memory (Ling et 
al.,2002).  
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1.6. AIM OF THE CURRENT WORK 
 
The signalling pathways from GPCRs towards ERK/MAPK activation involving EGFR 
transactivation are relatively good investigated. Little is known about the EGFR-mediated 
regulation of the constituents of these signalling pathways via tyrosine phosphorylation. 
Recently, many lines of evidence demonstrate tyrosine phosphorylation of PKC isoforms upon 
stimulation of cell surface receptors and with critrical involvement of cytoplasmic tyrosine 
kinases. PKCs are main elements of both GPCR and RTK signalling implicated in their cross 
talk. However, little is known about the role of PKC tyrosine phosphorylation in the cross talk 
between GPCRs and RTKs. 
The aim of the present work is to investigate the effect of EGFR stimulation on the 
tyrosine phosphorylation state of different PKC isoforms with the focus on the characterization of 
EGFR-mediated tyrosine phosphorylation of PKCζ. The involvement of EGFR and Src family 
tyrosine kinases as well as of PI3K in the PKC modification will be addressed. A potential 
physical association between EGFR and PKCζ will be investigated in detail. Another point of 
interest is to identify specific tyrosine residues targeted by EGFR-mediated phosphorylation. The 
effect of EGFR-mediated phosphorylation on PKCζ activity state will be analysed. We asked also 
the question whether the transactivated by GPCRs EGFR might also mediate tyrosine 
phosphorylation of PKCζ.  In addition, the involvement of PKCζ tyrosine phosphorylation on 
EGFR downstream signalling events will be assessed.  
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2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Cell lines  
 
COS-7 cell line – fibroblasts derived from the kidney of green African monkey (American Type 
Collection Culture-ATCC)  
MCF-7 cell line - human breast adenocarcinoma (Deutsche Sammlung für Mikroorganismen und 
Zellkulturen-DSMZ) 
A431 cell line - human epidermoid carcinoma (ATCC) 
 
2.1.2. Chemicals and medium for cell culture, transfection, cell stimulation and lysis 
 
Dulbecco’s modified Eagle’s medium (DMEM) high glucose with sodium pyruvate and L-
glutamine, fetal calf serum (FCS), antibiotic-antimycotic mixture (10000 u/ml penicillin G, 
10mg/ml streptomycin sulfate, 25 µg/ml amphotericin B), Gentamicin (10 mg/ml), Trypsin and 
Lipofectamine 2000 transfection reagent were from Invitrogen life technologies.  
Other reagents were obtained as follow: Polyfect transfection reagent (Qiagen), human 
recombinant epidermal growth factor receptor (EGF), heparin-binding epidermal growth factor 
(HB-EGF), AG1478, LY294002, wortmannin, phorbol-12-myristate-13-acetate (PMA) 
(Calbiochem), hydrogen peroxide (Fluka), PMSF (Serva), diethylaminoethyl (DEAE)-dextran, 
chloroquine, sodium orthovanadate, aprotinin, leupeptine, oleoyl-L-α-lysophosphatidic acid 
(LPA), isoproterenol, cytosine β-D-arabinofuranoside (Ara-C) (Sigma).  
Phosphate-buffered saline (PBS) used during transfections and for washes upon cell 
stimulation: 0.137M NaCl, 2.7mM KCl, 8.1mM Na2HPO4, 1.7mM KH2PO4 pH 7.4 
 
2.1.3. Bacterial strain and medium for bacterial cultivation  
  
Escherichia coli XL-1Blue (Stratagene) 
 
Luria-Bertani (LB) medium (Sambrook et. al., 1989) containing Bactotrypton – 10 g/l, yeast 
extract – 5 g/l, NaCl - 10 g/l, pH 7.0 supplemented with appropriate antibiotics- ampicillin 100 
µg/ml or kanamycin 50 µg /ml and for plates solidified with 15 g/l agar.   
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2.1.4. Antibodies 
 
Anti- PKCα, βI, δ, ε, η, θ and ζ isoform- rabbit polyclonal antibodies (Santa Cruz 
Biotechnology) (WB dilution 1:2000). 
Anti-EGFR antibodies: mouse monoclonal 13G8 (Nanotools) (WB dilution 1:333); mouse 
monoclonal clone 425  (Merck) and mouse monoclonal (Santa Cruz Biotechnology) (IP). 
Anti-phosphotyrosine antibodies: mouse monoclonal PY99 (Santa Cruz Biotechnology) and 
4G10 (Upstate) (WB dilution: 1:3500-1:5000). 
Anti-phosphothreonine mouse monoclonal antibody (Santa Cruz Biotechnology) (WB dilution: 
1:100). 
Anti-phospho-p44/42 MAPK (Thr 202/Tyr204) mouse monoclonal antibody (Cell Signaling) 
(WB dilution 1:2000). 
Anti-Erk1 and anti-Erk2 rabbit polyclonal antibodies (Santa Cruz Biotechnology) (WB dilution 
1:1500). 
Anti-phospho-Akt (Ser473) rabbit polyclonal antibody (Cell Signaling) (WB dilution 1:1000). 
Anti-Akt rabbit polyclonal antibody (BD Biosciences Pharmingen) (WB dilution 1:1000). 
Anti-HA.11 tag mouse monoclonal antibody (Babco and Santa Cruz Biotechnology) (IP) (WB 
dilution 1:4000). 
Anti-T7 tag mouse monoclonal antibody (Novagen) (WB dilution 1:4000). 
Anti-phospho- IκBα (Ser32/36) mouse monoclonal antibody (Cell Signaling) (WB dilution 
1:1000). 
Anti beta-actin mouse monoclonal kindly provided by Dr. T. Bondeva (WB dilution 1:5000). 
Anti-PARP rabbit polyclonal antibody (Roche) (WB dilution 1:2000). 
Anti-Src mouse monoclonal clone 327 antibody (Oncogene) (WB dilution 1:1000). 
Anti-GFP mouse monoclonal clone antibody (Santa Cruz Biotechnology) (WB dilution 1:500). 
Secondary antibodies: horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit 
(Santa Cruz Biotechnology) (WB dilution from 1:2000 up to 1:10000).  
Normal rabbit IgG – (Santa Cruz Biotechnology) (IP). 
 
2.1.5. Plasmid vectors   
 
PKC constructs: PKCα, βI, δ, ε, η, θ and ζ- wild type, human cDNAs in CMV promoter-driven 
expression vector (pcDNA3.0) (generous gift of Prof. K. Seedorf); PKCζ constitutively active 
(A to E mutation within the pseudosubstrate) and PKCζ inactive mutant (K281R) (described in 
Adomeit et al., 1999); PKCζ-EYFP-N1, PKCζ-ECFP-N1, PKCζ-T410A-EYFP-N1 and 
PKCζ-T410A-ECFP-N1 (kindly provided by Dr. A. Hausser and Prof. K. Pfitzenmaier, Institute 
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of Cell Biology and Immunology, Stuttgart, Germany); PKCζ-Y417F (created by site-directed 
mutagenesis as described below). 
 
EGFR constructs: EGFR-WT, EGFR-Y1173F, EGFR-Y992F, EGFR-Y1086F- in pRK5 
(generously provided by Prof. F. Boehmer, FSU Jena, Jena, Germany); EGFR-Y845F in 
pcDNA3 (kindly provided by Prof. Dr. S. J. Parsons, University of Virginia, Virginia, USA); 
EGFR-CFP-N1 (gift of Prof. Dr. L.E. Samelson, NIH, Bethesda, USA); EGFR-∆CR1 (∆242-
259) dimerization mutant (provided by Prof. A.W. Burgess, Ludwig Institute for Cancer 
Research, Melbourne, Australia).  
 
Other vectors: Human HA-MAPK in pcDNA3.0 was a kind gift of J. S. Gutkind (NIH, 
Bethesda, USA); mouse SrcWT and Src dominant negative mutant (SrcRF-K295R/Y527F) were 
from the lab of Joan Brugge (Harvard Medical School, USA); PTEN-T7 in pCGT7 vector, was 
generous gift of Prof. F. Boehmer (FSU Jena, Germany), p110betaWT and p110betaKR 
constructs were generous gift of Prof. R. Wetzker (FSU Jena, Germany).  
 
2
 
.1.6. Other reagents 
Enhanced chemiluminescence (ECL) detection reagent, [methyl-3H]-Thymidine (2 Ci/mmol), 
protein A-Sepharose CL-4B, protein G-Sepharose 4 Fast Flow and Hybond polyvinylidene 
difluoride (PVDF) membrane were from Amersham Pharmacia Biotech.  
[γ-32P] adenosine triphosphate (ATP) (3000 Ci/mmol) was from NEN Life Science Products.  
Other reagents and materials were as follow: myelin basic protein (MBP), BSA, ATP, Sepharose 
CL-4B, Tween 20, Triton X-100, glycerol 2-phosphate, sodium dodecyl sulfate (SDS), ethylene 
glycol-bis (β-aminoethylether)-N, N, N’, N’-tertaacetic acid (EGTA) (Sigma), agarose broad 
range, Rotiphorese Gel 30 (37.5:1), ethylendiamine tetraacetic acid (EDTA), Glycin, Tris -
(hydroxymethyl)-aminometan (Tris), NaCl, morpholinepropanesulfonic acid (MOPS) (Roth), 
Mowiol 4-88 reagent (Calbiochem), paraformaldehide (Merck), T-MAT Plus DG Film and 
Biomax MR Film (Kodak), prestained protein molecular weight marker (Fermentas).   
 
2.2. Methods 
 
2.2.1. Transfection methods 
 
2.2.1.1. DEAE-dextran transient transfection 
 
1.4-1.6 x 106 COS-7 cells were seeded per 100mm dish in 10ml DMEM supplemented with 10% 
FCS and 15 µg/ml gentamicin. Cells were incubated at 37oC and 5% CO2. The next day 
Materials and Methods  22 
subconfluent cells were washed twice with 5 ml phosphate buffered saline (PBS) 0.137M NaCl, 
2.7mM KCl, 8.1mM Na2HPO4, 1.7mM KH2PO4 pH 7.4) and incubated with DNA mix in 600µl 
0.67 mM DEAE-dextran in PBS. In order to achieve equal expression levels various amounts of 
DNA from different DNA constructs was used as indicated in the figure legends. In most of the 
cases 100 ng/105 cells PKC expression vectors were transfected along with 100 ng/105cells 
EGFR WT, Y992F, Y1086F, Y1173F constructs. The overall DNA amount upon co-transfection 
in most of the cases was not exceeding 200ng/105 cells DNA exept of the experiments that 
involve overexpression of EGFR-∆CR1 (200 ng/105 cells to achieve the same expression as upon 
transfection of 20 ng/105 cells EGFR WT) and EGFR Y845F (6 to 10 fold more DNA than 
EGFR WT construct). The cells were incubated with the DNA mix for 30 min at 37oC, then 6 ml 
serum-free DMEM supplemented with 0.13 mM chloroquine were added and the cells were 
incubated for additional 3 h at 37oC. Medium was exchanged with DMEM supplemented with 
10% FCS and 1% antibiotic mixture and cells were grown for additional 48h. The cells were 
serum-starvated over night prior stimulation (as described in fugure legends) and lysed in lysis 
buffer (see below in 2.2.2.). In most of the experiments transient transfection was performed by 
DEAE-dextran method, if not otherwise indicated. 
 
2.2.1.2. PolyFect transfection 
 
The day before transfection 5 x 104 COS-7 cells were seeded per well in 24-well plate in 1 ml 
DMEM supplemented with 10% FCS and 15 µg/ml gentamicin. The next day subconfluent cells 
were washed twice with 1 ml PBS and 750 µl DMEM with 10% FCS and 1% antibiotics was 
added per well. Separately, 180 ng DNA per transfection was diluted with serum-free medium up 
to 15µl and 1.5µl of PolyFect transfection reagent was added, mixed by pipetting and the samples 
were incubated for 10 min at room temperature to allow complex formation. Then the 
transfection complexes were transferred to the cells diluted up to 250 µl/well DMEM with 10% 
FCS and 1% antibiotics. The cells were incubated with the complexes for 48 h and then 
proceeded with [3H]-Td incorporation for proliferation analyses.  
 
2.2.1.3. Lipofectamine 2000 transfection  
 
The day before transfection 2.4 x 105 COS-7 cells were seeded per well in 6-well plate in 2 ml 
DMEM supplemented with 10% FCS without antibiotics. The next day the medium was changed 
to serum-free medium. For each transfection 4 µg DNA was diluted up to 250 µl with serum-free 
medium. Separately 10 µl Lipofectamine 2000 was diluted up to 250 µl with serum-free medium, 
incubated at room temperature and mixed with the diluted DNA within 5 min. The mixtures were 
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incubated for 20 min at room temperature to allow formation of the DNA-Lipofectamine 2000 
complexes and were added to the cells.  After 5 h incubation with the complexes medium was 
changed to DMEM supplemented with 10% FCS without antibiotics and the cells were grown for 
48 h before further analysis.  
 
2.2.2. Preparation of cell lysates 
 
Before lysis the cells were pretreated with appropriate inhibitors for 30 min at 37oC and 
stimulated as indicated in the figure legends, washed in ice-cold PBS and lysed on ice in a lysis 
buffer (LB) containing 20 mM Hepes, pH 7.5, 10 mM EGTA, 40 mM β-glycerophosphate, 1% 
Triton X-100, 2.5 mM MgCl2, 1mM dithiothreitol (DTT), 2mM sodium vanadate, 1mM 
phenylmethylsulfonylfluoride (PMSF), 20 µg/ml aprotinin and 20 µg/ml leupeptin. Total cell 
lysates were centrifuged at 14,000xg for 5 min at 4oC to pellet the nuclei and the supernatants 
were stored at -80oC.   
 
2.2.3. Preparation of cell lysates for PARP  
 
Extraction buffer was prepared by mixing per each sample 100 µl of 50 mM glucose, 25 mM 
Tris-HCl, pH 8.0, 10 mM EDTA, 1 mM PMSF and 50 µl of 50 mM Tris-HCl, pH 6.8, 6 M urea, 
6% β-mercaptoethanol, 3% SDS and 0.003% bromphenolblue. Whole cell lysates were sonicated 
(one 60 s pulse at 180V) and incubated for 15 min at 65oC.  
 
2.2.4. Colocalization of PKC zeta and EGFR 
 
Subconfluent COS-7 cells grown in 6 well plates on glass cover slips were transfected with 
PKCζ- EYFP and EGFR-CFP using Lipofectamine 2000. Serum-starved cells were stimulated 
with 10 nM EGF for 1 min, washed in PBS (0.1 M NaCl, 0.063 M Na2HPO4, 0.022 M NaH2PO4 
pH 7.4), fixed with 3.5% paraformaldehide in PBS for 20 min at room temperature and after 
extensive wash with PBS and final wash with bidestiled water the cover slips were mounted on 
glass slides with Mowiol. Mowiol was prepared by stirring 2.4g in 6g glycerol and 6 ml destilled 
water for 2 h at room temperature, followed by addition of 12 ml 0.2M Tris-HCl, pH 8.5 and 
incubation at 50-60oC for 10 min. Aliquates were stored at –20oC.  The slides were kept in dark 
until detection of sub-cellular localization of fluorescent proteins by laser scanning microscopy. 
Fluorescent specimen were analysed with Leica SP2 confocal microscope with argon laser and 
imaged using the Leica TCS software.  
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2.2.5. SDS-PAGE and Western blotting  
                                          
SDS-PAGE gels (7.5-13%) gels were used as follow: 10% for PKC detection, 7,5%-9% for 
EGFR detection, 8-9% for co-immunoprecipitations of EGFR and PKC, 13% for MBP 
phosphorylation, 12,5% for phospho-Erk and phospho-Akt detection. Cell lysates corresponding 
to 105 cells boiled in 1x Leammli buffer for 5 min and clarified by centrifugation for 2 min at 
14000 rpm were run per lane with constant current 22 mA/gel and maximal voltage 150V.  
 
Resolving gel: 7.5-13% PA, 380 mM Tris-HCl, pH 8.8, 0.1% SDS  
 
Stacking gel: 4% PA, 125 mM Tris-HCl, pH 6.8, 0.1% SDS 
 
Running buffer: 25 mM Tris, 200mM glycin, 0.1% SDS  
 
Laemmli sample buffer (3x): 6% SDS, 4.32 M β-mercaptoethanol, 40% glycerol and 
bromphenol blue.  
 
Resolved proteins were electrotransferred to Hybond PVDF membranes using semi-dry blotting 
with constant current 0.8 mA per cm2 membrane and maximal voltage 12V. 
 
Anode buffer: 0.3M Tris, 20% methanol. 
 
Cathode buffer: 25mM Tris, 40mM 6-aminohexanoic acid, 20% methanol and 0.05% SDS 
(freshly added).  
 
Background blocking was performed by incubating the membranes with 1% BSA and 1% dry 
milk (polyclonal antibodies), 1% BSA (for monoclonal antibodies), 5% dry milk (for phospho-
Erk, phospho-IκBα and Erk2-specific antibodies), 5% BSA (for anti-phospho-Akt antibody). 
Blocking solutions were prepared with Tris-buffered saline (TBS- 10 mM Tris, pH 7.5, 150 mM 
NaCl) for overnight blocking and in TBS with 0.1% Tween-20 for 1 hour blocking at room 
temperature. Membranes were incubated with the most of the primary antibodies for 1 h at room 
temperature (with phospho-Erk, Akt and IκBα-specific antibodies incubation was carried out over 
night at 4oC). After triple wash with TBS supplemented with 0.1% Tween-20 membranes were 
incubated with the respective secondary antibodies: anti-mouse or anti-rabbit HRP- conjugated 
diluted 1:3000 up to 1:10000. After four times wash with TBS-0.1% Tween-20 the visualization 
was performed by ECL.  
When necessary to reprobe with another antibody, the membrane was washed after ECL twice for 
10 min in TBS-0.1% Tween-20 and stripped in 50 mM Tris-HCl, pH 6.8, 2% SDS and 11.5 mM 
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β-mercaptoethanol for 30 min at 55-70oC. After extensive wash with TBS-0.1% Tween-20 
membrane were reprobed with appropriate antibodies as described above.  
 
2.2.6. Immunoprecipitation 
 
Clarified cell lysates from 1.4x106 COS-7 cells were incubated with 1-1.5 µg anti-PKCζ antibody 
or 1,5-2 µg anti-EGFR antibody clone 425 for 3 hours at 4oC with rotation. The PKCζ antibody 
was substituted with normal rabbit IgG in the negative controls. The immunocomplexes were 
collected on Protein A-Sepharose (3 mg beads per sample) for additional 1,5 h at 4oC with 
rotation. The beads with bound immuno-complexes were washed three times in phosphate-
buffered saline PBS (0.1 M NaCl, 0.063 M Na2HPO4, 0.022 M NaH2PO4 pH 7.4) supplemented 
with 1% TritonX-100 and 2 mM sodium orthovanadate, boiled in Leammli buffer for 5 min and 
the supernatants were subjected to Western blotting using anti-phosphotyrosine antibody to detect 
the tyrosine phosphorylation, or PKCζ immunoprecipitates were probed with anti-EGFR 
antibody and EGFR immunoprecipitates with PKCζ antibody (to assess the co-
immunoprecipitation), and after stripping reprobed anti-PKCζ antibody and anti-EGFR antibody 
13G8, respectively (to verify equal loading of the immunoprecipitates). Equivalent expression 
levels of the DNA constructs were detected by Western blotting with appropriate antibodies.  
 
2.2.7. HA-MAPK kinase activity assay 
Cells were transfected with HA-MAPK along with PKCζ and EGFR expressing constructs by 
DEAE-dextran method. Clarified cell lysates were immunoprecipitated with anti-HA monoclonal 
antibody 12CA5 (Babco, Berkley, CA) for 1 hour at 4oC and immunocomplexes were recovered 
on Protein G-sepharose beads for 30 min at 4oC. The beads were washed three times with PBS 
supplemented with 1% TX-100 and 2 mM sodium orthovanadate, once with 0.5 M LiCl in 100 
mM Tris-HCl (pH 7.5) and once with kinase reaction buffer (12.5 mM 
morpholinepropanesulfonic acid [pH 7.5], 12.5 mM β-glycerophosphate, 7.5 mM MgCl2, 0.5 mM 
EGTA, 0.5 mM sodium fluoride, 0.5 mM sodium vanadate). Reactions were performed in 30 µl 
of kinase buffer containing 1 µCi of [γ-32P] ATP, 20 µM cold ATP, 3.3 µM DTT and 40 µg of 
myelin basic protein (MBP) at 30oC for 20 min. Reactions were stopped by addition of Laemmli 
buffer, boiled for 5-10 min and separated on 13% SDS-polyacrylamide gels. Lower parts of the 
gels, containing phosphorylated MBP, were fixed in (45% methanol and 10% acetic acid), dried 
and MBP phoshorylation was visualized by autoradiography. The upper parts of the gels were 
electrotransferred on membranes and analysed with anti-HA antibody for immunoprecipitated of 
HA-MAPK.    
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2.2.8. PKC zeta kinase activity assay 
The kinase activity of PKCζ was determined on PKCζ immunoprecipitates using myelin basic 
protein (MBP) as a substrate. PKCζ immunoprecipitation was carried out as for tyrosine 
phosphorylation and co-immunoprecipitation analysis. The sepharose beads with attached 
immune complexes were washed three times with complete lysis buffer (LB) followed by one 
wash in kinase buffer containing 20 mM Tris, pH 7.4, 50 mM NaCl, 7.5 mM MgCl2, 0.5 mM 
EGTA and 2 mM sodium vanadate. Kinase reactions were carried out in 50 µl kinase buffer 
supplemented with 1 µCi of [γ-32P] ATP, 20 µM cold ATP and 40 µg MBP for 20 min at 37oC.  
Estimation of MBP phosphorylation was performed in the same manner as for MAPK activity. 
The upper parts of the gels were electrotransferred on membranes and analysed with 
phosphotyrosine-specific antibody or PKCζ-specific antibody and autophosphorylation of PKCζ 
was visulaized by autoradiography. 
 
2.2.9. Site-directed mutagenesis 
 
Y417F mutant of PKCζ was generated using QuikChange Site-Directed Mutagenesis kit 
(Stratagene) according to the manufacturer’s protocol based on the pcDNA3 construct containing 
wild type human PKCζ as a template. A pair of 35-mers fully complementary to each other 
primers was designed to contain the mutation – Y417Ff (sense strand, 5’- 
ctgcggaaccccgaatttcatcgcccccgaaatcc-3’) and Y417Fr (antisense strand, 5’-
ggatttcgggggcgatgaaattcggggttccgcag-3’). The whole plasmid containing 1779 bp coding for 
human PKCζ was amplified using PfuTurbo DNA polymerase. The PCR program included an 
initial denaturation step at 95oC for 3 min followed by 16 cycles each consisting of denaturation 
step at 95oC for 30 sec, annealing step at 54oC for 1 min and polymerization step at 68oC for 15 
min (2 min/kb DNA). Template DNA was digested with DpnI restriction endonuclease for 3 h at 
37oC and PCR product was used for transformation of XL-1 Blue cells. The colonies were picked 
and plasmid DNA was isolated and sequenced for confirmation of the tyrosine (Y) 417 mutation 
to phenylalanine (F). Additional overlapping sequencing runs were performed in order to check 
the identity of the remaining PKCζ coding sequence. 
 
2.2.10. Transformation of E.coli and plasmid DNA preparation 
 
For competent cells preparation 1 ml overnight culture of XL-1 Blue was inoculated in 100 ml 
LB medium without antibiotics and incubated at 37oC on shaker (200rpm) for 2-4 h until the 
culture reaches OD600 0.3-0.6. The cells were pelleted by centrifugation for 5 min at 5000rpm, 
resuspended in 10 ml TSB (10% polyethylenglycol 6000, 5% dimethylsulfoxide (DMSO), 20 
mM Mg2+ -10 mM MgCl2 and 10 mM MnCl2 in LB medium) and aliquots were kept at –80oC. 
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E.coli competent cells (100 µl per sample) were thawed on ice and added to the 10-50 ng DNA in 
1x KCM buffer (0.1 M KCl, 0.03 M CaCl2, 0.05 M MgCl2). Reaction was mixed and incubated 
on ice for 30 min, then transferred for 10 min at room temperature, followed by addition of 1ml 
LB without antibiotics and incubation for 1 h at 37oC. For plasmid amplification 10 µl (or half of 
the transformation mixtures for the mutagenesis) were spread on plates with LB medium 
supplemented with appropriate antibiotics. The plates were incubated at 37oC overnight. For 
plasmid DNA isolation single colonies were picked up and bacteria were grown in overnight 
culture (3 ml for miniprep extraction and 100 ml for maxiprep extraction of plasmid DNA) at 
37°C by shaking (200 rpm). The cells were harvested by centrifugation and plasmid DNA was 
extracted using Qiagen Plasmid Isolation kit following the supplier's protocol. 
Electrophoresis of plasmid DNA was carried out in 1% agarose gels with ethidium bromide (final 
concentration 2,5 µg/ml) in 1xTAE buffer  (40 mM Tris, Acetic acid, 1.14 ml/l and EGTA- 0.03 
g/l, pH 8) in horizontal apparatus at 80 V. DNA samples were resuspended in loading buffer (10x 
30% glycerol, 1xTAE 0,025% bromophenol blue, 0,025% xylene-glycol). The size of DNA was 
estimated using 1 kb Ladder (BioLabs). 
 
2.2.11. [3H]-thymidine incorporation assay 
 
COS-7 cells were transfected in 24-well plates and 48 h later were serum starved for 24 h. The 
cells were stimulated with 10 nM EGF for 20 h, followed by addition of 1 µCi per well [3H]-Td 
for additional 4 h. Cells were washed with ice-cold PBS, incubated with 10% TCA trichloracetic 
acid supplemented with 1% pyrophosphate (20 mM) for 30 min on ice and then subsequently 
washed twice with 1% TCA, 1% pyrophosphate, twice with 96% ethanol, followed by 
solubilization with 1 N NaOH for 10 min on ice with gentle shaking and neutralization with 2 N 
HCl. The samples were transferred into scintillation vials and the incorporation of [3H]-Td into 
newly synthesized DNA was measured in Lumasafe Plus by Beckman scintillation counter.
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. RESULTS 
 
3.1. Tyrosine phosphorylation of PKC isoforms overexpressed in COS-7 cells upon EGFR 
stimulation  
 
In order to analyse the tyrosine phosphorylation of protein kinase C (PKC) induced by EGFR 
stimulation we transiently transfected COS-7 cells with pcDNA3.0 expression vectors of 
particular PKC isoforms (classical PKC isoforms α and βI, novel PKC δ, ε, η and θ and atypical 
PKC ζ). COS-7 cells express endogenously PKCα, βI, δ, ε and ζ (predominantly PKCα, βI and ζ) 
whereas Western blot analysis for PKCη and θ did not show detectable amount of endogenously 
expressed protein. Transient transfection led to significant overexpression of all PKC isoforms.                 
The endogenous EGFR of COS-7 cell was stimulated with 100ng/ml (16.7nM) epidermal growth 
factor (EGF). First we tried to identify PKC tyrosine phosphorylation by Western blot of cell 
lysates with phosphotyrosine-specific antibody.    
 
 
Figure 3.1. EGF-induced tyrosine phosphorylation of PKC isoforms overexpressed in COS-7 cells. Cells were 
transiently transfected with 150ng DNA/105 cells of either empty vector or expression constructs for PKCα (A), 
PKCβI (B), PKCε (C), PKCη (D), PKCδ (E), PKCθ (F) and PKCζ (G). Serum starved cells were left untreated or 
stimulated with 100ng/ml EGF for 5 min at 37oC. Cell lysates from 105 cells were resolved by 10% SDS-PAGE, 
electroblotted on the PVDF membrane and the membranes were probed with phosphotyrosine-specific antibody 
PY99. After stripping, the membranes were reprobed with PKC isoform-specific antibodies. Respective PKC 
isoforms are indicated by arrows. The increase in PKC tyrosine phosphorylation in response to EGF is labeled by 
star. Shown is a representative of four independent experiments.  
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On Figure 3.1 is shown that with this approach it was difficult to detect pronounced tyrosine 
phosphorylation of most of the overexpressed PKC isoforms. Only a weak phosphotyrosine 
signal was found corresponding to the positions of PKCη, θ and ζ and stronger tyrosine 
phosphorylated band was detected on the respective positions of PKCα, βI and ε and 
overexpressed PKCδ. This signal was not influenced either by PKC overexpression or upon EGF 
stimulation in the case of PKCβI and η. Increase in the tyrosine phosphorylation upon stimulation 
with 100ng/ml EGF was visible on Western blot only very weakly in the case of PKCθ, faint for 
PKCα and ζ as well as more pronounced increase in the case of PKCε and PKCδ. Tyrosine 
phosphorylated PKCε (C) and δ (E) showed reduced electrophoretic mobility. Since hydrogen 
peroxide and phorbol ester (PMA) are well known as PKC tyrosine phosphorylation inducers 
(Table 1), we compared their ability to induce tyrosine phosphorylation of PKCε and PKCδ with 
that of EGF. As it is demonstrated on Figure 3.2 the stimulation with 5mM hydrogen peroxide for 
10 min led to high increase in the tyrosine phosphorylation of both PKCε and PKCδ. Both 
isoforms had similar patterns of tyrosine phosphorylation upon treatment with 100 nM PMA for 
10 min but PMA effect was less pronounced compared to the tyrosine phosphorylation induced 
by hydrogen peroxide. Stimulation with 10 and 100ng/ml EGF induced also tyrosine 
phosphorylation of both PKC isoforms. The lower tyrosine phosporylation of PKCε induced by 
100ng/ml EGF compared to 10ng/ml EGF stimulation can be explained by lower protein loading 
in that case. EGF treatment seems to be less potent in inducing PKC tyrosine phosphorylation 
than hydrogen peroxide but more effective than phorbol ester treatment.   
 
 
Figure 3.2. Tyrosine phosphorylation of PKCε and δ induced by EGF, H2O2 and PMA treatment in COS-7 
cells. Cells transfected with PKCε (A), PKCδ (B) expression constructs or empty vector were serum starved and 
either left untreated or treated with 5mM H2O2 for 10 min, 10ng/ml EGF for 5 min, 100ng/ml EGF for 5 min, or 
100nM PMA for 10 min as indicated. Protein extracts were analysed by Western blotting with phosphotyrosine-
specific antibody PY99 and reprobed with PKC ε (A) or PKCδ (B)-specific antibodies, respectively. The arrows 
indicate the position of PKC on phosphotyrosine blot.  Similar results were obtained in two additional experiments. 
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In this way we confirmed the already described EGF-induced tyrosine phosphorylation of PKCδ 
(Denning et al., 1993) and obtained some indications about tyrosine phosphorylation of other 
PKC isoforms as well. Despite of that, Western blot of cell lysates seemed to be not suitable for 
more detailed characterization of the PKC modification in response to EGF. Using 
phosphotyrosine blot of PKC immunoprecipitates we confirmed the EGF-induced tyrosine 
phosphorylation of PKCε and PKCζ observed on cell lysates (Figure 3.3.), whereas the results for 
PKCα were not conclusive and tyrosine phosphorylation of PKCβI was excluded (data not 
shown). Figure 3.3.A demonstrates that overexpressed PKCε is tyrosine phosphorylated upon 
short (2 to 3 min) stimulation with 10nM EGF. The tyrosine phosphorylation of the 
overexpressed PKCζ upon stimulation of the endogenous EGFR was more pronounced compared 
to that of PKCε (Figure 3.3.B).  
 
 
 
                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Tyrosine phosphorylation of PKCε and PKCζ upon EGF stimulation - detection in PKC 
immunoprecipitates. COS-7 cells were transfected with PKCε alone or together with EGFR coding vector (A), or 
EGFR alone, PKCζ alone and PKCζ in combination with EGFR (B). The amount of plasmid DNA used for 
transfection was 180 ng/105 cells for single transfection of PKCε, 100ng/105 cells for single transfections of EGFR 
and PKC ζ, and not more that 200ng/105 cells (125ng/105 cells PKC and 62.5ng/105 cells EGFR) in the case of 
double overexpression (2µg PKC and 1µg EGFR per 1.6x106 cells). PKCs were immunoprecipitated with isoform-
specific antibodies from cell lysates of either untreated or EGF-stimulated COS-7 cells. EGF stimulation was for 5 
min if not otherwise indicated. Immunoprecipitates were analysed by Western blotting with PY99 phosphotyrosine-
specific antibody and reprobed with PKC isoform-specific antibodies. Similar results were obtained in three 
additional experiments. 
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Moreover, tyrosine phosphorylation of endogenous PKCζ upon stimulation of the overexpressed 
EGFR was detected as well. Tyrosine phosphorylation of endogenous PKCε upon stimulation of 
the overexpressed EGFR was not observed, probably due to the lower endogenous level of PKCε 
in COS-7 cells relatively to PKCζ (data not shown). However the phosphotyrosine signal for both 
PKC isoforms was not high enough to enable us to study quantitatively their tyrosine 
phosphorylation. Therefore we used a double overexpression system. COS-7 cells that 
overexpress transiently either PKC ζ or PKCε along with the EGFR showed pronounced increase 
in the basal and EGF-induced tyrosine phosphorylation of these PKC isoforms (Figure 3.3.). 
As a result of these preliminary experiments we confirmed that EGF induces tyrosine 
phosphorylation of PKCδ and identified that two additional PKC isoforms are subjected to 
tyrosine phosphorylation upon EGFR stimulation in COS-7 cells- PKCζ and PKCε. Since the 
tyrosine phosphorylation of PKCδ is studied in detail (Denning et al., 1993, 1996, 2000) we 
focused our study on EGFR-induced tyrosine phosphorylation of PKCζ and PKCε. 
 
3.2. EGF-induced tyrosine phosphorylation of PKC zeta and PKC epsilon 
 
3.2.1. Stimulus concentration dependence and time course of PKC zeta and PKC epsilon 
tyrosine phosphorylation 
 
Next we analysed EGFR-induced modification of PKCζ and PKCε by tyrosine phosphorylation 
with respect of the time course and EGF concentration dependence. On Figure 3.4 is compared 
the tyrosine phosphorylation of PKCζ and PKCε in response to EGF stimulation of endogenous 
EGFR (A and C) and co-overexpressed EGFR (B and D). EGFR-mediated tyrosine 
phosphorylation of both isoforms was dependent on the EGF concentration used for stimulation 
and substantially increased in the concentration range from 0.1nM up to 10nM EGF. The tyrosine 
phosphorylation observed upon endogenous EGFR stimulation is significantly less pronounced 
compared to the modification induced by treatment with 5 mM hydrogen peroxide for 10min as a 
positive control. The difference between both effects is extremely big in the case of PKCε (Figure 
3.4.C). The concentration dependence in the case of overexpressed EGFR is shifted compared to 
the endogenous system with substantial increase in the tyrosine phosphorylation of PKCζ and 
PKCε upon stimulation with 1-10nM EGF. Comparable significant effect on the tyrosine 
phosphorylation of PKCζ under endogenous EGFR conditions is found only upon stimulation 
with high EGF concentration of 10nM and has not been observed for PKCε. Stimulation with 
10nM EGF of COS-7 cells co-overexpressing EGFR along with either PKCζ or PKCε 
corresponds to the hydrogen peroxide treatment in its potency for inducing tyrosine 
phosphorylation. 
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Figure 3.4. EGF induces tyrosine phosphorylation of PKCζ and PKCε in a concentration-dependent maner. 
COS-7 cells were transiently transfected with PKCζ (A), PKCε (C), co-transfected with PKCζ and EGFR expression 
vectors (B) or PKCε and EGFR expression vectors (D). Cells were serum starved and then left untreated, treated with 
indicated EGF concentrations for 5 min or treated with 5mM H2O2 for 10 min as a positive control. PKC 
immunoprecipitates were analysed by Western blotting with PY99 phosphotyrosine-specific antibody and reprobed 
with PKCζ-specific antibody (A, B) or PKCε-specific antibody (C, D). Results shown are representative of four 
independent experiments. 
 
 
Figure 3.5. Tyrosine phosphorylation of PKCζ and PKCε is early event in response to EGF stimulation. COS-
7 cells co-expressing either EGFR and PKCζ (A) or EGFR and PKCε (B) were stimulated with 10nM EGF for 
indicated time periods. PKC immunoprecipitates were analysed by Western blotting with PY99 phosphotyrosine-
specific antibody and reprobed with PKCζ- (A) or PKCε- specific antibody (B). Shown is a representative of two 
independent experiments. 
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The time course of the modification of PKCζ and PKCε by tyrosine phosphorylation was 
followed in COS-7 cells co-expressing EGFR and PKCζ or EGFR and PKCε. Tyrosine 
phosphorylation of both isoforms can be detected very early- after 30 sec stimulation with 10nM 
EGF. The level of the tyrosine phosphorylation of PKCζ peaked at this early time point, 
decreased slightly upon EGF stimulation for 1min, again increased after 2 min and sustained for 
the prolonged time periods of stimulation - up to 10 min as it is shown on Figure 3.5.A. The level 
of PKCε tyrosine phosphorylation increased after 30 sec EGF stimulation, showed some decrease 
upon EGF stimulation for 1min and gradual increased in response to EGF stimulation for 2 –10 
min (Figure 3.5.B). Thus it became clear that both PKCζ and PKCε are tyrosine phosphorylated 
in response to EGFR stimulation in a ligand concentration-dependent manner. Moreover, the 
modification of both PKC isoforms appeared to be early event upon EGFR stimulation with 
slightly biphasic patterns and different kinetic of PKCζ and PKCε tyrosine phosphorylation. As 
the experiments using 5 min stimulation with 1 to 10 nM EGF were best reproducible we have 
followed this conditions in our further experiments. 
 
3.2.2. Dependence on EGFR tyrosine kinase activity 
 
In order to assess the importance of EGFR tyrosine kinase activity for EGF-induced tyrosine 
phosphorylation of PKCζ and PKCε we pretreated the cells with 10nM AG1478, an inhibitor of 
EGFR kinase activity, for 30 min prior stimulation with 10nM EGF for 5 min.  
 
 
 
Figure 3.6. Tyrosine phosphorylation of PKCζ is dependent on the kinase activity of the EGFR. (A) COS-7 
cells co-transfected with 2µg PKCζ and 1µg wt EGFR were serum starved, pretreated for 30 min with vehicle or 
10nM AG1478 and then left untreated or stimulated with EGF as indicated. PKCζ was immunoprecipitated and 
analysed by Western blotting with anti-phosphotyrosine PY99 antibody and reprobed with PKCζ antibody. (B) COS-
7 cells were transfected with 0.3µg PKCζ plus 0.3µg wt EGFR or 0.3µg PKCζ along with 3µg EGFR dimerization 
mutant ∆CR1. Cells were serum starved and then left untreated or stimulated with EGF as indicated. PKCζ 
immunoprecipitates were analysed as in (A). Expression levels of EGFR wild type and EGFR ∆CR1 were compared 
in cell lysates, probed with anti-EGFR antibody 13G8. Results are representative of four independent experiments 
for AG1478 effect and two independent experiments for ∆CR1 influence. 
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Inhibition of the EGFR activity by such pretreatment fully abolished the basal as well as EGF-
induced tyrosine phosphorylation of both PKCζ (Fig. 3.6.A) and PKCε (not shown). This 
observation demonstrated that the tyrosine kinase activity of EGFR is critically involved in the 
tyrosine phosphorylation of both PKC isoforms. From this point the tyrosine phosphorylation of 
PKCε downstream of EGFR activation became a task for the diploma work of Sabine Maerz. 
Additional evidence supporting the role of the receptor tyrosine kinase in PKCζ tyrosine 
phosphorylation came from the experiment in which we overexpressed a dimerization mutant of 
EGFR (∆CR1) instead of the wild type (Figure 3.6.B). This mutant EGFR is not able to dimerize 
upon ligand stimulation, due to the lack of the entire dimerization arm in domain II (Garrett et al., 
2002). When the dimerization mutant of EGFR is coexpessed together with PKCζ the basal as 
well as the EGF-induced tyrosine phosphorylation of PKCζ is significantly reduced, compared to 
the tyrosine phosphorylation mediated by wild type EGFR. The effect of both AG1478 and 
EGFR dimerization mutant on the basal tyrosine phosphorylation might be explained by 
involvement of the ligand-independent basal activity of the overexpressed EGFR. The results 
obtained upon EGFR dimerization mutant co-expression further supported the suggestion that 
functional and catalytically active EGFR is required for the observed PKCζ modification on 
tyrosine residues upon EGF stimulation.  
 
3.2.3. Dependence on Src tyrosine kinase activity 
 
Many recent reports demonstrate involvement of Src family of non-receptor tyrosine kinases in 
tyrosine phosphorylation of PKC upon number of stimuli. On the other hand Src is activated 
downstream of EGFR activation. Therefore, we investigated the involvement of Src family 
tyrosine kinases as possible mediators of EGFR-induced tyrosine phosphorylation of PKCζ. We 
found that overexpression of wild type Src resulted in a significantly increased level of basal as 
well as EGF-induced tyrosine phosphorylation of PKCζ (Figure 3.7). Moreover, upon co-
transfection of the dominant negative (RF) mutant of Src, both the basal and EGF-induced 
tyrosine phosphorylation of PKCζ were severely abrogated. Wild type and dominant negative Src 
were equally expressed. PKCζ and EGFR expression levels were in similar manner reduced upon 
either wild type or dominant-negative Src co-expression and can not account for the differences 
observed in the tyrosine phosphorylation. Thereby the effects of wild type and dominant negative 
Src unequivocally suggest that Src family cytoplasmic tyrosine kinase activity is necessary for 
the tyrosine phosphorylation of PKCζ downstream of EGFR activation.  
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Figure 3.7. PKCζ tyrosine phosphorylation depends on the kinase activity of Src. COS-7 cells were co-
transfected with 0,6µg (40 ngDNA/105 cells) PKCζ and EGFR and either 0.7µg (50 ngDNA/105 cells) wild type Src 
or 1.2µg (80 ng cDNA/ 105 cells) dominant negative Src. Cells were serum-starved and left untreated or EGF 
stimulated as indicated. PKCζ was immunoprecipitated and analysed by Western immunoblotting with 
phosphotyrosine-specific antibody PY99 and reprobed with PKCζ-specific antibody. Expression of Src and EGFR 
were analysed in aliquots of the cell lysates (corresponding to 105 cells) using anti-Src antibody (clone 327) and anti-
EGFR (13G8) antibody. Similar results were obtained in two independent experiments. 
 
 
3.2.4. Dependence on PI3K activity and PIP3 production. 
Next we used PI3K inhibitors to check the possible involvement of PI3K activity in EGFR-
induced tyrosine phosphorylation of PKCζ. As it is shown on Figure 3.8.A the pretreatment either 
with 25µM LY294002 or 100nM Wortmannin for 30 min led to partial decrease in EGF-induced 
PKCζ tyrosine phosphorylation. The effect of PI3K inhibitors was less pronounced than the 
effects of EGFR tyrosine kinase inhibitor, EGFR dimerization mutant or Src dominant negative 
mutant. This was the indication for partial dependence of PKCζ tyrosine phosphorylation on the 
activity of PI3K. We suggested that it could be the product of PI3K function PIP3, which is of 
importance for PKCζ tyrosine phosphorylation downstream of EGFR activation. Therefore, we 
analysed the influence of co-expression of PTEN- a lipid phosphatase implicated in the removal 
of phosphate from the third position of PIP3. The effect of PTEN co-expression on EGF-induced 
PKCζ tyrosine phosphorylation was really strong inhibition (Figure 3.8.B) but since the EGFR is 
lower expressed the PTEN effect probably is only partial. Upon co-expression of wild type 
110beta catalytic subunit of PI3K the EGF-stimulated tyrosine phosphorylation of PKCζ was not 
positively influenced. Moreover, the basal tyrosine phosphorylation of PKCζ was decreased (data 
not shown). The results demonstrated partial dependence of PKCζ tyrosine phosphorylation on 
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the PI3K activity probably based on the need of PIP3 production for recruitment of PKCζ close to 
the membrane.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. PI3K is involved in PKCζ tyrosine phosphorylation downstream of EGFR activation. COS-7 cell 
were cotransfected with 40ng/105 cells PKCζ and EGFR (A), or with 75ng/105 cells of each PKCζ, EGFR and 
PTEN-T7 expression vectors (B). Serum-starved cells were pretreated with vehicle, 25µM LY 294002 or 100nM 
Wortmannin  (A) for 30 min prior to 10nM ЕGF stimulation for 5 min as indicated. PKCζ was immunoprecipitated 
and analysed by Western blotting with phosphotyrosine-specific antibody 4G10 (A) or PY99 (B) and reprobed with 
PKCζ-specific antibody. Expression of T7-PTEN and EGFR were analysed in aliquots of the cell lysates 
(corresponding to 105 cells) using anti-T7 tag antibody and anti-EGFR (13G8) antibody. Similar results were 
obtained in two independent experiments. 
 
3.2.5. Involvement of the tyrosine residues in the cytoplasmic part of the EGFR  
 
Further we tried to identify which of the tyrosine residues in the cytoplasmic part of EGFR are 
required for tyrosine phosphorylation of PKCζ to occur. We co-expressed PKCζ together with 
EGFR mutants each possessing a substitution of distinct tyrosine residue serving as a docking site 
in its phosphorylated state to unphosphorylatable phenylalanine residue. In this way we attempted 
to estimate first whether the activation of distinct signalling cascades downstream of EGFR 
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contributes to PKCζ tyrosine phosphorylation and second, whether some of these docking sites 
are involved in assembling the proteins involved in PKCζ tyrosine phosphorylation. 
Phosphotyrosine 992 is a direct binding site for the phospholipase C-γ (PLC-γ) SH2 domain. 
Phosphotyrosine 1173 represents an additional docking site that couple EGFR to PLC-γ pathway. 
Via Gab1 and p85 recruitment to phosphotyrosine 1086 EGFR activation is linked to activation 
of Akt/PKB cascade (Figure 1.1.). In contrast to these autophosphorylation sites tyrosine 845 in 
the activation loop of EGFR represents Src-phosphorylation site. In our cell model we must 
always consider the function of endogenous EGFR in COS-7 cells, which is not impaired by the 
overexpression of different EGFR mutants and could account for at least part of the observed 
PKCζ tyrosine phosphorylation.  Coexpression of Y1173F Y992F, and Y1086F EGFR mutants 
influenced PKCζ tyrosine phosphorylation state in a positive, rather that in a negative manner 
(Figure 3.9.A).  
 
   
Figure 3.9. Role of tyrosine phosphorylation sites of EGFR on EGFR-induced tyrosine phosphorylation of 
PKCζ. COS-7 cells were cotransfected with 100ng/105 cells PKCζ and EGFR expression constructs WT, Y1173F, 
Y992F or Y1086F (A) or with 40ng/105cells PKCζ and wild type EGFR or 260ng /105cells EGFR Y845F mutant 
(B). Serum-starved cells were treated with 10nM EGF as indicated. PKCζ was immunoprecipitated and analysed by 
Western blotting with phosphotyrosine-specific antibody PY99 and reprobed with PKCζ-specific antibody. 
Expression of WT EGFR and EGFR mutants were analysed in aliquots of the cell lysates (corresponding to 105 cells) 
using anti-EGFR (13G8) antibody. Similar results were obtained in two (A) independent experiments. (C) PKCζ 
tyrosine phosphorylation in cells expressing EGFR Y845F related to the cells expressing wild type EGFR. The 
results are expressed as means ± standard errors from 5 independent experiments. A representative one is shown in 
(B). 
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EGF-induced PKCζ tyrosine phosphorylation in cells coexpressing one of the listed above EGFR 
mutants was even higher compared to the wild type EGFR-mediated one. Interestingly, upon 
coexpression of Y845F mutant of EGFR, tyrosine phosphorylation of PKCζ is significantly 
diminished compared to the modification observed upon coexpression of wild type EGFR (Figure 
3.9.B). Quantification of the reduction in PKCζ tyrosine phosphorylation upon expression of 
EGFR Y845F mutant revealed that its basal phosphorylation is 40% and the EGF-stimulated 
increase is 65 % of the respective levels in cells that express wild type EGFR (Figure 3.9.C). This 
suggests that phosphorylation of tyrosine 845 is necessary for the PKCζ tyrosine phosphorylation 
downstream of EGFR. As long as it has been demonstrated that tyrosine 845 of EGFR is Src 
phosphorylation site this is further evidence for the functional involvement of Src in EGFR-
mediated PKCζ tyrosine phosphorylation.  
 
3.2.6. Tyrosine phosphorylation of PKCζ and PKCε in correlation with its activity state 
 
Another interesting point was to adrress the relation of the modification of PKCζ by tyrosine 
phosphorylation to the activity state of the enzyme. We assessed that by comparison of the 
EGFR-mediated tyrosine phosphorylation of wild type, constitutively active and kinase inactive 
PKCζ or PKCε. Constitutively active mutants of both PKC isoforms possess mutation of Ala to 
Glu in the pseudosubstrate region, which prevents pseudosubstrate inhibiton (Decock et al., 
1994). The kinase inactive mutants harbor substitution of critical Lys residue to Arg at the ATP 
binding site of the kinase domain (Jaken et al., 1996). Despite that COS-7 cells express 
endogenously PKCζ, whose tyrosine phosphorylation masks that of the respective mutants, we 
found significant and reproducible differences between their levels of tyrosine phosphorylation. 
Constitutively active mutant of PKCζ is less tyrosine phosphorylated compared to the wild type 
enzyme, whereas the inactive mutant of PKCζ is significantly higher tyrosine phosphorylated in 
response to EGF stimulation (Figure 3.10.A). The differences were even more pronounced in the 
case of the respective mutants of PKCε (Figure 3.10.B). The absolute increase in the EGF-
induced tyrosine phosphorylation of both PKCζ and PKCε inactive species is more significant 
when we consider their lower expression levels. In addition, using different ratios of the 
expression vectors for PKCζ and EGFR during transfection we found that when the PKCζ : 
EGFR ratio is 2:1 the tyrosine phosphorylation of PKCζ is lower compared to the modification 
observed under 1:1 ratio of both constructs (not shown). These results indicated that the activity 
state or the relative amount of PKCζ influences its EGFR-mediated tyrosine phosphorylation 
might reflect the negative feedback regulation of EGFR tyrosine kinase activity probably by 
PKC-mediated threonine phosphorylation.  
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Figure 3.10. Tyrosine phosphorylation of PKCζ and PKCε is dependent on PKC activity state. COS-7 cells 
were cotransfected with 60ng/105 cells EGFR and 125ng/105 cells of WT, constitutive active, or inactive PKCζ 
expression constructs (A), or WT, constitutive active, or inactive PKCε (B). Serum-starved cells were stimulated 
with 1nM and 10nM EGF as indicated. PKCs were immunoprecipitated and analysed by Western blotting with anti-
phosphotyrosine PY99 antibody and reprobed with PKCζ (A) or PKCε (B). Similar results were obtained in two 
independent experiments. 
 
 
3.3. Interaction of PKCζ and EGFR 
 
3.3.1. Co-immunoprecipitation 
 
In the course of our investigation on the EGFR-mediated PKCζ tyrosine phosphorylation we 
identified a co-immunoprecipitation of tyrosine phosphorylated PKCζ with another tyrosine 
phosphorylated protein with apparent molecular weight about 170-180 kDa (Figure 3.11.A). 
Furthermore, the reprobing with EGFR-specific antibody revealed that the tyrosine- 
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phosphorylated band could be identified as EGFR, thus indicating for direct or indirect 
interaction between the EGFR and PKCζ.  
 
 
Figure 3.11. Co-immunoprecipitation of EGFR and PKCζ. COS-7 cells were transfected with 75ng/105 cells 
EGFR expression construct or cotransfected with 150ng/105 cells PKCζ and 75ng/105 cells EGFR (A), or with 100 
ng/105 cells of PKCζ and 100 ng/105 cells EGFR (B and C), with 120ng/105 cells PKCζ along with different amount 
of EGFR as indicated (D), with 100ng/105 cells PKCζ and 100ng/105 cells EGFR for 1:1 ratio or 135ng/105 cells 
PKCζ and 65ng/105 cells EGFR for 2:1 ratio upon transfection (E). Serum-starved cells were stimulated with EGF as 
indicated. PKCζ immunoprecipitates or control immunoprecipitates with normal rabbit immunoglobulin (B) were 
analysed by Western blotting with phosphotyrosine-specific antibody PY99 and reprobed with EGFR-specific 
antibody (A, D) and PKCζ-specific antibody (A, B and C). Expression of WT EGFR was analysed in aliquots of the 
cell lysates (corresponding to 105 cells) using anti-EGFR (13G8) antibody (A). The results are respresentative of 
three independent experiments. 
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In parallel lane immunoprecipitate of endogenous PKCζ from EGFR overexpressing COS-7 cell 
shows no unspecific reactivity of the PKCζ antibody to the highly expressed EGFR. The 
specificity of the co-immunoprecipitation of PKCζ with EGFR was further tested by the use of 
normal rabbit immunoglobulin as a negative control in the immunoprecipitation of cell lysates 
from cells co-transfected with EGFR and PKCζ. The co-immunoprecipitation was observed only 
in the PKCζ-specific antibody immunoprecipitates but not upon immunoprecipitation performed 
with the same amount of normal rabbit immunoglobulin (Figure 3.11.B). The first result 
indicating co-immunoprecipitation (Figure 3.11.A) showed that more EGFR is found in PKCζ 
immunoprecipitates in the non-stimulated cells. Upon stimulation with 1nM and 10nM EGF the 
amount of EGFR co-immunoprecipitating with PKCζ as well as its tyrosine phosphorylation were 
clearly reduced. These patterns of the tyrosine phosphorylation of the EGFR in PKCζ 
immunoprecipitates were not reproduced in all further experiments (Figure 3.11. A and B). More 
typical result was as it is shown on Figure 3.11.C- EGFR interacting with PKCζ under non-
stimulated conditions was lower tyrosine phosphorylated, whereas EGFR in PKCζ 
immunoprecipitates from cells treated for 5 min with 1-10nM EGF was highly tyrosine 
phosphorylated. In order to explain these different patterns of co-immunoprecipitation we 
compared the tyrosine phosphorylation of the EGFR in PKCζ immunoprecipitates under non-
stimulated conditions in relation to the amount of EGFR expression vector used for transfection. 
We observed that the co-immunoprecipitation was more pronounced in the cells transfected with 
lower amount EGFR 25-50ng EGFR per 105 cells and respectively decreased upon transfection of 
more 75-100ng/105 cells (Fig.3.11.D). In addition, the detection of co-immunoprecipitation 
between EGFR and PKCζ showed dependency on the ratio of both expression constructs used for 
transfection, thereby dependent on the stoichiometric ratio of both expressed proteins, similarly 
to PKCζ tyrosine phosphorylation. When both vectors are used during transfection in the ratio 1:1 
(1.5 µg : 1.5 µg) 10nM EGF stimulation leads to increased tyrosine phosphorylation of the EGFR 
in PKCζ immunoprecipitates. In contrast when the transfection ratio was 1:2 (1µg EGFR: 2 µg 
PKCζ) the tyrosine phosphorylation of the EGFR co-immunoprecipitating with PKCζ was higher 
under basal conditions (Figure 3.11.E). Therefore small changes in the plasmid DNA amount and 
ratio used in different transfections could explain the variations we found in the co-
immunoprecipitation patterns. 
Under completely endogenous conditions no co-immunoprecipitation was found in lysates from     
the typical number of COS-7 cells used in our experiments (1.4-1.6 x 106). Using lysates from 3 x 
106 cells stimulated with 1nM EGF PKCζ was identified in EGFR immunoprecipitates (Figure 
3.12.A). Vice versa EGFR has been found in PKCζ immunoprecipitates upon EGF stimulation 
but not in normal rabbit IgG immunoprecipitates. 
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Figure 3.12. Co-immunoprecipitation of EGFR and PKCζ under endogenous conditions. 3 x 106 COS-7 cells 
(A) or 1.5 x 106 A431 (B) and MCF-7 cells (C) untreated or stimulated with EGF as indicated were lysed. Parallel 
immunoprecipitations with EGFR-specific antibody, PKCζ-specific antibody, or normal rabbit immunoglobulin were 
carried on. Immunoprecipitates were analysed by Western blotting with phosphotyrosine-specific antibody PY99 and 
reprobed with either EGFR-specific antibody 13G8 or PKCζ-specific antibody. Expression level of EGFR and PKCζ 
were analyzed in aliquots of the cell lysates (corresponding to 105 cells) using EGFR-specific antibody (13G8) and 
PKCζ-specific antibody (D). Similar results were obtained in two independent experiments. 
 
In epidermoid carcinoma cell line A431 harboring highly overexpressed EGFR (106 
receptors/cell) PKCζ seemed to be only faintly tyrosine phosphorylated upon stimulation with 
10nM EGF. Figure 3.12.B shows that neither non-immune IgG nor PKCζ-specific antibody 
recognizes EGFR despite of its huge amount. Only the phosphotyrosine-specific antibody 
detected a band on its position in PKCζ immunoprecipitates from cells stimulated with 10nM 
EGF. In EGFR immunoprecipitates other tyrosine-phosphorylated protein with slightly lower 
molecular weight than PKCζ was identified. Obviously, if any interaction between EGFR and 
PKCζ occurs in A431 cells, it is detectable only after 10nM EGF stimulation and only in one 
direction- EGFR in PKCζ immunoprecipitates but not vice versa.  Breast carcinoma cell line 
MCF-7 has normal levels of EGFR (1.5 x 104 receptors/cell). As it is shown on Figure 3.12.C 
EGFR was detected in PKCζ immunoprecipitates and vice versa PKCζ was found in EGFR 
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immunoprecipitates. In addition PKCζ was tyrosine phosphorylated upon EGF stimulation. These 
results indicate that both the interaction of EGFR and PKCζ and EGFR-induced tyrosine 
phosphorylation of PKCζ take place under endogenous conditions and could be of some 
importance in the signal transduction of cancer cell lines. Figure 3.12.D shows that PKCζ 
expression in COS-7, A431 and MCF-7 is similar, whereas they express different amount EGFR- 
low in MCF-7 and COS-7 cells and highly overexpressed in A431.     
In COS-7 cells transfected with both PKCζ and EGFR we not only found EGFR in PKCζ 
immunoprecipitates but we also identified vice versa PKCζ in EGFR-specific antibody 
immunoprecipitates. The time course of the interaction between PKCζ and EGFR is shown on 
Figure 3.13. The co-immunoprecipitation was detected under basal conditions in both directions 
and both EGFR in PKCζ immunoprecipitates as well as PKCζ in EGFR immunoprecipitates 
showed an increase after short-term stimulation with 10nM EGF (30 sec). The EGFR detected in 
the PKCζ immunoprecipitates dropped to the basal amount for stimulation times ranging from 1 
min up to 5 min. The amount of PKCζ detected in the EGFR immunoprecipitates is still high 
after 1 min stimulation and decreased during 3 to 15 min long EGF stimulation time. A second 
phase of increased co-immunoprecipitation was observed between 10 and 30 min for EGFR in 
the PKCζ immunoprecipitates and after 20 min EGF stimulation for PKCζ in EGFR 
immunoprecipitates, respectively. There is good correlation of the time course of the vice versa 
co-immunoprecipitations with some shift for PKCζ in EGFR immunoprecipitates to the late time 
points.  The threonine phosphorylation of EGFR followed PKCζ presence in the EGFR 
immunoprecipitates showing corresponding time-dependent changes with some increase between 
1 and 5 min, decrease after 10 to 15 min and further increase after 20 min EGF stimulation 
(Figure 3.13.A). The only difference is that while upon 3-5 min EGF stimulation PKCζ co-
immunoprecipitation with the EGFR decreases, EGFR threonine phosphorylation remained 
elevated.  PKCζ tyrosine phosphorylation is significantly increased after 30 sec EGF stimulation 
and remained at this elevated level for the whole time period studied (Figure 3.13.B). Tyrosine 
phosphorylation of EGFR in PKCζ immunoprecipitates was correspondent to the amount of 
EGFR. It is worth to point that from 1 up to 5 min EGF stimulation less EGFR with elevated 
threonine phosphorylation interacts with PKCζ. Endogenous EGFR was detected in 
immunoprecipitates of overexpressed PKCζ and vice versa overexpressed PKCζ was detected in 
endogenous EGFR immunoprecipitates (Figure 3.13.C). We found that wild type PKCζ 
interaction with EGFR is slightly increased upon 10nM EGF stimulation for 5 min. 
Constitutively active PKCζ was found in high amount in EGFR co-immunoprecipitates under 
basal conditions and the interaction decreased in response to EGF stimulation, whereas the 
interaction of inactive PKCζ with the EGFR is significantly lower. It seems that the inactive 
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mutant of PKCζ, which is higher tyrosine-phosphorylated, interacts with the EGFR to a less 
extent, compared to the less tyrosine-phosphorylated constitutively active PKCζ. 
 
Figure 3.13. coIP vice versa and time course of the coIP.  COS-7 cells were cotransfected with 100 ng/105 cells 
PKCζ and 100 ng/105 cells EGFR expression vectors (A, B) or transfected with 100ng/105 cells either wild type, 
constitutively active, or inactive mutant of PKCζ (C). Serum-starved cells were stimulated with 10nM EGF for 
different time periods as indicated (A, B) or for 5 min (C).  Immunoprecipitations were performed with EGFR-
specific antibody clone 425 (A) or from Santa cruz (C) and with PKCζ-specific antibody (B, C). The 
immunoprecipitates were analysed by Western blotting with EGFR-specific antibody 13G8 (A, B, C) or 
phosphotyrosine-specific antibody PY99 (C) and reprobed with phosphothreonine-specific and PKCζ-specific 
antibody (A) phosphotyrosine-specific antibody and PKCζ-specific antibody (B) or with PKCζ-specific antibody (C). 
Similar results were obtained in two independent experiments. 
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This might indicate that the presence of PKCζ in EGFR signalling complex is related to the PKC-
dependent threonine phosphorylation of EGFR, but is not directly related to the level of EGFR-
induced tyrosine phosphorylation of PKCζ. Thus we can hypothesize that PKCζ tyrosine 
phosphorylation takes place via indirect interaction with the EGFR, probably through some 
adaptor protein. 
Next we analysed the co-immunoprecipitation of PKCζ with different EGFR mutants. As it is 
shown on Figure 3.14.A all EGFR mutants were found to co-immunoprecipitate with PKCζ but 
in different manner. In this experiment the interaction of the wild type EGFR with PKCζ was 
higher under the unstimulated conditions and decreased upon EGF stimulation (1-10nM). The 
same were the patterns of the co-immunoprecipitation with PKCζ of EGFR mutants Y992F and 
Y1086F. The overall amount of EGFR Y1086F in PKCζ immunoprecipitates is less compared to 
that of wild type EGFR and EGFR Y992F. These differences cannot be explained with different 
expression of EGFR mutants. Western blot analysis of aliquots from the same lysates with 
EGFR-specific antibody revealed that different EGFR mutants have equal expression levels 
(Figure 3.14.A). Since tyrosine 1086 is involved in PI3K activation our finding could indicate 
that functional activation of PI3K pathway downstream of EGFR is important for the interaction 
of PKCζ with the EGFR- probably mediated via PIP3 generation and PIP3-dependent recruitment 
of PKCζ to the membrane compartment, which increase the probability for the interaction with 
the EGFR. The interaction of EGFR Y992F with the PKCζ is to some extent more pronounced 
than that of the EGFR wild type indicating probably for some competition between PKCζ and 
PLCγ for interaction with EGFR. Moreover, the EGFR mutant harboring substitution of the PLCγ 
and SHP1-docking tyrosine 1173 to phenylalanine showed EGF-stimulation-dependent increase 
of the co-immunoprecipitation with PLCγ. This suggests that upon EGF-stimulation and in the 
absence of bound PLCγ and or SHP1 the interaction of EGFR and PKCζ is favored. Interestingly, 
in correlation with the lower EGF-induced tyrosine phosphorylation of PKCζ upon expression of 
EGFR mutant Y845F, the amount of the EGFR co-immunoprecipitating with PKCζ is very low. 
This finding demonstrates the critical role for the phosphorylation of tyrosine 845 on EGFR and 
probably the activated downstream of phosphotyrosine 845 signalling pathways in the interaction 
between EGFR and PKCζ.  Figure 3.14.B shows that in addition to tyrosine 845, EGFR 
dimerization is also required for the interaction of both molecules. Demonstration for that is the 
diminished co-immunoprecipitation of the EGFR dimerization mutant with PKCζ. Both EGFR 
mutants, which showed diminished PKCζ tyrosine phosphorylation, have also impared co-
immunoprecipitation with PKCζ. Figure 3.14.C represents quantification of the decrease in the 
co-immunoprecpitation of EGFR Y845F with PKCζ in comparison to the wild type EGFR. 
Substitution of tyrosine 845 of EGFR to phenylalanine caused around 45 % decrease in the 
interaction with PKCζ. 
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Figure 3.14. Co-immunoprecipitation of EGFR mutants with PKCζ.  COS-7 cells were cotransfected with 
40ng/105 cells PKCζ along with either 40ng/105 cells EGFR wild type, Y1173F, Y992F, Y1086F or 270ng/105 cells 
EGFR Y845F (A); with 20ng/105 cells PKCζ along with either 20ng/105 cells wild type EGFR, 200ng/105 cells 
EGFR ∆CR1, or 200ng/105 cells EGFR Y845F (B). Serum-starved cells were stimulated with 1-10nM EGF as 
indicated. PKCζ was immunoprecipitated and immunoprecipitates were analysed by Western blotting with anti-
phosphotyrosine antibody PY99 and reprobed with EGFR-specific antibody 13G8 (A), and PKCζ-specific antibody 
(A and B). Expression of WT EGFR and EGFR mutants were analysed in aliquots of the cell lysates (corresponding 
to 105 cells) using anti-EGFR (13G8) antibody. Similar results were obtained in two independent experiments for all 
mutants. In (C) co-immunoprecipitation of EGFRY845F with PKCζ as the mean ± SEM from five independent 
experiments is expressed as the percentage of the co-immunoprecipitation of EGFR-WT with PKCζ. 
 
Next we addressed the importance of PI3K function for the interaction of EGFR and PKCζ. 
Pretreatment with PI3K inhibitor wortmannin had no influence on the basal interaction, but led to 
abolishment of the EGF stimulation-induced increase in the interaction (Figure 3.15.A). 
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Therefore, EGFR-mediated activation of PI3K probably via PIP3 production contributes to the 
recruitment of PKCζ to the receptor complex. Moreover, co-expression of p110beta subunit of 
PI3K caused dramatic decrease in EGFR co-immunoprecipitation with PKCζ (Figure 3.15.B). 
When instead of wild type 110beta the respective kinase dead mutant was co-expressed, there 
was no influence on the EGFR co-immunoprecipitation with PKCζ.  Figure 3.15.C shows that 
there is interaction of endogenous 110beta with overexpressed PKCζ under unstimulated 
conditions, which is not detectable upon stimulation with 10nM EGF.   
 
 
Figure 3.15. Influence of the PI3K signalling pathway on the interaction of PKCζ with the EGFR. COS-7 cells 
were cotransfected with 40ng/105 cells PKCζ along with 40ng/105 cells EGFR expression constructs (A); with 
100ng/105 cells PKCζ along with 100ng/105 cells EGFR (B and D) or with 70ng/105 cells each PKCζ, EGFR and 
either 110 beta wild type, or 110 beta KR mutant (B); with 125ng/105 cells PKCζ (C). Serum-starved cells were 
pretreated with 100nM Wortmannin for 30 min (A) and stimulated with 10nM EGF for 5 min as indicated. PKCζ 
was immunoprecipitated and the immunoprecipitates were analysed by Western blotting with phospho-tyrosine 
antibody 4G10 (A), PY99 (B), PI3K 110 beta subunit-specific antibody (C), or phospho-Akt-specific antibody (D) 
and reprobed with EGFR-specific antibody 13G8 (A) or PKCζ-specific antibody (B, C and D). Similar results were 
obtained in two independent experiments. 
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Another potential interacting partner of PKCζ in the PI3K-dependent pathway is Akt/PKB. As it 
is shown on figure 3.15.D in COS-7 cells such interaction occurs and is stimulated under 
complete endogenous conditions by EGF but is reduced upon EGFR overexpression. PKCζ co-
immunoprecipitation patterns of both 110beta and Akt may reflect interaction of PKCζ with 
110beta and Akt under basal conditions and recruitment of PKCζ from PI3K complex to EGFR 
signalling complex in response to EGF stimulation. EGFR and PKCζ co-immunoprecipitated vice 
versa upon overexpression in COS-7 cells, as well as under endogenous conditions and this 
finding was indicative for their direct or indirect interaction. EGFR stimulation caused transient 
increase in the association. Moreover, the interaction seems to be dependent on the EGFR 
dimerization, on the phosphorylation of tyrosine 845 of EGFR and on the PI3K activity.  
 
3.3.2. Co-localization of EGFR and PKCζ 
 
We performed co-localization studies with green fluorescent protein fusion variants of both 
proteins as an additional approach to study the association of EGFR and PKCζ. First we proved 
that PKCζ fused to either EYFP or ECFP is also tyrosine phosphorylated in response to EGF 
stimulation (Figure 3.16.A). Figure 3.16.B demonstrates that EGF stimulation of EGFR-CFP-
expressing cells leads also to tyrosine phosphorylation of PKCζ. In both cases the intensity of 
PKCζ tyrosine phosphorylation is similar to that of wild type PKCζ upon stimulation of wild type 
EGFR. We selected Lipofetamine 2000 transfection for the colocalization studies as less toxic for 
the cells and confering equal delivery of coexpressed proteins. COS-7 cells were transfected with 
EGFR-CFP and PKCζ-EYFP alone or in combination. The cellular localization of fluorescent 
label-fused EGFR and PKCζ was detected by the use of laser scanning microscopy on fixed cells.  
 
Figure 3.16. Characterization of EGFR-CFP and PKCζ-EYFP/ECFP fusion constructs. COS-7 cells were 
cotransfected by DEAE-dextran method with 100ng/105 cells PKCζ, PKCζ-EYFP or PKCζ-ECFP along with 
100ng/105 cells EGFR (A) or with 40ng/105 cells PKCζ along with the same amount of either EGFR or EGFR-CFP 
(B). PKCζ immunoprecipitates were analysed with phosphotyrosine-specific antibody and reprobed with PKCζ-
specific antibody. Similar results were obtained in three independent experiments.   
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Figure 3.17. Co-localization of EGFR-CFP and PKCζ-EYFP. COS-7 cells were transfected in 6 well plates using 
Lipofectamine 2000 with either 2.5µg EGFR-CFP or 1.5µg PKCζ-EYFP (A) or co-transfected with 2.5µg EGFR-
CFP along with 1.5µg PKCζ-EYFP (B). Serum-starved cells either left untreated or stimulated with 10nM EGF for 1 
min or 5 min (A) or for 1 min (B) were fixed. Confocal fluorescent images of CFP, YFP ant their overlay were 
obtained using laser scanning microscope. The arrows (B) point to the colocalized structures in the overlay. 
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Figure 3.17.A shows the distribution of EGFR-CFP and PKCζ-EYFP upon their single 
overexpression. Figure 3.17.B demonstrates the subcellular localization of EGFR-CFP and 
PKCζ-EYFP in cells cotransfected with both expression constructs. Under unstimulated 
conditions PKCζ label was diffusely distributed throughout the whole cytoplasm with some 
concentration in the perinuclear area. Upon stimulation with 10nM EGF for 1min there is 
translocation of PKCζ to the plasma membrane. Membrane localization of PKCζ was reduced 
after 5 min EGF simulation. EGFR showed cytoplasmic granular localization under basal 
conditions without significant membrane labeling what is consistent with the basal localization 
reported by Yamazaki et al., 2002. In response to 1 min EGF stimulation significant EGFR label 
is found on the membrane and after 5 min EGF stimulation there was increasingly ruffled 
appearance of EGFR label on the plasma membrane (Figure 3.17.). In fact, only a small part of 
both EGFR and PKCζ translocates to the membrane, probably due to their high overexpression 
level. Co-expression of EGFR did not change the subcellular localization of PKCζ. In contrast 
EGFR subcellular localization is changed upon PKCζ co-expression with more granular 
cytoplasmic and perinuclear localization under basal conditions and less membrane labeling in 
response to EGF stimulation. There was some co-localization of EGFR and PKCζ without EGF 
stimulation in the perinuclear region. Upon stimulation with 10nM EGF for 1 min EGFR as well 
as PKCζ are detected on the plasma membrane and the overlay indicated that both molecules 
colocalize at the cell surface (Figure 3.17.B). Thus, PKCζ translocation to the membrane and co-
localization with EGFR in response to EGF stimulation observed by laser scanning microscopy 
represent an additional evidence for their interaction. 
 
3.4. Identification of tyrosine 417 of PKCζ as phosphorylation site  
 
Next question we addressed was which are the tyrosine residues of PKCζ targeted by EGFR-
induced phosphorylation. We used site-directed mutagenesis in order to introduce point mutation 
in PKCζ coding sequence, conferring substitution of particular tyrosine residue with 
phenylalanine, amino acid that is structurally related to the tyrosine but unphosphorylatable one. 
The vector construct with mutated PKCζ cDNA was used for transient transfection in COS-7 
cells for overexpression of mutated PKCζ protein, harboring the respective amino acid 
substitution. The residue we selected for mutagenesis was the highly conserved among all PKC 
isoforms as well as in the whole ABC family of protein kinases tyrosine neighboring the 
threonine residue at the activation loop. This conserved tyrosine resides in highly conserved 
region of the PKC catalytic domain (Figure 3.18.A). 
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            A AA  
Figure 3.18. EGF-induced phosphorylation of  
PKCζ triggers tyrosine 417. 
(A) Protein kinase C activation loop harbors  
conserved threonine and conserved tyrosine 
residue. Present is an alignment of the sequences  
surrounding activation loop threonine between 
PKC family members, Akt1, p70S6k, PRK2 and  
PKA. The activation loop threonine residue is  
labeled in yellow; the neighboring tyrosine is  
marked with red lines. 
 
 
 
 
(B) COS-7 cells were cotransfected 
 with 100ng/105 cells EGFR along  
with 100ng/105 cells of either wild 
 type PKCζ or PKCζ Y417F.  
Serum-starved cells were treated  
with 10nM EGF as indicated.  
 Immunoprecipitation was carried  
out either with PKCζ-specific 
antibody or the same amount of 
normal rabbit IgG as negative control. 
Immunoprecipitates were analysed  
  
omparison of the EGFR-induced tyrosine phosphorylation of PKCζ Y417F to that of wild type 
by Western blotting with  
phosphotyrosine-specific  
antibody PY99 and reprobed
with PKCζ- specific antibody. 
 
 
C
PKCζ in COS-7 cells cotransfected with EGFR revealed that its basal tyrosine phosphorylation is 
reduced compared to that of the wild type PKCζ. The EGF-induced tyrosine phosphorylation of 
PKCζ Y417F is reduced despite that the mutant is obviously still targeted by tyrosine 
phosphorylation (Figure 3.18.B). This revealed that Y417 is one of the tyrosines phosphorylated 
downstream of EGFR stimulation but that the EGFR-mediated modification targets other 
tyrosines as well. The interaction of Y417F PKCζ with the EGFR was not affected indicating that 
the association of PKCζ with the receptor is not dependent on the phosphorylation of this 
particular tyrosine residue.  
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3.5. EGFR-induced phosphorylation of PKCζ on tyrosine 417 is critically implicated in 
PKCζ activation downstream of EGFR stimulation 
 
In order to estimate the influence of EGFR stimulation-induced tyrosine phosphorylation on 
PKCζ enzyme activity we performed kinase activity assay of immunoprecipitated PKCζ with 
MBP (myelin basic protein) as phosphorylation substrate. Despite that after long exposure period 
we detected activation of endogenous PKCζ upon EGFR stimulation with 10nM EGF for 5 min 
(Figure 3.19.A), completely endogenous system did not allow us to study PKCζ activity in 
relation to its tyrosine phosphorylation. Overexpressed by transient transfection PKCζ had 
significantly elevated basal activity compared to the endogenous PKCζ activity (Figure 3.19.B).  
 
 
 
Figure 3.19. PKCζ activation by EGF stimulation. COS-7 cells were transfected with empty vector (A and B) or 
with PKCζ 150ng/105 cells (B). Serum-starved cells were left untreated or treated either with 5 mM hydrogen 
peroxide for 10 min (B) or with EGF as indicated.  PKCζ was immunoprecipitated and kinase assay was carried out 
with myelin basic protein as substrate. (C) EGF-induced PKCζ activation in relation to basal PKCζ activity. Resuts 
are expressed as means ± standart errors from five independent experiments. 
 
The high basal activity of PKCζ is known to cause difficulties in detecting stimulus-dependent 
activation but we found that overexpressed PKCζ is activated upon EGFR stimulation with 1-
10nM EGF for 5 min. Hydrogen peroxide treatment was used as a positive control for PKC 
activation in COS-7 cells (Konishi et al., 1997). PKCζ activity in response to 10nM EGF 
stimulation was quantified as 180% compared to the basal PKCζ activity (Figure 3.19.C). 
Moreover the PKCζ activity was corresponding to its tyrosine phosphorylation state. Inhibitors 
that influenced the tyrosine phosphorylation of PKCζ affected its activity state as well. The EGF-
dependent increase in PKCζ activity was sensitive to pretreatment with AG1478, thereby being 
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dependent on EGFR tyrosine kinase activity (Figure 3.20.). Despite of its partial effect on the 
tyrosine phosphorylation pretreatment with PI3K inhibitor LY294002 also abolished EGF-
induced increase in PKCζ activity, demonstrating dependence on PI3K activity during PKCζ 
activation downstream of EGFR stimulation. Interestingly, both EGF and H2O2 treatments further 
stimulated the elevated basal activity of constitutive active mutant of PKCζ in parallel with 
increase in its tyrosine phosphorylation. Moreover, the EGF-dependent increase in the activity of 
constitutive active PKCζ was AG1478 sensitive like that of wild type PKCζ (data not shown).   
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20.  EGFR and PI3K are involved in EGF-induced PKCζ activation. Serum-starved COS-7 cells 
transfected with 150ng/105 cells PKCζ were pretreated either with 10nM AG1478 or with 25 µM LY294002 for 30 
min prior to stimulation with 10nM EGF for 5 min as indicated. PKCζ was immunoprecipitated and immune 
complex kinase assay with MBP as substrate was performed. PKCζ immunoprecipitates used in the kinase assay 
were analysed by Western blotting with phosphotyrosine-specific antibody PY99 and reprobed with PKCζ-specific 
antibody. Similar results were obtained in three independent experiments.    
 
Next step was to estimate whether the phosphorylation of PKCζ on tyrosine 417 contributes to its 
EGFR-dependent activation. Surprisingly the mutant behaved as inactive one. The basal activity 
of PKCζ Y417F was significantly reduced and only weak activation was detected upon H2O2 
treatment whereas EGF treatment did not influence its activity at all (Figure 3.21.). In addition to 
MBP phosphorylation PKCζ autophosphorylation was estimated. Both H2O2 and EGF stimulated 
the autophosphorylation of wild type PKCζ with stronger effect of H2O2. Similar to the 
pronounced decrease in MBP phosphorylation by PKCζ Y417F mutant, its autophosphorylation 
is also affected and slightly stimulated only by H2O2 but not influenced by EGF. Again a 
correlation between the activity and the tyrosine phosphorylation was identified with higher 
phosphorylation and respectively higher activation induced by H2O2. The remaining tyrosine 
phosphorylation, which EGF stimulation induces on PKCζ Y417F obviously did not contribute to 
PKCζ activation. For comparison H2O2-induced tyrosine phosphorylation of PKCζ Y417F was 
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not significantly different to that of the wild type but also was not related to pronounced PKCζ 
activation.  
                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21. Comparison of PKCζ wt and PKCζ Y417F activity upon EGF and hydrogen peroxide 
stimulation. Serum-starved COS-7 cells cotransfected with 100ng/105 cells EGFR along with 100ng/105 cells either 
wild type PKCζ or PKCζ Y417F were stimulated with 5mM hydrogen peroxide for 5 min or 10 nM EGF for 5 min 
as indicated. PKCζ was immunoprecipitated and immune complex kinase assay with MBP as substrate was 
performed. In addition to MBP phosphoryaltion PKCζ autophosphorylation was estimated. PKCζ 
immunoprecipitates used in the kinase assay were analysed by Western blotting with phosphotyrosine-specific 
antibody PY99 and reprobed with PKCζ-specific antibody. Shown is representative of two independent experiments. 
 
We compared the PKCζ mutant harboring substitution of the activation loop threonine to alanine 
(T410A) and PKCζ Y417F concerning their tyrosine phosphorylation and activity state upon 
EGFR stimulation. As it was expected on the basis of well-established critical role of the 
threonine phosphorylation at the activation loop for PKCζ activity (Chou et al., 1998), PKCζ 
T410A was inactive, with low basal activity and absence of activation by EGFR stimulation. 
However, PKCζ T410A is tyrosine phosphorylated in response to EGFR stimulation. PKCζ 
Y417F basal activity and the activity upon EGF stimulation did not differ significantly from that 
of PKCζ T410A (Figure 3.22.). EGF stimulates the autophosphorylation of wild type PKCζ. 
PKCζ T410A had lowered and non-stimulated by EGF autophosphorylation, whereas the 
autophosphorylation of PKCζ Y417F was slightly higher but still unresponsive to EGF 
stimulation. Site-directed mutagenesis procedure targeting tyrosine-417 did not change the 
threonine-410 and respectively threonine-410 mutagenesis did not alter tyrosine-417. Thus, it 
appeared the tyrosine phosphorylation could not induce activation in the absence of threonine 
phosphorylation at the activation loop. Vice versa PKCζ Y417F harbors intact activation loop 
threonine but nevertheless is inactive. Therefore both the basal activity of PKCζ and EGFR-
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dependent activation of PKCζ require not only phosphorylation of the threonine at the activation 
loop, but phopshorylation of the neighboring tyrosine residue as well. 
    
                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22. Activity of wild type PKCζ, PKCζ Y417F and PKCζ T410A upon EGF stimulation. Serum-starved 
COS-7 cells were cotransfected with 100ng/105 cells EGFR along with 100ng/105 cells either wild type PKCζ, PKCζ 
T410A-EYFP or PKCζ Y417F were stimulated with 10nM EGF as indicated. PKCζ was immunoprecipitated ánd 
immune complex kinase assay with MBP as substrate was performed. PKCζ autophosphorylation was estimated as 
well. PKCζ immunoprecipitates used in the kinase assay were analysed by Western blotting with phosphotyrosine-
specific antibody PY99 and reprobed with PKCζ-specific antibody. Shown is representative of three independent 
experiments. 
 
3.6. Role of PKCζ and its tyrosine phosphorylation in the EGFR-activated signalling 
pathways 
 
3.6.1. MAPK (Erk1/Erk2) activation 
 
PKCζ is involved in the MAPK signalling cascades in many cell types and in the EGFR-induced 
Erk1/2 activation as well (Hirai and Chida, 2003). We determined the effect of PKCζ 
overexpression on the EGF-induced Erk activation by MBP phosphorylation assay with 
immunoprecipitates of overexpressed HA-MAPK (Erk2) along with immunoblot analysis with 
phospho-specific antibody (anti-phospho-Erk1/2). Moreover we compared the influences of wild 
type PKCζ, PKCζ Y417F and PKCζ T410A mutants on EGF-induced MAPK activation. 
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Figure 3.23.  Influence of wt PKCζ, PKCζ Y417F and PKCζ T410A on activation of MAPK. (A) COS-7 cells 
were cotransfected with 70ng/105 cells HA-MAPK along with 40 ng/105 cells EGFR and 40 ng/105 cells of either 
empty vector, wild type PKCζ, PKCζ T410A-EYFP or PKCζ Y417F. Serum-starved cells were stimulated with 
0.1nM EGF for 5 min as indicated. Activity assay was performed on MAPK immunoprecipitated with anti-HA 
antibody using MBP as substrate. MBP phosphorylation was detected by autoradiography. Immunoprecipitates were 
analysed by Western blotting with HA tag-specific antibody. In parallel aliquots (corresponding to 105 cells) of the 
same lysates analysed by Western blotting with phospho-Erk1/2-specific antibody, EGFR-specific antibody 13G8 or 
PKCζ-specific antibody and reprobed Erk2-specific antibody. EGF-induced increase in ERK activity expressed in 
percentage related to the basal activity upon expression of wt PKCζ, PKCζ Y417F and PKCζ T410A is presented as 
means ± SEM from four independent experiments (B). *-Significantly different from the basal level, +- significantly 
higher than the empty vector transfected cells. 
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Since stimulation with 10nM EGF led to almost maximal MAPK activation no big differences 
could be seen in the MAPK activity due to the overexpression of PKCζ and/or EGFR (not 
shown). In contrast, upon cell stimulation with lower EGF concentration (0.1nM) a substantially 
increased EGF-induced MAPK activation was detected in cells that overexpress wild type PKCζ 
(Figure 3.23.A). The quantification shown on Figure 3.23.B. revealed that EGF stimulates 
MAPK activity in empty vector-transfected cells around four-fold and that EGF-stimulated 
MAPK activity increased 1.75 fold upon overexpression of wild type PKCζ. Upon both PKCζ 
T410A and PKCζ Y417F overexpression the effect of PKCζ overexpression on MAPK activity 
downstream of EGFR is abolished and EGF-induced MAPK activity is similar to that in empty 
vector-transfected cells. The same trend was detected when instead of radioactive HA-MAPK 
activity assay Western blot analysis with phospho-Erk1/2-specific antibody was performed. Thus 
PKCζ catalytic activation in response to EGFR stimulation contributes to the MAPK (Erk1/Erk2) 
activation downstream of EGFR.  Since both catalytically inactive mutants are unable to exert 
such an effect, the PKCζ catalytic activation and EGF-induced tyrosine phosphorylation as its 
integral part are critically involved in EGFR-induced MAPK pathway.  
 
3.6.2. Akt/PKB pathway 
 
Next we assessed the role of PKCζ in Akt/PKB activation downstream of EGFR stimulation. We 
analysed Akt activation using phospho-specific antibody that recognizes the indicative for 
activation phosphoserine 473. Akt phosphorylation/activation reached maximum after 5-10 min 
EGF stimulation and gradually decrease upon longer EGF treatment (not shown). We estimated 
the impact of PKCζ overexpression or coexpression with EGFR on activation-related Akt 
phosphorylation upon stimulation with lower EGF concentrations (0.1-1 nM). As it is shown on 
Figure 3.24.A the overexpression of wild type PKCζ did not affect significantly EGF-induced 
Akt phosphorylation. In cells transfected either with empty vector, EGFR or wild type PKCζ 
EGF-induced Akt phosphorylation is higher compared to the cells cotransfected with PKCζ and 
EGFR. Thus Akt activation is counteracted in cells overexpressing both EGFR and PKCζ. When                     
instead of wild type PKCζ PKCζ Y417F was transfected along with EGFR, Akt phosphorylation 
upon stimulation with 0.1-1nM EGF was significantly less. Therefore, it seems that 
phosphotyrosine 417 of PKCζ is implicated in Akt phosphorylation and activation in EGFR 
downstream signalling. Since overexpression of wild type PKCζ does not influences positively 
Akt phosphorylation it might be that the phosphorylation of tyrosine 417 itself, rather than the 
catalytic activity of PKCζ contributes to Akt phosphorylation and activation.  
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Figure 3.24. Influence of PKCζ and PKCζ Y417F on Akt activation (A) and on IκBα phosphorylation 
downstream of EGFR (B). COS-7 cells were transfected with empty vector, 40ng/105 cells EGFR or 40ng/105 cells 
PKCζ or co-transfected with EGFR and either wild type PKCζ or PKCζ Y417F. Serum-starved cells were stimulated 
with 0.1-10 nM EGF for 5 min as indicated. Cell lysates from 105 cells were analysed by Western blotting with 
phospho-Akt (Ser473)-specific antibody (A) or with anti-phospho- (Ser 32/34) IκBα antibody (B) and respectively 
reprobed with Akt-specific antibody (A) or with beta-actin-specific antibody as a control for equal protein loading. 
Results are representative of two independent experiments. 
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.6.3. NFκB pathway-IκBα phosphorylation  
IκBα phosphorylation increased upon stimulation of COS-7 cells with 10nM EGF as detected by 
phospho- IκBα (Ser32/36) monoclonal antibody. This was indicative for NFκB activation 
downstream of EGFR receptor activation in cells transfected with either empty vector, PKCζ or 
EGFR (Figure 3.24.B and not shown) Cells transfected with PKCζ, EGFR, or both together 
showed elevated basal phosphorylation of IκBα compared to empty vector-transfected cells thus 
indicating for involvement of both EGFR and PKCζ in signalling leading to phosphorylation of 
IκBα. Overexpression of PKCζ Y417F instead of wild type PKCζ caused decreased IκBα 
phosphorylation, demonstrating in this way role for PKCζ activity itself or for tyrosine-417 
phosphorylation in IκBα phosphorylation. Therefore, it seems that catalytic activation of PKCζ as 
well as its phosphorylation on tyrosine 417 upon EGFR stimulation are implicated in many 
aspects of the proliferative and pro-survival signalling downstream of EGFR.  
 
3.7. Role of PKCζ in the cell signalling – towards apoptosis or cell growth?  
In the literature there are reports about pro-apoptotic as well as for pro-survival role of PKCζ. We 
checked whether PKCζ influences either the rate of cell apoptosis or the proliferating capabilities 
of COS-7 cells. Figure 3.25.A shows the absence of cleavage of poly- (ADP-ribose)-polymerase 
(PARP)- an early characteristic marker for cells undergoing apoptosis under conditions and 
combinations we used for transient transfection of COS-7 cells. Cleaved fragment of PARP was 
detected only in cells treated for 48-72 h with araC (cytarabin, 1βD-arabinofuranosylcytosine) as 
positive control for PARP cleavage induction. We carried out [3H]-thymidine incorporation assay 
to estimate the influence of PKCζ on cell proliferation. It was problematic to perform such 
proliferation assay with COS-7 cells transfected with DEAE-dextran transfection method. 
Obviously due to the elevated toxic effect during the transfection procedure, we obtained only a 
small proliferative response to stimulation with 10nM EGF. Therefore we used Polyfect as 
another transfection method, which is less toxic for the cells. 10nM EGF stimulation of empty 
vector transfected cells led to more that 200% increase in the level of [3H]-thymidine 
incorporation (Figure 3.25.B). Overexpression of wild type PKCζ induced increased DNA 
synthesis in the absence of any stimulation as measured by [3H]-thymidine incorporation. PKCζ 
overexpressing cells showed the same level of DNA synthesis upon 10nM EGF stimulation as 
empty vector-transfected ones. Upon transfection of PKCζ Y417F the basal DNA synthesis was 
reduced but still significantly elevated in comparison to the wild type PKCζ effect. However, the 
incorporation of [3H]-thymidine in response to 10nM EGF stimulation was clearly reduced in 
cells transfected with PKCζ Y417F mutant. These results demonstrate that PKCζ has a mitogenic 
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effect, which is lost in PKCζ Y417F mutant, either due to its catalytic inactivity, or to the absence 
of tyrosine phosphorylation on tyrosine 417.  
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Figure 3.25. Effect of PKCζ on apoptosis and cell growth. (A) COS-7 cells transfected with empty vector, 100 
ng/105 cells EGFR, 100ng/105 cells PKCζ or cotransfected with EGFR and PKCζ were serum-starved and stimulated 
with 10nM EGF as indicated. Whole cell lysates were prepared and analysed by Western blotting with PARP-
specific antibody, which recognizes full length PARP as well as the large PARP fragment generated by caspases.  
Negative control was lysate from non-transfected COS-7 cells, indicated with (-). Non-transfected COS-7 cells were 
treated for indicated time periods with 1mg/ml araC as positive control. Arrows point to the positions of full length 
PARP-116kDa and the large product of cleavage-89kDa. (B) Effect of EGF stimulation on the DNA synthesis versus 
the basal level upon transfection with empty vector, wild type PKCζ or PKCζ Y417F. COS-7 cells were transfected 
in 24-well plates with empty vector, 100ng EGFR together with 100ng either wild type PKCζ or PKCζ Y417F using 
Polyfect transfection method. Serum-starved cells were stimulated with 10nM EGF for 20 hours and [3H]-thymidine 
incorporation assay was carried out. Results expressed as means ± SEM from two independent experiments in 
triplicate. 
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3.8. Tyrosine phosphorylation of PKCζ induced by stimulation of G-protein coupled 
receptors 
Next question we asked was whether stimulation of G-protein coupled receptors could also 
induce tyrosine phosphorylation of PKCζ. We estimated PKCζ tyrosine phosphorylation upon 
stimulation of the endogenously expressed in COS-7 cells GPCRs -lysophosphatidic acid 
receptor and beta 2-adrenergic receptor with lysophosphatidic acid (LPA) and Isoproterenol (Iso), 
respectively.  For both receptors signalling pathways involving EGFR transactivation and 
downstream MAPK/Erk activation are reported (Daub et al., 1997, Maudsley et al., 2000).  First 
we compared the EGF, LPA (A) and Iso (B)-induced tyrosine phosphorylation of PKCζ under 
different overexpression conditions (Figure 3.26). In COS-7 cells transfected only with empty 
vector it was not possible to detect EGF or LPA-induced tyrosine phopshorylation of PKCζ, 
whereas stimulation with Iso led to slight increase in the tyrosine phosphorylation of endogenous 
PKCζ. In cells transfected with PKCζ alone the increased amount of PKCζ allowed detection of 
its tyrosine phosphorylation under basal conditions. Although PKCζ tyrosine phosphorylation 
does not change significantly upon 1 nM EGF stimulation, it increased slightly upon stimulation 
with both 10µM LPA and 10µM Iso. In cells co-transfected with PKCζ and EGFR the basal as 
well as stimuli-induced tyrosine phosphorylation of PKCζ were elevated. Clearly both LPA and 
Iso stimulations induced PKCζ tyrosine phosphorylation similar to that induced by 1nM EGF 
stimulation.  Moreover, EGFR co-immunoprecipitation with PKCζ was identified upon LPA and 
Iso stimulation like upon EGF stimulation. The phosphotyrosine band at the level of EGFR was 
visible in PKCζ immunoprecipitates upon EGF and Iso stimulation under completely endogenous 
conditions as well as under basal, EGF, LPA or Iso stimulated conditions in cells overexpressing 
PKCζ alone. In cells co-transfected with PKCζ and EGFR there was pronounced increase in the 
tyrosine phosphorylation of EGFR co-immunoprecipitating with PKCζ upon EGF, LPA and Iso 
treatment.  Both LPA and Iso stimulation mediated ERK and LPA mediates Akt activation as 
well. LPA and Iso-mediated ERK activation was lowered in double overexpression system, 
whereas LPA-mediated Akt activation was not changed. Next step was to determine whether 
GPCR-mediated tyrosine phosphorylation of PKCζ target also tyrosine-417 in the activation loop 
vicinity. On Figure 3.27.A is presented a comparison of EGF, LPA and Iso-induced tyrosine 
phosphorylation of wild type PKCζ and of PKCζ Y417F mutant. EGF-induced tyrosine 
phosphorylation of PKCζ Y417F is normally only partly decreased (as shown on Figure 3.18. B). 
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Figure 3.26. LPA and Iso stimulation also induce tyrosine phosphorylation of PKCζ. COS-7 cells were 
transfected with either empty vector pcDNA 3.0, 70ng/105 cells PKCζ or 70ng/105 cells PKCζ along with 40ng/105 
cells EGFR. Serum-starved cells were left untreated or stimulated with 1nM EGF, 10µM LPA (A) or 10µM Iso (B) 
for 5 min. PKCζ immunoprecipitates were by Western blotting with phosphotyrosine-specific antibody 4G10, and 
reprobed with PKCζ-specific antibody. Cell lysates (corresponding to 105 cells) were analysed by western blotting 
with phospho-Erk1/2 or phospho-Akt-specific antibodies and reprobed with anti-Akt antibody. Similar results were 
obtained in two independent experiments. 
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The stronger decrease in the experiment shown on Figure 3.27.A was due to the lower amount 
immunoprecipitated PKCζ on the respective lane. LPA stimulation seems to be not able to induce 
tyrosine phosphorylation of PKCζ Y417F indicating that tyrosine-417 is the main target of LPA 
receptor-mediated PKCζ tyrosine phosphorylation.  PKCζ Y417F was only faintly tyrosine 
phosphorylated upon Iso stimulation, suggesting that for beta 2-adrenergic receptor-mediated 
PKCζ tyrosine phosphorylation tyrosine–417 is a major target as well. It is well known that 
transactivation of EGFR could be mediated via release of HB-EGF (Prenzel et al., 1999). 
Therefore we asked whether HB-EGF stimulation could also induce tyrosine phosphorylation of 
PKCζ. Figure 3.27.B shows that HB-EGF is indeed able to induce tyrosine phosphorylation of 
PKCζ. EGF-induced tyrosine phosphorylation of PKCζ was sensitive to inhibition of EGFR 
tyrosine kinase activity by AG1478. 
 
Figure 3.27. LPA and Iso–induced tyrosine phosphorylation of PKCζ triggers tyrosine 417 as main target via 
transactivation of EGFR. COS-7 cells were cotransfected with 40ng/105 cells EGFR and 40ng/105 cells either wild 
type PKCζ (A, B, C, D) or PKCζ Y417F (A). Serum-starved cells were preincubated with AG1478 for 30 min (C) 
and treated with 1nM EGF, 1nM HB-EGF, 10µM LPA or 10µM Iso for 5 min as indicated.   Either PKCζ  (A, B and 
C) or EGFR (D) was imunoprecipitated and analysed by Western blotting with phosphotyrosine-specific antibody 
4G10 (A, B, C and D) and reprobed with PKCζ-specific antibody (A, B and C). Cell lysates (corresponding to 105 
cells) were analysed by western blotting with EGFR-specific antibody 13G8 and PKCζ-specific antibody. Results are 
representative of three independent experiments. 
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We identified that at least Iso-induced tyrosine phosphorylation of PKCζ was sensitive in part to 
AG1478 treatment (Figure 3.27.C). AG1478 treatment influenced in the similar manner the co-
immunoprecipitation of EGFR with PKCζ upon EGF and Iso stimulation. In addition we found 
by Western blot with phosphotyrosine-specific antibody of EGFR immunoprecipitates that both 
LPA and Iso induced increase in the tyrosine phosphorylation of EGFR (Figure 3.27.D). This is 
the indication that both GPCRs transduce signals through EGFR transactivation and that 
transactivated EGFR can also mediate PKCζ tyrosine phophorylation. We performed PKCζ 
kinase activity assay to evaluate PKCζ activation upon GPCR stimulation. Both LPA and Iso 
activate wild type PKCζ but do not activate PKCζ Y417F (Figure 3.28).  
     
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28. GPCR activation by LPA and Iso mediates activation of wild type PKCζ, but not of PKCζ Y417F. 
COS-7 cells were cotransfected with 40ng/105 cells EGFR and 40ng/105 cells either wild type PKCζ or PKCζ 
Y417F. Serum-starved cells were either left untreated or incubated with 1nM EGF, 10µM LPA or 10µM Iso for 5 
min as indicated. PKC activity assay was performed on PKCζ immunoprecipitates with MBP as substrate. 
Immunoprecipitation of equal amount PKCζ was confirmed by immunoblot with PKCζ-specific antibody. ). Cell 
lysates (corresponding to 105 cells) were analysed by Western blotting with phospho-Erk1/2-specific antibody or 
phosphotyrosine-specific antibody and reprobed with Erk2-specific antibody. Shown is a representative of four 
independent experiments.    
 
This is the indication that the common mechanism for PKCζ activation operates downstream 
from ligand-activated and transactivated EGFR and that crucial for this activation process is the 
phosphorylation of tyrosine-417 in the vicinity of PKCζ activation loop.  
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4. DISCUSSION 
 
In this study we investigated the tyrosine phosphorylation of PKC isoforms overexpressed in 
COS-7 cells upon EGFR activation. EGFR activation in normal keratinocytes as well as autocrine 
stimulation of EGFR via TGFα release in ras-transformed keratinocytes has been reported to 
mediate tyrosine phosphorylation of PKCδ, but not of PKCα, ε, η and ζ (Denning et al., 1993, 
1996). We found that in COS-7 cells PKCδ but also PKC isoforms ε and ζ are subjected to 
tyrosine phosphorylation upon EGFR stimulation. The EGF-induced modification of PKCδ, ε 
and ζ was less pronounced compared to the tyrosine phosphorylation induced by hydrogen 
peroxide treatment and in the case of PKC δ and ε similar to the effect of phorbol ester treatment 
(Figure 3.2 and 3.3). Phorbol ester and hydrogen peroxide are well-known inducers of PKC 
tyrosine phosphorylation. Phorbol ester-induced tyrosine phosphorylation has been reported for 
PKCα, βII and δ (Braiman et al., 1999; Li et al., 1994). PKC α, βI, γ, δ, ε and ζ overexpressed in 
COS-7 cells were tyrosine phosphorylated upon hydrogen peroxide treatment (Konishi et al., 
1997), independently of the PTP inhibition (Yamamoto et al., 2000). In our experiments we 
observed increased tyrosine phosphorylation of PKCε and ζ in cells co-transfected with EGFR. 
PKCζ is stronger tyrosine phosphorylated than PKCε upon stimulation of endogenous EGFR 
whereas in cells co-expressing PKC and EGFR both PKC isoforms were tyrosine phosphorylated 
to a similar extent (Figure 3.3.). Tyrosine phosphorylation of PKC isoforms downstream of many 
other receptors has been identified. Activation of FcεRI receptor for IgE in rat basophilic 
leukemia mast cells RBL-2H3 leads to tyrosine phosphorylation of PKCδ, θ, α and βI (Haleem-
Smith et al., 1995; Liu et al., 2001; Kawakami et al., 2003). PKCθ is tyrosine phosphorylated 
upon activation of adhesion receptors in platelets (Crosby and Poole, 2002) and downstream of 
TCR in T cells (Liu et al., 2000). Stimulation of NGFR mediates tyrosine phosphorylation of 
atypical PKCs in PC12 cells (Wooten et al., 2001a). PKCδ is tyrosine phosphorylated 
downstream of B cell receptor engagement (Barbazuk and Gold, 1999), insulin receptor 
stimulation (Rosenweig et al., 2004) as well as upon activation of GPCRs by carbachol and 
substance P (Soltoff et al., 1995) and in vitro by PDGFR (Li et al., 1994). Braiman et al., 1999, 
have shown that insulin stimulation of primary skeletal muscle cultures induces tyrosine 
phosphorylation of PKCβII and PKCζ. It is apparent that in most of the cases tyrosine 
phosphorylation of PKC isoforms is induced by cell surface receptors either with intrinsic 
tyrosine kinase activity or receptors, which do not possess their own tyrosine kinase activity but 
recruit cytoplasmic tyrosine kinases upon activation. Even the tyrosine phosphorylation induced 
by hydrogen peroxide and phorbol ester might be discussed in the same connection, based on the 
recent findings that H2O2 (Fischer et al., 2004) as well as PMA (Amos et al., 2004) mediate RTK 
transactivation.  
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In our experiments the critical involvement of EGFR is supported by the significant increase in 
PKC tyrosine phosphorylation in cells overexpressing EGFR as well as by its dependence on 
EGF concentration (Figure 3.4). The time course of the tyrosine phosporylation occurrence 
revealed that it is very early event upon stimulation of EGFR. It can be detected for both PKCε 
and ζ to increase rapidly after 30 sec of EGF stimulation and slightly decrease after EGF 
stimulation for 1 min. Despite of this similarity, there were differences in the time course of the 
tyrosine phosphorylation of both PKC isoforms upon prolonged EGF stimulation. Whereas PKCζ 
tyrosine phosphorylation was kept elevated, PKCε tyrosine phosphorylation was gradually 
increasing in response to EGF stimultion up to 10 min (Figure 3.5.). The different time course of 
tyrosine phosphorylation of both PKC isoforms could reflect either different kinetic of their 
phosphorylation or their different susceptibility with PKCζ being more resistant to protein 
tyrosine phosphatases-mediated PKC dephosphorylation. Indeed, PTPs are also activated by 
EGFR stimulation and PTPs-dependent dephosphorylation may counteract the tyrosine 
phosphorylation of PKC. A receptor-tyrosine phosphatase CD45 is shown to be involved in 
dephosphorylation of PKCδ in monocytic cells (Deszo et al., 2001). Haleem-Smith et al., 1995 
demonstrated that PKCδ tyrosine phosphorylation induced by antigen stimulation of FcεRI has 
very rapid rate of phosphorylation (detected at 30 sec) followed by rapid dephosphorylation rate 
since the modification has been no longer detected after 3 min of stimulation. Tyrosine 
phosphorylation of PKCθ in the same cell system had another time schedule occurring with a 
delay compared to the rapid modification of PKCδ (Liu et al., 2001). We did not assess the 
involvement of PTPs in the transient decrease in the tyrosine phosphorylation of PKCε and ζ. 
EGF-induced tyrosine phosphorylation of PKCζ as well as that of PKCε was completely 
abolished by pretreatment with EGFR tyrosine kinase inhibitor AG1478, demonstrating the 
involvement of EGFR tyrosine kinase activity in PKC modification. This finding was further 
confirmed by the diminishing effect of EGFR dimerization mutant expression on tyrosine 
phosphorylation of PKCζ (Figure 3.6). Since both AG1478 and EGFR dimerization mutant 
caused decrease in the basal tyrosine phosphorylation of PKCζ as well, we suggest that 
overexpressed EGFR evokes PKCζ tyrosine phophorylation under non-stimulated conditions 
probably due to its basal activity. Thus, it became clear that functional EGFR is required for 
PKCζ modification by tyrosine phosphorylation. Similarly, tyrosine phosphorylation of PKCδ in 
keratinocytes induced by TGFα requires a functional EGFR. However, PKCδ was tyrosine 
phosphorylated in vitro by Src and Fyn tyrosine kinases but not by EGFR (Denning et al., 1996). 
Li et al., 1994 reported in vitro phosphorylation of PKCδ by Fyn, IR and PDGFR. Without to 
exclude the involvement of receptor tyrosine kinases, many reports from in vitro and in vivo 
studies reveal the role for cytoplasmic tyrosine kinases as proximate kinases in PKC tyrosine 
phosphorylation. Src family kinases - Src, Fyn, Lyn, Lck as well as other cytosolic tyrosine 
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kinases such as Btk, Abl, Syk, and Ca2+-dependent Pyk2 are implicated in the tyrosine 
phosphorylation of PKC isoforms in different cell systems upon various stimuli (Table 1). Src 
family kinases have been implicated in PDGF-induced tyrosine phosphorylation of PKCδ in C6 
glioma cells but the authors did not exclude direct phosphorylation of PKCδ by PDGFβR upon 
PDGF binding (Kronfeld et al., 2000). Upon co-expression of wild type Src we observed 
increased tyrosine phosphorylation of PKCζ, whereas upon transfection of dominant negative Src 
EGF-induced tyrosine phosphorylation of PKCζ was completely abolished (Figure 3.7). This was 
strong evidence that Src is critically involved in the tyrosine phosphorylation of PKCζ 
downstream of EGFR activation. We suggested that Src activated upon EGFR stimulation might 
be the proximate kinase that mediates EGF-induced tyrosine phopshorylation of PKCζ.  
Since PKCζ is downstream effector of PI3K in many cell systems and EGFR stimulation 
activates PI3K as well we assessed the influence of PI3K on EGFR-mediated PKCζ tyrosine 
phosphorylation. In addition, Naknishi et al., 1993 have shown that PKCζ is activated by PIP3. 
Partial decrease in EGF-induced tyrosine phosphorylation of PKCζ caused by PI3K inhibitors 
Wortmannin and LY294002 suggested that PI3K activity contributes to PKCζ tyrosine 
phosphorylation (Figure 3.8). PI3K inhibitors blocked the effect of insulin on tyrosine 
phosphorylation of PKCβII and ζ in primary skeletal muscle cultures (Braiman et al., 1999). 
PI3K involvement in our system might reflect the requirement for its product PIP3 in recruitment 
of PKCζ close to the tyrosine kinase. Using PTEN co-expression we found a decrease in EGF-
induced tyrosine phosphorylation of PKCζ, but the result are not conclusive due to the significant 
decrease in EGFR expression level upon triple co-transfection. Nevertheless the experiments with 
the PI3K inhibitors demonstrated that PI3K activity is implicated to some extent in PKCζ 
tyrosine phosphorylation downstream of EGFR.  
We determined the importance of tyrosine residues in the cytoplasmic part of EGFR for the 
tyrosine phosphorylation of PKCζ. Upon co-expression of Y1173F, Y992F and Y1086F EGFR 
mutants PKCζ tyrosine phosphorylation was even enhanced. Phospho-tyrosine 992 and phospho-
tyrosine 1173 couple EGFR to phospholipase C-γ (PLC-γ) pathway, phospho-tyrosine 1086 and 
phospho-tyrosine 1173 represent link to activation of ERK/MAPK and phospho-tyrosine 1086 
additionally contributes to activation of Akt/PKB cascade (Figure 1.1). One possible explanation 
for the stimulating effect on PKCζ tyrosine phosphorylation found upon expression of the 
respective EGFR mutants might be that the impairment of binding of respective docking proteins 
increases the accessibility of EGFR for PKCζ tyrosine phosphorylation machinery via release of 
some sterical interference. On the other hand the increase in PKCζ tyrosine phosphorylation 
could be explained by the involvement of at least tyrosine 1173 in recruitment of protein tyrosine 
phosphatase (SHP1) that promote downregulation of EGFR by dephosphorylation. This finding 
might either represent additional support for the interrelation of EGFR activity state and PKCζ 
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tyrosine phosphorylation or suggest involvement of EGFR-activated PTPs in dephosphorylation 
of PKCζ. In cells expressing EGFR Y845F mutant the basal as well as the EGF-induced tyrosine 
phosphorylation of PKCζ was clearly reduced (Figure 3.9). In contrast to the autophosphorylation 
sites tyrosine 845 in the activation loop of EGFR represents Src-phosphorylation site (Biscardi et 
al., 1999). Thereby our results demonstrate critical involvement of Src-phosphorylation site in the 
process of PKCζ tyrosine phosphorylation. Moreover in combination with the dramatic effect of 
dominant negative Src these findings reveal that Src activation upon EGFR stimulation and 
subsequent Src-dependent phosphorylation of EGFR on tyrosine 845 are necessary steps 
mediating EGFR-dependent tyrosine phosphorylation of PKCζ. We cannot exclude EGFR or Src 
family kinases as upstream tyrosine kinase mediating PKCζ tyrosine phosphorylation. Src 
activation in response to EGF and the following phosphorylation of tyrosine 845 could assist for 
the recruitment of PKCζ to the EGFR signalling complex and it can be EGFR tyrosine kinase 
itself that mediate the tyrosine phosphorylation of PKCζ.  Thus, our results implicate PKCζ 
tyrosine phosphorylation of as one of the targets of the functional synergism between Src and 
EGFR in the cancer progression. Both c-Src and EGFR are overexpressed in high percentages of 
human breast cancers. C-Src potentiates the mitogenic and tumorigenic capacity of overexpressed 
EGFR, in part by physical association with the receptor and Src-dependent phosphorylation of 
tyrosine 845 and tyrosine 1101 (Biscardi et al., 2000). Y845F mutant of EGFR was found to 
retain full catalytic activity and its ability to activate ERK2, but to affect in dominant-negative 
fashion EGF, serum and LPA-induced DNA synthesis (Tice et al., 1999). The mitogenic pathway 
involving phosphorylation of tyrosine 845 of EGFR can be initiated by cytokine and estrogen 
receptors as well, is independent of ERK2 activation and might involve PI3K and ERK5. A 
plausible candidate for ERK-independent mitogenic effect downstream of EGFR is STAT5 
whose tyrosine phosphorylation in response to EGF has been reported to be dependent in part on 
Src activity and the presence of Src-mediated phosphorylation of EGFR Tyr-845 (Kloth et al., 
2003). In A431 cells Sato et al., 2003 demonstrated that Src phosphorylation of EGFR Tyr-845 
triggers cell cycle arrest and apoptosis via upregulation of STAT-p21waf1 pathway. Recently, 
cytochrome c oxidase subunit II has been found to bind to phospho-tyrosine 845 on the EGFR 
(Boerner et al., 2004). Our findings suggest that PKCζ might represent another target of the 
synergistic signalling of Src and EGFR triggered by tyrosine phosphorylation similarly to 
STAT5a.   
It is increasingly apparent that signal transduction involves the physical assembly of individual 
components of a pathway into multiprotein complex. Such a multiprotein complex that induce 
mitogenic signaling assembles on the prototypical receptor tyrosine kinase EGFR. Moreover, the 
association of PKC with respective tyrosine kinases very often accompanies the process of PKC 
tyrosine phosphorylation (Table 1). There are evidences for PKCδ interactions in vitro with Lck 
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(Konishi et al., 2001) and Src (Blake et al., 1999) as well as association in vivo with Src 
(Shnamugam et al., 1998; Song et al., 1998), Pyk2 (Wrenn et al., 2001) and Lyn (Song et al., 
1998). PKCδ was found to be constitutively associated with Src in phosphorylation-independent 
manner, whereas PDGF stimulation-induced PKCδ association with Fyn was dependent on the 
phosphorylation of tyrosine 187 (Kronfeld et al., 2000). Interactions of other PKC isoforms with 
cytoplasmic tyrosine kinases have been also identified- PKCθ-Lck in T cells (Liu et al., 2000), 
PKCθ-Btk in platelets (Crosby and Poole, 2002), PKCθ- Src and Lyn in mast cells (Liu et al, 
2001), PKCι-Src in PC12 cells (Wooten et al, 2001a). Recruitment of PKCδ to the FcεRI upon 
antigen stimulation has been reported (Haleem-Smith et al., 1995) and tyrosine-phosphorylated 
PKC was less associated with the receptor. PKCζ interaction with many receptor complexes has 
been investigated (IL-1R, TFFR, NGFR) and is mediated via PKCζ-interacting protein (p62/ZIP) 
(see Figure 1.11.), but up to now there are no data about the presence of PKCζ in the EGFR 
signalling complex.  
We identified the co-immunoprecipitation of PKCζ and EGFR as an indication for either direct or 
indirect physical association of both proteins (Figure 3.11). Co-immunoprecipitation was 
detected vice versa- PKCζ in EGFR immunoprecipitates and EGFR in PKCζ immunoprecipitates 
upon their overexpression as well as endogenously in COS-7 cells and in MCF-7 cells (Figure 
3.12). We expected that PKCζ-EGFR interaction might be present in cell line with highly 
overexpressed EGFR such as A431. In EGFR immunoprecipitates from A431 we detected 
another tyrosine-phosphorylated protein with lower molecular weight than PKCζ, which might be 
Src family kinase member. Only in PKCζ immunoprecipitates small amount of EGFR has been 
detected upon stimulation with 10nM EGF. Moreover, PKCζ was only slightly tyrosine 
phosphorylated in A431 in response to EGF, whereas in MCF-7 cells EGF-induced tyrosine 
phosphorylation of PKCζ was much more pronounced. Therefore it could be that another 
important mediator of the physical interaction of PKCζ and EGFR plays a limiting role in the 
complex assembly in A431.  
The dependence of the interaction on the stoichiometric ratio of both proteins indicated that 
PKCζ could exert negative feedback control on EGFR function and therefore to regulate its level 
of tyrosine phosphorylation mediated by EGFR. Tyrosine phosphorylation of PKCζ was lowered 
when the ratio of both DNAs during transfection was 2:1 (PKCζ : EGFR). Moreover, the 
association of PKCζ with EGFR upon such ratio was higher under basal conditions and decreased 
in response to EGF stimulation. In contrast, when both DNAs were transfected in ratio 1:1 the 
interaction was lower under basal conditions and increased upon EGF stimulation. Furthermore, 
the same trend was valid for the tyrosine phosphorylation of EGFR in PKCζ immunoprecipitates 
(Figure 3.11). This observation could be an indication for increased association of the excess 
amount of PKCζ with the EGFR under basal conditions and PKCζ-dependent decrease in its 
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tyrosine phosphorylation and activity leading to decreased tyrosine phosphorylation of PKCζ. 
Thereby kind of novel cross talk might take place between EGFR and PKCζ with EGFR inducing 
PKCζ tyrosine phosphorylation and feedback regulation on EGFR tyrosine kinase activity by 
PKCζ. Recently, cross talk among serine/threonine and tyrosine kinases is demonstrated to 
involve reciprocal phosphorylation and regulation of their activities (Crosby and Poole, 2003). 
Additional line of evidence supporting our idea came from the experiments with PKC mutants 
with different activity state.  The constitutively active mutants of both PKCζ and PKCε were 
significantly lower tyrosine phosphorylated, whereas the respective inactive mutants showed 
higher tyrosine phosphorylation in response to EGF stimulation (Figure 3.10.). Increased 
interaction of constitutively active PKCζ with EGFR under basal conditions detected by co-
immunoprecipitation (Figure 3.13) probably provides the structural bases for PKC-dependent 
threonine phosphorylation of EGFR. PKC-dependent phosphorylation of EGFR on threonine 654 
in the juxtamembrane domain is implied in inhibition of its tyrosine kinase activity (Lund et al., 
1990). Threonine-phosphorylated EGFR molecules undergo normal internalization, but instead of 
sorting to lysosomal degradation, they recycle back to the cell surface. Thereby, the heterologous 
desensitization restrains ligand-induced down-regulation of EGFR (Bao et al., 2000). PMA-
regulated PKCs are implicated in both rapid and long term effects on RTK phosphorylation and 
degradation (Seedorf et al., 1995). The short-term effect of decreased EGFR tyrosine 
phosphorylation within minutes of PMA treatment is mediated via activity of PTPs, rather than 
by PKC-mediated receptor phosphorylation. In contrast, sustained activation of PKCα by PMA 
results in stable complex with EGFR. Co-immunoprecipitation was detected in the absence of 
EGF and was further increased by ligand addition similarly to our observation for the association 
of PMA-unresponsive PKCζ with the EGFR.  
The time course of the interaction of PKCζ and EGFR has been followed in vice versa co-
immunoprecipitation and revealed interesting biphasic patterns. There is some constitutive 
association of PKCζ and EGFR under non-stimulated conditions, which increases upon EGF-
stimulation very fast within the 30 sec-1 min followed by a reduced interaction accompanied with 
elevated threonine phosphorylation of EGFR between 1 and 5 min EGF stimulation (Figure 
3.13). The interaction is restored upon prolonged EGF stimulation (15-30 min). Kronfeld I. et al., 
2000 investigated the kinetic of PDGF-induced PKCδ interaction with Fyn. They reported fast 
increase in the association after 1 min treatment, which further gradually increase up to 15 min 
PDGF stimulation and decreased upon 30 min prolonged stimulation time. Thereby PKCδ 
physical association with Fyn appears to be more stable and longer lasting over the time.  
Upon co-expression of EGFR dimerization mutant the co-immunoprecipitatation of EGFR and 
PKCζ was abrogated, thereby demonstrating that PKCζ associates with the activated receptor 
(Figure 3.14). Co-immunoprecipitation of PKCζ with EGFR mutants harboring mutations of 
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single tyrosine residue in the cytoplasmic part indicated decreased interaction with EGFR 
Y1086F, probably reflecting that functional activation of PI3K pathway downstream of EGFR is 
important for the interaction of PKCζ with the EGFR- mediated via PIP3 generation and PIP3-
dependent recruitment of PKCζ to the membrane compartment, which increase the probability for 
the interaction with the EGFR. The interaction of EGFR Y992F with the PKCζ is to some extent 
more pronounced than that of the EGFR wild type indicating probably for some competition 
between PKCζ and PLCγ for interaction with EGFR. Moreover, the EGFR mutant harboring 
substitution of the PLCγ and SHP1-docking tyrosine 1173 to phenylalanine showed EGF-
stimulation-dependent increase of the co-immunoprecipitation with PKCζ. This suggests that 
upon EGF-stimulation and in the absence of bound PLCγ and/or SHP1 the interaction of EGFR 
and PKCζ might be favored. In addition to its critical implication in mediating PKCζ tyrosine 
phosphorylation downstream of EGFR activation, phopshorylation of tyrosine 845 of EGFR is 
necessary for the interaction of PKCζ with the receptor. Upon co-expression of EGFR Y845F 
mutant the co-immunoprecipitation was clearly abrogated. Seedorf et al., 1995 observed 
association of PMA-responsive PKCα with kinase-deficient EGFR (K721A) and suggested that 
receptor autophosphorylation is not required for PKC binding. We found that the physical 
association of PMA-unresponsive PKCζ with the EGFR strongly depends on the phosphorylation 
of tyrosine 845 on EGFR. Moreover, the EGF-dependent increase in the interaction of PKCζ with 
EGFR was diminished in cells treated with PI3K inhibitors-LY294002 and Wortmannin, 
suggesting a role of PI3K or its product PIP3 in recruitment of PKCζ close to the receptor 
complex and that this especially is necessary to support the increased association upon EGF 
stimulation, via activation of PI3K. Gomez et al., 1996 demonstrated association of PI3K to 
PKCζ upon IL-2 stimulation. Our results show that interaction of PKCζ with 110 beta subunit of 
PI3K as well as with Akt takes place mostly under basal conditions and that either overexpression 
of EGFR or its stimulation with EGF abolished the interaction of PKCζ with these signalling 
proteins from PI3K/Akt pathway (Figure 3.15). The interaction of PKCζ with wild type 110 beta 
subunit of PI3K under basal conditions together with the decreased association of PKCζ with 
EGFR in cells cotransfected with wild type 110 beta might explain the decreased basal tyrosine 
phosphorylation of PKCζ. We can speculate that under non-stimulated conditions PKCζ is 
sequestered in the cytoplasm by interactions with PI3K beta and Akt, whereas upon EGF 
stimulation PKCζ interaction with EGFR is favored.  
Very important for the appropriate PKC function is its targeting via protein-lipid and protein-
protein interactions to specific subcellular compartments, close to its activators and substrates.  
Membrane translocation of PKC is considered as indicative for its activation.  In some cases 
tyrosine phosphorylation of PKC is accompanied with membrane translocation- PKCδ and θ 
upon antigen stimulation of FcεRI  (Haleem-Smith et al., 1995; Liu et al., 2001) and PKCδ upon 
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BCR activation (Barbazuk and Gold, 1999).  It has been suggested that the tyrosine kinase, which 
is involved, is membrane localized since the translocation is required for tyrosine 
phosphorylation of PKCδ, rather than the membrane translocation being dependent on PKCδ 
tyrosine phosphorylation. On the other hand, there are many examples for tyrosine 
phosphorylation of PKC without significant membrane translocation – upon hydrogen peroxide 
treatment (Konishi et al., 1997) and in response to EGFR stimulation in keratinocytes (Denning 
et al., 1993). PKCδ tyrosine phosphorylation has been shown to occur simultaneously with Golgi 
translocation in response to IFN-γ (Kajimoto et al., 2001), or to be related to nuclear 
translocation during etoposide-induced apoptosis  (Blass et al., 2002). Tyrosine phosphorylation 
of PKCθ and translocation to the immunological synapse between T cell and antigen presenting 
cell has been demonstrated (Liu et al., 2000). NGF-induced tyrosine phosphorylation of PKCλ/ι 
regulates its localization in a complex with p62/ZIP in the late endosomes (Samuels et al., 2001) 
or facilitated its nuclear import dependent on the phosphorylation of tyrosine 256 (White et al., 
2002). A role of tyrosine kinases as RACKs (Fyn for PKCθ in T cells) has been discussed (Ron et 
al., 1999). Growth factors (e.g. EGF) activate PKC in several cell types including the epithelium 
as evidenced by increased amount of PKC found in the membrane fraction. EGF caused 
translocation of both PKCα and βI into membranes of canine gastric cells (Wang et al., 1996) and 
membrane association of PKCα in mammary epithelial cultures (Birkenfeld et al., 1996). EGF 
treatment has been shown to cause redistribution of PKCα, βI and ζ to membrane fractions in 
human intestinal cell line Caco-2 (Banan et al., 2001). Recently, Sun et al., 2005 have found 
EGF-induced translocation of PKCζ from the cytosol to the plasma membrane in human breast 
cancer cells. 
There are contradictory data about the subcellular localization patterns of PKCζ. Diffuse 
cytosolic staining for ectopically expressed PKCζ has been observed (Goodnight et al., 1995; 
Puls et al., 1997). On the other hand, endogenous PKCζ showed a vesicular punctate pattern of 
localization (Westermann et al., 1996). Sanchez et al., 1998 demonstrated punctate vesicular 
pattern of subcellular localization for either ectopically expressed or endogenous aPKC isoforms 
- PKCλ/ι and PKCζ and p62 in HeLa cells. The constitutive colocalization of p62 with aPKCs 
has not changed in response to EGF stimulation. Furthermore, p62 colocalizes with the 
internalized EGFR in the lysosome-targeted late endosomes. The authors proposed that atypical 
PKCs anchored by p62 in the lysosome-targeted endosomal compartment are involved in the 
control of the growth factor receptor trafficking. Similar endosomal colocalization of aPKC, 
p62/ZIP and the internalized NGFR was shown to contribute to MEK5 activation during NGF-
mediated differentiation process (Samuels et al., 2001; Geetha et al., 2003).  
Using confocal microscopy we observed membrane translocation of PKCζ upon EGF stimlation 
and its colocalization with EGFR (Figure 3.17).  Under unstimulated conditions we found diffuse 
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subcellular localization of PKCζ with some concentration in the perinuclear area in COS-7 cells 
expressing PKCζ-EYFP. Upon 1 min stimulation with 10nM EGF we detected membrane 
translocation of PKCζ. In cells co-expressing EGFR-CFP and PKCζ-EYFP we identified that 
EGFR and PKCζ colocalize to some extent in the perinuclear region under basal conditions and 
more pronounced at the plasma membrane upon EGF stimulation. Whereas the colocalization 
without cell stimulation might reflect the transport of both overexpressed proteins through Golgi, 
the membrane colocalization of EGFR and PKCζ is indication for recruitment of PKCζ to the 
EGFR signalling complex at the membrane, localization, which is required for EGFR-mediated 
tyrosine phosphorylation of PKCζ.  It was not our aim to investigate whether PKCζ colocalize 
with EGFR during receptor internalization.  
Concerning the mechanism of association of PKCζ with the EGFR we can give some ideas 
based on the known interactions. ZIP/p62 association to TrkA has been mapped to the 
juxtamembrane region (amino acids 472-493) (Wooten et al., 2001a). Sequence comparison 
revealed that the motif involved in p62/ZIP binding to TrkA is highly conserved in EGFR 
(amino acids 710-732), thus suggesting for possible interaction. 
 
(TrkA)   LGEGAFG 
(EGFR)   LGSGAFG 
 
ZIP/p62 may bind to the EGFR also indirectly via receptor-interacting protein (RIP), since 
EGFR has been found to ineract with RIP (Habib et al., 2001) and on the other hand RIP 
association with ZIP/p62 has been demonstrated in context of TNFR (Sanz et al., 1999).  
Another possible link between the EGFR and PKCζ might be provided by tyrosine-containing 
tight turn structures present in the endocytic codes of many receptors. EGFR synthetic code 
NFAYF (native QQGFF) was recognized in two-hybrid system by LIM domains of PKC-
interacting partner ENH (Enigma homolog) (Wu and Gill et al., 1994; Kuroda et al., 1996). 
Whereas modification of PKC by serine/threonine phopshorylation involves highly conserved 
residues in the catalytic domain, various tyrosine residues in the regulatory and the catalytic 
domain are targets for phosphorylation in PKC isoform- and stimulus-specific manner. 
Conserved among all members of the PKC family are PKC tyrosine residues 451, 469, 512, 523 
triggered by H2O2-induced tyrosine phosphorylation of PKCδ, but none of them is 
phosphorylated by Src within atypical PKCι. Hydrogen peroxide induces phosphorylation of 
tyrosines located in the catalytic domain (Konishi et al., 2001), Src is involved in 
phosphorylation of tyrosine-311 at the hinge region (Blake et al., 1999), whereas many stimuli 
target PKCδ tyrosine residues in the regulatory domain- tyrosine-52 upon engagement of IgE 
receptor (Szallasi et al, 1995), tyrosine-187 following PMA and PDGF stimulation in NIH 3T3 
(Li et al, 1996; Szallasi et al., 1995) and C6 cells (Kronfeld et al., 2000), tyrosine-155-upon 
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PMA stimulation of C6 cells (Kronfeld et al., 2000). Isoform-specific phosphorylation sites were 
identified for other PKC isoforms as well. Lck in involved in phosphorylation of PKCθ at 
tyrosine-90 during T cell activation (Liu et al., 2000). NGF- stimulated multisite tyrosine 
phosphorylation of atypical PKCι has been shown to involve three residues within the catalytic 
domain- tyrosines 256, 271 and 325 (Wooten et al., 2001a). It seems that modification triggers 
sets of tyrosine residues rather than only one. For example, Kronfeld et al., 2000 reported that 
only after substitution of five tyrosines in the regulatory domain with phenylalanine (PKCδ5 -52, 
64, 155, 187 and 565) there is no significant degree of enhanced tyrosine phosphorylation in 
response to PMA and PDGF.  
We identified tyrosine 417 in the catalytic domain of PKCζ as one of the phosphorylation sites in 
response to EGFR stimulation. The tyrosine phosphorylation of PKCζ Y417F was partly reduced 
compared to wild type PKCζ, demonstrating that there are still other tyrosines targeted by EGF-
induced phosphorylation within PKCζ (Figure 3.18). Intrestingly, tyrosine 417 is located in the 
vicinity of the activation loop threonine residue, embedded in highly conserved region of the 
PKC catalytic domain and is conserved among all members of PKC family as well as in PKA, 
PKBα/Akt1 and p70S6K. The corresponding tyrosine 512 within PKCδ is one of residues 
phosphorylated upon hydrogen peroxide treatment (Konishi et al., 1997).   
Tyrosine phosphorylation of PKC isoforms may have quite different effects on PKC activity 
ranging from inhibition of PKCδ upon Ras-transformation and in response to EGFR stimulation 
in keratinocytes (Denning et al., 1996) up to constitutively active DAG-independent PKCδ upon 
hydrogen peroxide-induced tyrosine phosphorylation in the catalytic domain (Konishi et al., 
1997). Phosphorylation of some tyrosines (e.g. tyrosine 187 of PKCδ, Li et al., 1996) has no 
influence on PKC activity. Similarly, Kronfeld I. et al, 2000 showed that single substitution of 
tyrosine-52, 155 or 187 as well as of all five (in PKCδ5 mutant) did not change enzyme activity. 
Tyrosine phosphorylation could alter the substrate specificity as well. Tyrosine-phosphorylated 
PKCδ in response to IgE receptor engagement had diminished activity toward the receptor γ-
chain peptide as a substrate (Haleem-Smith et al., 1995).  
PKCλ activation has been found to occur through PI3K upon EGF and PDGF stimulation 
(Akimoto et al., 1996). In our expression model PKCζ wild type was activated in response to 
EGFR stimulation (Figure 3.19). The EGF-induced PKCζ activity is around 180% in relation to 
the basal activity, but is significantly lower compared to PKCζ activation caused by hydrogen 
peroxide treatment. Moreover, the activity of PKCζ correlated with its tyrosine phosphorylation 
state. Inhibitors affecting the tyrosine phosphorylation  (AG1478 and LY294002) were 
diminishing PKCζ activation as well (Figure 3.20). Chou et al., 1998, have reported the 
activation of PKCζ downstream of EGFR activation and its complete dependency on PI3K and 
PDK1 mediated phosphorylation at the activation loop. The crucial role of the phoshorylation of 
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threonine 410 at the activation loop for the catalytic activity of PKC is well established.  The 
negative charge at the AL site aligns correctly the residues for catalysis and unmasks the entrance 
to the substrate-binding cavity, thereby being absolutely required for the PKC maturation (Orr 
and Newton, 1994). Fully functional, mature enzyme results from mimicking this negative charge 
by substitution of Thr for Glu, whereas mutant with unphosphorytable Ala instead of Thr is 
inactive (Cazaubon et al., 1994). PKCδ phosphorylation of Thr in the activation loop is not 
necessary because a five residues upstream positioned Glu partially fulfill the requirement for 
negative charge (Stempka et al., 1997). The activity of PKCζ catalytic domain depends on 
transphosphorylation at the activation loop (Smith and Smith, 2002). We found that PKCζ Y417F 
mutant was catalytically inactive, similarly to PKCζ T410A mutant, showing absence of basal 
activity and no activation upon EGF stimulation.  Only a slight increase of the activity of the 
mutant was observed in response to hydrogen peroxide treatment. Neither hydrogen peroxide nor 
EGF induced further autophosphorylation of the PKCζ Y417F. The absence of catalytic activity 
was accompanied with only a slight decrease in the tyrosine phosphorylation induced by both 
stimuli (Figure 3.21 and 3.22). Thus, tyrosine 417 of PKCζ is triggered by hydrogen peroxide-
dependent phosphorylation similarly to the corresponding tyrosine 512 of PKCδ. PKCδ Y512F 
showed attenuated activation in response to hydrogen peroxide but the same properties as the 
wild type enzyme upon in vitro phosphorylation by Lck (Konishi et al., 1997, 2001). Our results 
confirm the role of the respective tyrosine 417 of PKCζ in hydrogen peroxide-induced activation. 
Our results provide first evidence that tyrosine 417 of PKCζ is involved in EGFR-mediated 
activation. Moreover, a direct comparison of PKCζ Y417F and PKCζ T410A revealed that both 
threonine phosphorylation at the activation loop and tyrosine phosphorylation in its vicinity are 
required for PKCζ activity in response to EGFR. T410A mutant has intact tyrosine-417 and 
respectively Y417F mutant has intact threonine 410, but neither threonine-410 phosphorylation 
nor tyrosine-417 phosphorylation alone is sufficient for the catalytic activation. This observation 
suggests that similarly to the MAPK activation, EGF-induced PKCζ activation involves both 
threonine and tyrosine phosphorylation.  
Many PKC functions in various cellular processes are influenced by its tyrosine 
phosphorylation. Tyrosine phosphorylation can affect protein functions either by change in the 
enzyme activity, or via creating new binding sites for proteins containing phospho-tyrosine 
binding domains. Phosphorylation of PKCα and βI upon FcεRI activation on tyrosines 
neighboring serine residues at the turn motif creates docking sites for Grb2 and contributes to 
the activation of Ras/ERK cascade (Kawakami et al., 2003). Role of PKCθ tyrosine 
phosphorylation during T cell (Liu et al., 2001) and platelets (Crosby and Poole, 2002) 
activation has been proposed as well as importance of PKCδ tyrosine phosphorylation in mast 
cells degranulation (Haleem-Smith et al., 1995) and for the process of GPCR agonists-induced 
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fluid secretion from the salivary gland (Soltoff et al., 1995). PKC tyrosine phosphorylation can 
contribute to apoptosis induction. Phosphorylation of tyrosines in the hinge region surrounding 
caspase-cleavage site of PKCδ might contribute to oxidative stress-induced apoptosis (Konishi 
et al., 1999) and phosphorylation at tyrosine 311 is shown to promote PKCδ degradation (Blake 
et al., 1999). Tyrosine phosphorylation and activation of PKCδ by UV in HaCaT human 
keratinocytes is implicated in induction of apoptosis (Fukunaga et al., 2001). Etoposide-induced 
apoptosis depends on tyrosine phosphorylation-dependent PKCδ cleavage by caspases (Blass et 
al., 2002). Tyrosine phosphorylation of PKC is related to the differentiation of many cell types 
as well. Positive influence of tyrosine phosphorylated PKCλ/ι in NGF-induced neurite 
differentiation (Wooten et al., 2001) and of PKCδ in TPA induced monocytic differentiation of 
32D hematopietic cells (Li et al., 1994) has been demonstrated. PKCδ is critically involved in 
the process of Ca2+-induced keratinocyte differentiation  (Denning et al., 2000). Its inactivation 
via EGFR-mediated tyrosine phosphorylation serves to turn off the differentiation program at 
last stages of normal differentiation process and to block differentiation program during 
neoplastic transformation. Tyrosine phosphorylation of PKCδ on tyrosine 155 upon PE 
stimulation of NIH3T3 plays a role in the control of the growth rate and of density at 
confluency, with tumorigenic properties of Y155F mutant (Acs et al., 2000). Similarly, 
phosphorylation of PKCδ on tyrosine 155 by PE in C6 glioma cells is critical for inhibition of 
proliferation. In contrast phosphorylation of tyrosine-187 in reponse to PMA has different 
outcome concerning the differentiation in different cellular context- inducing monocytic 
differentition or inhibition of differentiation of glioma cells. Kronfeld I. et al, 2000 proposed 
that tyrosine phosphorylation of PKC on different tyrosine residues might represent a point of 
divergence in its functions. It has been demonstrated in C6 glioma cells that phosphorylation of 
different tyrosines mediate different functions of PKCδ with Y155 mediating PKCδ inhibitory 
effect on cell proliferation whereas Y187 mediates PKCδ inhibitory effect on GS astrocyte 
differentiation marker expression.  
MEK5 represents one known target of PKCζ during EGF mitogenic signalling, whose 
activation is independent on PKCζ enzymatic activity (Diaz-Meco and Moscat 2001). We found 
that expression of wild type PKCζ leads to increased EGF-induced ERK/MAPK activity, 
indicating that PKCζ is involved in ERK/MAPK cascade activated downstream of EGFR 
(Figure 3.23). The role of PKCζ in ERK/MAPK cascade has been demonstrated in many cell 
systems (see Intoduction).  PKCζ function as MEK1 kinase in this signalling pathway has been 
suggested. Indeed PKCζ associates with MEK1, but it is still unclear whether PKCζ 
phosphorylates MEK1 directly (Monick et al., 2000). Our results reveal that the catalytic 
activation of PKCζ upon EGFR stimulation is of importance for ERK/MAPK pathway. In 
response to stimulation with low ligand concentration (0.1nM EGF) there was a significant 
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increase in MAPK activity in cells expressing PKCζ WT. This effect on MAPK activity was 
lost when instead of wild type either PKCζ Y417F or PKCζ T410A were transfected.  
Another EGFR activation-triggered signalling pathway in which PKCζ could take part involves 
pro-survival Akt/PKB.  Both PKCζ and Akt/PKB are activated downstream of PI3K activation 
in response to EGFR stimulation via PDK1-dependent phosphorylation. PKCζ is known as an 
adaptor for PKBγ/AKT3 phosphorylation by PDK2 (Hodgkinson et al., 2002). Interaction of 
PKCζ and PKBα/AKT1 has been reported in EGFR-overexpressing human breast carcinoma 
cell line and PKCζ-dependent decrease in Akt phosphorylation/activity was observed (Mao et 
al., 2000). There are no reports for PKCζ-mediated Akt1/PKBα phosphorylation. In our 
experiments EGF stimulation in COS-7 induced transient Akt activation as indicated by 
phosphorylation of serine-473. In cells expressing PKCζ EGF-dependent Akt activation was not 
significantly affected, whereas in cells co-transfected with PKCζ along with EGFR Akt 
activation upon EGF stimulation was reduced. Akt activation might involve PKCζ kinase 
activity and/or tyrosine phosphorylation, since in cells co-transfected with PKCζ Y417F along 
with EGFR, the increase in Akt phosphorylation in response to 0.1nM EGF was diminished 
(Figure 3.24). The reduction in EGF-induced Akt activation upon co-expression of PKCζ and 
EGFR might have another mechanism, not related to PKCζ activation by tyrosine 
phosphorylation.  
The transcription factor nuclear factor-κB (NF- κB) is activated by a diverse number of stimuli 
including TNFα, IL-1, UV irradiation, viruses, as well as receptor-tyrosine kinases such as 
EGFR. Downstream of TNFR, IL-1R or NGFR PKCζ functions as IκB kinase (IKK) (Hirai and 
Chida, 2003). Activated by PKCζ-dependent phosphorylation IKK phosphorylates IκB, 
targeting it for ubiquitination and proteasome degradation and thereby NF-κB is released from 
cytoplasmic sequestration, translocates to the nucleus and activates gene expression. Recently, 
it has been found that PKCζ may contribute to NF-κB activation directly by phosphorylation of 
Ser311 of RelA (Duran et al., 2003). EGFR has been shown to activate NF-κB slowly in aortic 
smooth muscle cells, more robust in A431 cell, transiently in mouse embryo fibroblasts (Sun 
and Carpenter, 1998) and in several EGFR-overexpressing breast cancer cell lines. Downstream 
of growth factors stimulation MAPK/ERK cascade via NAK activation as well as SAPK/JNK 
cascade induces phosphorylation and activation of IKK. PKCζ could represent another EGFR 
target that act as IKK kinase. A novel EGFR multiprotein complex termed signalosome has 
been identified to involve RIP and NF-κB-inducing kinase (NIK), which mediates NF- κB 
induction via I-κBα phosphorylation on serines 32 and 36 (Habib et al., 2001). Moreover, high 
level of EGFR overexpression, a frequent occurrence in human tumors, is optimal for EGFR-
induced NF- κB activation. There are controversial data about the role of PKCζ in NF-κB 
activation downstream of EGFR. Banan A. et al, 2003 have reported that epidermal growth 
Discussion  78 
factor protects intestinal Caco-2 cells from oxidant-induced NF-κB activation by PKCζ 
activation via enhanced stability of I-κBα due to reduced phosphorylation. These observations 
provoked us to analyse PKCζ function in I-κBα phosphorylation downstream of EGFR. EGF-
stimulation in COS-7 cells led to increased phosphorylation of I-κBα, indicative for NF- κB 
activation. PKCζ as well as EGFR overexpression caused increased I-κBα phosphorylation. In 
cells expressing PKCζ Y417F mutant I-κBα phosphorylation was clearly reduced (Figure 3.24). 
This finding supports the suggestion that the catalytic activity of PKCζ is implicated in I-κBα 
phosphorylation and thereby in NF- κB activation downstream of EGFR. Similarly to the Akt 
activation I-κBα phosphorylation was diminished upon stimulation with high EGF 
concentration in cells co-transected with PKCζ along with EGFR. This could be some 
preventive cross-talk mechanism, which avoid increased Akt and NF- κB activation. 
The influence of PKCζ Y417F mutant on EGFR-activated ERK/MAPK, PKB/Akt and NF- κB 
pathways reveals involvement of PKCζ catalytic activity and/or tyrosine phosphorylation and that 
EGFR-mediated PKCζ phosphorylation on tyrosine 417 is necessary for PKCζ function 
downstream of EGFR.  
There are contradictory results concerning the pro-apoptotic, as well as pro-survival role of PKCζ 
(see introduction). We found that neither PKCζ nor EGFR expression cause PARP cleavage in 
unstimulated cells as well as upon EGF stimulation. Moreover, PKCζ catalytic activation and 
tyrosine phosphorylation are implicated in the EGFR-activated signalling cascades with 
proliferatve and pro-survival functions. Therefore we assessed the effect of PKCζ on cell 
proliferation. [3H]-thymidine incorporation assay demonstrated that cells overexpressing wild 
type PKCζ have increased basal proliferation level, which is not further increased upon EGF 
stimulation. Similarly, Le Good et al., 2004 have identified enhanced proliferation of Rat2 
fibroblasts over-expressing wild type PKCζ. Moreover, expressed PKCζ activity was paralleled 
by cell transformation. In contrast, Montaner et al., 1995 have shown that PKCζ does not induce 
cell transformation in fibroblasts. Very recently, a role of PKCζ in cancer cell metastasis via 
modulation of actin cytoskeleton structure has been suggested. PKCζ has been identified as an 
essential component of the EGF-stimulated chemotaxis in human breast cancer cells (Sun et al., 
2005). PKCζ is implicated in estradiol-triggered G1/S progression of MCF-7 cells (Castoria et 
al., 2004). Activated in PI3K-dependent manner PKCζ recruits Ras to a multimolecular complex 
that consists of estrogen receptor, src, PI3K and facilitates Src-dependent Ras activation. We 
obtained evidence that proliferative, pro-survival function of PKCζ requires its catalytic activity 
and/or tyrosine phosphorylation since upon transfection of PKCζ Y417F mutant no increase in 
the basal rate of DNA synthesis was observed and EGF-stimulated DNA synthesis was also 
clearly diminished (Figure 3.25).  
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PKC isoforms involvement in GPCR signaling toward ERK/MAPK activation might occur at 
many levels: in GPCR-mediated ERK/MAPK activation independent of RTK transactivation, in 
GPCR-induced transactivation of EGFR and in downstream signalling of transactivated EGFR 
as well. For example, recently Buteau et al., 2003 have demonstrated the involvement of PKCζ 
in glucagon-like peptide-induced pancreatic beta-cell proliferation downstream of EGFR 
transactivation. On the other hand, tyrosine phosphorylation of PKCδ upon GPCR stimulation 
has been already demonstrated in acinar cells in response to carbachol and substance P (Soltoff 
et al., 1995; Wrenn, 2001) and upon cholecystokinin (CCK) stimulation (Tapia et al., 2002). 
We identified that tyrosine phosphorylation of PKCζ occurs upon stimulation of two 
endogenously expressed GPCRs in COS-7 cells - lysophosphatidic acid receptor and β2-
adrenergic receptor with LPA and isoproterenol respectively (Figure 3.26).  Lysophosphatidic 
acid (LPA) is a mitogenic phospholipid messenger that binds to GPCR family receptor and 
mediates Gi-dependent inhibition of adenylyl cyclase (AC). Involvement of PKCζ activation in 
LPA signalling has been already reported to mediate increase in type II AC activity in 
macrophages (Lin et al., 1999), mitogenesis in vascular smooth muscle cells (Seewald et al., 
1999) and Ras and Raf-independent MAPK activation in CHO cells that overexpress a 
dominant-negative mutant of Sos (Takeda et al., 1999). Dual pathway of LPA-induced 
stimulation of ERK/MAPK was described- via EGFR transactivation and via PI3-K (Daub et 
al., 1997). LPA induced transactivation of EGFR is mediated via HB-EGF release (Prenzel et 
al., 1999). Beta2-adrenergic receptor-mediated ERK/MAPK activation involves EGFR 
transactivation via assembly of a multi-receptor complex with the EGFR (Maudsley et al., 
2000), but is independent of HB-EGF release.  
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Figure 4.1. Model depicting 
tyrosine phosphorylation of 
PKCζ downstream of ligand-
activated and transactivated 
EGFR. Shown is the critical 
involvement of c-Src and Src-
phosphorylation site of EGFR and 
the requirement for PIP3 at the 
plasma membrane for initial 
recruitement of PKCζ to the 
membrane compartment 
.
We observed that in COS-7 cells both LPA and Iso induce Erk1/2 activation (Figure 3.26). 
Moreover both stimuli mediate EGFR transactivation as demontsrated by LPA and Iso-induced 
tyrosine phosphorylation of EGFR (Figure 3.27). Iso-induced tyrosine phosphorylation of PKCζ 
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was sensitive to pretreatment with AG1478, which represents evidence that Iso mediates 
tyrosine phosphorylation of PKCζ via EGFR transactivation. Both GPCR ligands not only 
mediate PKCζ tyrosine phosphorylation but also caused increased physical association of EGFR 
with PKCζ as detected by co-immunoprecipitation. Furthermore, we observed that PKCζ 
tyrosine-417 is the major phosphorylation site triggered by transactivated EGFR whereas it is 
one of the phosphorylated tyrosines downstream of ligand-activated EGFR (Figure 3.27). We 
found PKCζ activation upon LPA or Iso stimulation. Moreover, the activation involves 
tyrosine-417 phosphorylation since both LPA and Iso cannot activate PKCζ Y417F mutant 
(Figure 3.28). These results indicate that GPCRs also mediate tyrosine phosphorylation and 
activation of PKCζ via their transactivation pathways. This cannot rule out in general the 
potential contribution of other GPCR-activated pathways independent on EGFR transactivation 
to the tyrosine phosphorylation and activation of PKCζ.  
In the cellular signalling network signal convergence at the level of EGFR (ligand-activated as 
well as transactivated via GPCRs) involves PKCζ activation and tyrosine phosphorylation at the 
EGFR signalling module (Figure 4.1.). PKCζ is recruited to the plasma membrane upon EGFR 
stimulation partly via PIP3 generation and there physically associates with EGFR in 
dependence on Src-phosphorylation site on EGFR- tyrosine-845. Critical role of Src in PKCζ 
tyrosine phosphorylation suggests that PKCζ might represent another target of the synergism 
between EGFR and Src implicated in the control of cell proliferation.  
 
 
 
Figure 4.2. Activation of PKCζ downstream 
of EGFR.  Shown is the involvement of both  
PDK-1 mediated threonine phosphorylation at  
the activation loop and tyrosine phosphorylation 
in its vicinity dependent on EGFR and Src  
kinase activities as well as on EGFR  
phospho-tyrosine 845.    
 
 
 
 
 
Interestingly, PKCζ activation downstream of EGFR involves both PI3K/PDK1 mediated 
phosphorylation of threonine 410 in the activation loop as well as phosphorylation of the 
tyrosine 417 in the activation loop vicinity dependent on EGFR, Src and Src-phosphorylation 
site on EGFR (Figure 4.2.). This represents a novel paradigm for the mechanism of PKCζ 
activation. 
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AC  adenylate cyclase 
AKAP  A-kinase-anchoring protein 
AL  activation loop  
aPKC  atypical PKC 
ATP  adenosine-triphosphate 
β2AR  beta 2-adrenergic receptor 
BMK1  big MAP kinase  
Btk  Bruton’s tyrosine kinase 
CaMK  calcium/calmodulin-activated protein kinase   
CD  catalytic domain 
cPKC  clasical PKC       
CRIB  Cdc42- and Rac-interacting binding 
DAG  1,2- diacylglycerol 
DEAE  diethylaminoethyl   
ECFP  enhanced cyan fluorescent protein 
ECL  enhanced chemiluminescence 
EGF  epidermal growth factor receptor 
EGF(R) epidermal growth factor (receptor) 
ERK  extracellular signal-regulated kinase 
EYFP  enhanced yellow fluorescent protein 
FKHR1  Forkhead transcription factor1   
Gab  Grb-associated binder 
GPCR(s) G protein-coupled receptor(s) 
Grb2  growth-factor-receptor-bound protein 2 
GSK-3  glycogen synthase kinase-3 
HB-EGF heparin-binding epidermal growth factor  
HM  hydrophobic motif 
IFN  interferon 
IgG  immunoglobulin 
IKK  inhibitor of κB kinase 
IL  interleukin 
Ins(1,4,5)P3 inositol-(1,4,5)- triphosphate 
IP  immunoprecipitation 
IR  insulin receptor 
Iso  isoproterenol 
IκBα  inhibitor of κB 
JNK  c-jun N-terminal kinase 
LIP  lambda-interacting protein 
LPA(R) lysophosphatidic acid (receptor) 
MAPK  mitogen-activated protein kinase        
MARCKS myristoylated alanine-rich C kinase substrate 
MBP  myelin basic protein 
MEK  mitogen-activated protein kinase kinase 
mTOR  mammalian target of rapamycin 
NAK  NF-κB-activating kinase 
NF-κB  nuclear factor-kappa B  
NGF(R) nerve growth factor (receptor) 
NIK  NF-κB-inducing kinase 
nPKC  novel PKC 
PAR-3/ASIP partitioning defective gene-3 product/aPKC-specific interacting protein 
Par-4  prostate apoptosis response-4  
   
PAR-6  partitioning defective gene-6 product 
PB1  (Phox and Bem1p) domain 
PBS  phosphate-buffered saline 
PDGFR platelet-derived growth factor receptor 
PDK1  phosphoinositide-dependent kinase 1 
PE  phorbol ester 
PH  plecstrin homology 
Pi-Thr/Tyr/Ser  phospho-Thr/Tyr/Ser 
PI3K  phosphoinositide-3-kinase 
PIP3  phosphatidylinositole-(3,4,5)-triphosphate 
PKA  protein kinase A 
PKB  protein kinase B 
PKB  protein kinase B    
PKC  protein kinase C 
PLA2  phospholipase A2 
PLCβ/γ  phospholipase C β/γ 
PLD  phospholilase D 
PMA  phorbol 12-myristate 13-acetate 
PRK  protein kinase C-related kinase 
PS  pseudosubstrate 
PTB  phosphotyrosine-binding domain  
PtdIns(3,4)P2 phosphatidylinositol-(3,4)- biphosphate 
PtdIns(3,4,5)P3 phosphatidylinositole-(3,4,5)-triphosphate 
PtdIns(4,5)P2  phosphatidylinositol-(4,5)-biphosphate 
PtdSer  phosphatidylserine 
PTEN  phosphatase and tensin homologue 
PTP(s)  protein tyrosine phosphatase (s)   
PY  phosphotyrosine 
Pyk-2  calcium-dependent tyrosine kinase 2 
RACKs  receptors for activated C kinase 
RIP  receptor-interacting protein 
ROS  reactive oxigen species 
RTK(s)  receptor tyrosine kinase(s) 
SAPK  stress-activated protein kinase 
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SH2  Src homology 2 
SH3  Src homology 3  
Shc  Src homology and collagen protein 
Sos  son-of-sevenless 
STAT  signal transducers and activators of transcription 
STICKs substartes that interact with C kinase   
TBS  Tris-buffered saline 
TCR  T cell receptor 
TGFα  transforming growth factor alpha 
TM  turn motif 
TNF(R) tumor necrosis factor receptor 
WT  wild type 
WB  Western blot 
ZIP  zeta-interacting protein 
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